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The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution.
Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human
genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.
The rediscovery of Mendel's laws of heredity in the opening weeks of
the 20th century1±3 sparked a scienti®c quest to understand the
nature and content of genetic information that has propelled
biology for the last hundred years. The scienti®c progress made
falls naturally into four main phases, corresponding roughly to the
four quarters of the century. The ®rst established the cellular basis of
heredity: the chromosomes. The second de®ned the molecular basis
of heredity: the DNA double helix. The third unlocked the informa-
tional basis of heredity, with the discovery of the biological mechan-
ism by which cells read the information contained in genes and with
the invention of the recombinant DNA technologies of cloning and
sequencing by which scientists can do the same.
The last quarter of a century has been marked by a relentless drive
to decipher ®rst genes and then entire genomes, spawning the ®eld
of genomics. The fruits of this work already include the genome
sequences of 599 viruses and viroids, 205 naturally occurring
plasmids, 185 organelles, 31 eubacteria, seven archaea, one
fungus, two animals and one plant.
Here we report the results of a collaboration involving 20 groups
from the United States, the United Kingdom, Japan, France,
Germany and China to produce a draft sequence of the human
genome. The draft genome sequence was generated from a physical
map covering more than 96% of the euchromatic part of the human
genome and, together with additional sequence in public databases,
it covers about 94% of the human genome. The sequence was
produced over a relatively short period, with coverage rising from
about 10% to more than 90% over roughly ®fteen months. The
sequence data have been made available without restriction and
updated daily throughout the project. The task ahead is to produce a
®nished sequence, by closing all gaps and resolving all ambiguities.
Already about one billion bases are in ®nal form and the task of
bringing the vast majority of the sequence to this standard is now
straightforward and should proceed rapidly.
The sequence of the human genome is of interest in several
respects. It is the largest genome to be extensively sequenced so far,
being 25 times as large as any previously sequenced genome and
eight times as large as the sum of all such genomes. It is the ®rst
vertebrate genome to be extensively sequenced. And, uniquely, it is
the genome of our own species.
Much work remains to be done to produce a complete ®nished
sequence, but the vast trove of information that has become
available through this collaborative effort allows a global perspective
on the human genome. Although the details will change as the
sequence is ®nished, many points are already clear.
X The genomic landscape shows marked variation in the distribu-
tion of a number of features, including genes, transposable
elements, GC content, CpG islands and recombination rate. This
gives us important clues about function. For example, the devel-
opmentally important HOX gene clusters are the most repeat-poor
regions of the human genome, probably re¯ecting the very complex
coordinate regulation of the genes in the clusters.
XThere appear to be about 30,000±40,000 protein-coding genes in
the human genomeÐonly about twice as many as in worm or ¯y.
However, the genes are more complex, with more alternative
splicing generating a larger number of protein products.
XThe full set of proteins (the `proteome') encoded by the human
genome is more complex than those of invertebrates. This is due in
part to the presence of vertebrate-speci®c protein domains and
motifs (an estimated 7% of the total), but more to the fact that
vertebrates appear to have arranged pre-existing components into a
richer collection of domain architectures.
XHundreds of human genes appear likely to have resulted from
horizontal transfer from bacteria at some point in the vertebrate
lineage. Dozens of genes appear to have been derived from trans-
posable elements.
XAlthough about half of the human genome derives from trans-
posable elements, there has been a marked decline in the overall
activity of such elements in the hominid lineage. DNA transposons
appear to have become completely inactive and long-terminal
repeat (LTR) retroposons may also have done so.
XThe pericentromeric and subtelomeric regions of chromosomes
are ®lled with large recent segmental duplications of sequence from
elsewhere in the genome. Segmental duplication is much more
frequent in humans than in yeast, ¯y or worm.
XAnalysis of the organization of Alu elements explains the long-
standing mystery of their surprising genomic distribution, and
suggests that there may be strong selection in favour of preferential
retention of Alu elements in GC-rich regions and that these `sel®sh'
elements may bene®t their human hosts.
XThe mutation rate is about twice as high in male as in female
meiosis, showing that most mutation occurs in males.
XCytogenetic analysis of the sequenced clones con®rms sugges-
tions that large GC-poor regions are strongly correlated with `dark
G-bands' in karyotypes.
XRecombination rates tend to be much higher in distal regions
(around 20 megabases (Mb)) of chromosomes and on shorter
chromosome arms in general, in a pattern that promotes the
occurrence of at least one crossover per chromosome arm in each
meiosis.
XMore than 1.4 million single nucleotide polymorphisms (SNPs)
in the human genome have been identi®ed. This collection should
allow the initiation of genome-wide linkage disequilibrium
mapping of the genes in the human population.
In this paper, we start by presenting background information on
the project and describing the generation, assembly and evaluation
of the draft genome sequence. We then focus on an initial analysis of
the sequence itself: the broad chromosomal landscape; the repeat
elements and the rich palaeontological record of evolutionary and
biological processes that they provide; the human genes and
proteins and their differences and similarities with those of other
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organisms; and the history of genomic segments. (Comparisons
are drawn throughout with the genomes of the budding yeast
Saccharomyces cerevisiae, the nematode worm Caenorhabditis
elegans, the fruit¯y Drosophila melanogaster and the mustard weed
Arabidopsis thaliana; we refer to these for convenience simply as
yeast, worm, ¯y and mustard weed.) Finally, we discuss applications
of the sequence to biology and medicine and describe next steps in
the project. A full description of the methods is provided as
Supplementary Information on Nature's web site (http://www.
nature.com).
We recognize that it is impossible to provide a comprehensive
analysis of this vast dataset, and thus our goal is to illustrate the
range of insights that can be gleaned from the human genome and
thereby to sketch a research agenda for the future.
Background to the Human Genome Project
The Human Genome Project arose from two key insights that
emerged in the early 1980s: that the ability to take global views of
genomes could greatly accelerate biomedical research, by allowing
researchers to attack problems in a comprehensive and unbiased
fashion; and that the creation of such global views would require a
communal effort in infrastructure building, unlike anything pre-
viously attempted in biomedical research. Several key projects
helped to crystallize these insights, including:
(1) The sequencing of the bacterial viruses FX1744,5 and lambda6, the
animal virus SV407 and the human mitochondrion8 between 1977
and 1982. These projects proved the feasibility of assembling small
sequence fragments into complete genomes, and showed the value
of complete catalogues of genes and other functional elements.
(2) The programme to create a human genetic map to make it
possible to locate disease genes of unknown function based solely on
their inheritance patterns, launched by Botstein and colleagues in
1980 (ref. 9).
(3) The programmes to create physical maps of clones covering the
yeast10 and worm11 genomes to allow isolation of genes and regions
based solely on their chromosomal position, launched by Olson and
Sulston in the mid-1980s.
(4) The development of random shotgun sequencing of comple-
mentary DNA fragments for high-throughput gene discovery by
Schimmel12 and Schimmel and Sutcliffe13, later dubbed expressed
sequence tags (ESTs) and pursued with automated sequencing by
Venter and others14±20.
The idea of sequencing the entire human genome was ®rst
proposed in discussions at scienti®c meetings organized by the
US Department of Energy and others from 1984 to 1986 (refs 21,
22). A committee appointed by the US National Research Council
endorsed the concept in its 1988 report23, but recommended a
broader programme, to include: the creation of genetic, physical
and sequence maps of the human genome; parallel efforts in key
model organisms such as bacteria, yeast, worms, ¯ies and mice; the
development of technology in support of these objectives; and
research into the ethical, legal and social issues raised by human
genome research. The programme was launched in the US as a joint
effort of the Department of Energy and the National Institutes of
Health. In other countries, the UK Medical Research Council and
the Wellcome Trust supported genomic research in Britain; the
Centre d'Etude du Polymorphisme Humain and the French Mus-
cular Dystrophy Association launched mapping efforts in France;
government agencies, including the Science and Technology Agency
and the Ministry of Education, Science, Sports and Culture sup-
ported genomic research efforts in Japan; and the European Com-
munity helped to launch several international efforts, notably the
programme to sequence the yeast genome. By late 1990, the Human
Genome Project had been launched, with the creation of genome
centres in these countries. Additional participants subsequently
joined the effort, notably in Germany and China. In addition, the
Human Genome Organization (HUGO) was founded to provide a
forum for international coordination of genomic research. Several
books24±26 provide a more comprehensive discussion of the genesis
of the Human Genome Project.
Through 1995, work progressed rapidly on two fronts (Fig. 1).
The ®rst was construction of genetic and physical maps of the
human and mouse genomes27±31, providing key tools for identi®ca-
tion of disease genes and anchoring points for genomic sequence.
The second was sequencing of the yeast32 and worm33 genomes, as
articles
862 NATURE | VOL 409 | 15 FEBRUARY 2001 | www.nature.com
1984 1990 1991 1992 1993 1994 1995 1996 1997 1998 2000 20011999
Bacterial genome sequencing













































Figure 1 Timeline of large-scale genomic analyses. Shown are selected components of
work on several non-vertebrate model organisms (red), the mouse (blue) and the human
(green) from 1990; earlier projects are described in the text. SNPs, single nucleotide
polymorphisms; ESTs, expressed sequence tags.
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well as targeted regions of mammalian genomes34±37. These projects
showed that large-scale sequencing was feasible and developed the
two-phase paradigm for genome sequencing. In the ®rst, `shotgun',
phase, the genome is divided into appropriately sized segments and
each segment is covered to a high degree of redundancy (typically,
eight- to tenfold) through the sequencing of randomly selected
subfragments. The second is a `®nishing' phase, in which sequence
gaps are closed and remaining ambiguities are resolved through
directed analysis. The results also showed that complete genomic
sequence provided information about genes, regulatory regions and
chromosome structure that was not readily obtainable from cDNA
studies alone.
In 1995, genome scientists considered a proposal38 that would
have involved producing a draft genome sequence of the human
genome in a ®rst phase and then returning to ®nish the sequence in
a second phase. After vigorous debate, it was decided that such a
plan was premature for several reasons. These included the need ®rst
to prove that high-quality, long-range ®nished sequence could be
produced from most parts of the complex, repeat-rich human
genome; the sense that many aspects of the sequencing process
were still rapidly evolving; and the desirability of further decreasing
costs.
Instead, pilot projects were launched to demonstrate the feasi-
bility of cost-effective, large-scale sequencing, with a target comple-
tion date of March 1999. The projects successfully produced
®nished sequence with 99.99% accuracy and no gaps39. They also
introduced bacterial arti®cial chromosomes (BACs)40, a new large-
insert cloning system that proved to be more stable than the cosmids
and yeast arti®cial chromosomes (YACs)41 that had been used
previously. The pilot projects drove the maturation and conver-
gence of sequencing strategies, while producing 15% of the human
genome sequence. With successful completion of this phase, the
human genome sequencing effort moved into full-scale production
in March 1999.
The idea of ®rst producing a draft genome sequence was revived
at this time, both because the ability to ®nish such a sequence was no
longer in doubt and because there was great hunger in the scienti®c
community for human sequence data. In addition, some scientists
favoured prioritizing the production of a draft genome sequence
over regional ®nished sequence because of concerns about com-
mercial plans to generate proprietary databases of human sequence
that might be subject to undesirable restrictions on use42±44.
The consortium focused on an initial goal of producing, in a ®rst
production phase lasting until June 2000, a draft genome sequence
covering most of the genome. Such a draft genome sequence,
although not completely ®nished, would rapidly allow investigators
to begin to extract most of the information in the human sequence.
Experiments showed that sequencing clones covering about 90% of
the human genome to a redundancy of about four- to ®vefold (`half-
shotgun' coverage; see Box 1) would accomplish this45,46. The draft
genome sequence goal has been achieved, as described below.
The second sequence production phase is now under way. Its
aims are to achieve full-shotgun coverage of the existing clones
during 2001, to obtain clones to ®ll the remaining gaps in the
physical map, and to produce a ®nished sequence (apart from
regions that cannot be cloned or sequenced with currently available
techniques) no later than 2003.
Strategic issues
Hierarchical shotgun sequencing
Soon after the invention of DNA sequencing methods47,48, the
shotgun sequencing strategy was introduced49±51; it has remained
the fundamental method for large-scale genome sequencing52±54 for
the past 20 years. The approach has been re®ned and extended to
make it more ef®cient. For example, improved protocols for
fragmenting and cloning DNA allowed construction of shotgun
libraries with more uniform representation. The practice of sequen-
cing from both ends of double-stranded clones (`double-barrelled'
shotgun sequencing) was introduced by Ansorge and others37 in
1990, allowing the use of `linking information' between sequence
fragments.
The application of shotgun sequencing was also extended by
applying it to larger and larger DNA moleculesÐfrom plasmids
(, 4 kilobases (kb)) to cosmid clones37 (40 kb), to arti®cial chro-
mosomes cloned in bacteria and yeast55 (100±500 kb) and bacterial
genomes56 (1±2 megabases (Mb)). In principle, a genome of arbi-
trary size may be directly sequenced by the shotgun method,
provided that it contains no repeated sequence and can be uni-
formly sampled at random. The genome can then be assembled
using the simple computer science technique of `hashing' (in which
one detects overlaps by consulting an alphabetized look-up table of
all k-letter words in the data). Mathematical analysis of the
expected number of gaps as a function of coverage is similarly
straightforward57.
Practical dif®culties arise because of repeated sequences and
cloning bias. Small amounts of repeated sequence pose little
problem for shotgun sequencing. For example, one can readily
assemble typical bacterial genomes (about 1.5% repeat) or the
euchromatic portion of the ¯y genome (about 3% repeat). By
contrast, the human genome is ®lled (. 50%) with repeated
sequences, including interspersed repeats derived from transposable
elements, and long genomic regions that have been duplicated in
tandem, palindromic or dispersed fashion (see below). These
include large duplicated segments (50±500 kb) with high sequence
identity (98±99.9%), at which mispairing during recombination
creates deletions responsible for genetic syndromes. Such features
complicate the assembly of a correct and ®nished genome sequence.
There are two approaches for sequencing large repeat-rich
genomes. The ®rst is a whole-genome shotgun sequencing
approach, as has been used for the repeat-poor genomes of viruses,
bacteria and ¯ies, using linking information and computational
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Figure 2 Idealized representation of the hierarchical shotgun sequencing strategy. A
library is constructed by fragmenting the target genome and cloning it into a large-
fragment cloning vector; here, BAC vectors are shown. The genomic DNA fragments
represented in the library are then organized into a physical map and individual BAC
clones are selected and sequenced by the random shotgun strategy. Finally, the clone
sequences are assembled to reconstruct the sequence of the genome.
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analysis to attempt to avoid misassemblies. The second is the
`hierarchical shotgun sequencing' approach (Fig. 2), also referred
to as `map-based', `BAC-based' or `clone-by-clone'. This approach
involves generating and organizing a set of large-insert clones
(typically 100±200 kb each) covering the genome and separately
performing shotgun sequencing on appropriately chosen clones.
Because the sequence information is local, the issue of long-range
misassembly is eliminated and the risk of short-range misassembly
is reduced. One caveat is that some large-insert clones may suffer
rearrangement, although this risk can be reduced by appropriate
quality-control measures involving clone ®ngerprints (see below).
The two methods are likely to entail similar costs for producing
®nished sequence of a mammalian genome. The hierarchical
approach has a higher initial cost than the whole-genome approach,
owing to the need to create a map of clones (about 1% of the total
cost of sequencing) and to sequence overlaps between clones. On
the other hand, the whole-genome approach is likely to require
much greater work and expense in the ®nal stage of producing a
®nished sequence, because of the challenge of resolving misassem-
blies. Both methods must also deal with cloning biases, resulting in
under-representation of some regions in either large-insert or
small-insert clone libraries.
There was lively scienti®c debate over whether the human
genome sequencing effort should employ whole-genome or hier-
archical shotgun sequencing. Weber and Myers58 stimulated these
discussions with a speci®c proposal for a whole-genome shotgun
approach, together with an analysis suggesting that the method
could work and be more ef®cient. Green59 challenged these conclu-
sions and argued that the potential bene®ts did not outweigh the
likely risks.
In the end, we concluded that the human genome sequencing
effort should employ the hierarchical approach for several reasons.
First, it was prudent to use the approach for the ®rst project to
sequence a repeat-rich genome. With the hierarchical approach, the
ultimate frequency of misassembly in the ®nished product would
probably be lower than with the whole-genome approach, in which
it would be more dif®cult to identify regions in which the assembly
was incorrect.
Second, it was prudent to use the approach in dealing with an
outbred organism, such as the human. In the whole-genome shot-
gun method, sequence would necessarily come from two different
copies of the human genome. Accurate sequence assembly could be
complicated by sequence variation between these two copiesÐboth
SNPs (which occur at a rate of 1 per 1,300 bases) and larger-scale
structural heterozygosity (which has been documented in human
chromosomes). In the hierarchical shotgun method, each large-
insert clone is derived from a single haplotype.
Third, the hierarchical method would be better able to deal with
inevitable cloning biases, because it would more readily allow
targeting of additional sequencing to under-represented regions.
And fourth, it was better suited to a project shared among members
of a diverse international consortium, because it allowed work and
responsibility to be easily distributed. As the ultimate goal has
always been to create a high-quality, ®nished sequence to serve as a
foundation for biomedical research, we reasoned that the advan-
tages of this more conservative approach outweighed the additional
cost, if any.
A biotechnology company, Celera Genomics, has chosen to
incorporate the whole-genome shotgun approach into its own
efforts to sequence the human genome. Their plan60,61 uses a
mixed strategy, involving combining some coverage with whole-
genome shotgun data generated by the company together with the
publicly available hierarchical shotgun data generated by the Inter-
national Human Genome Sequencing Consortium. If the raw
sequence reads from the whole-genome shotgun component are
made available, it may be possible to evaluate the extent to which the
sequence of the human genome can be assembled without the need
for clone-based information. Such analysis may help to re®ne
sequencing strategies for other large genomes.
Technology for large-scale sequencing
Sequencing the human genome depended on many technological
improvements in the production and analysis of sequence data. Key
innovations were developed both within and outside the Human
Genome Project. Laboratory innovations included four-colour
¯uorescence-based sequence detection62, improved ¯uorescent
dyes63±66, dye-labelled terminators67, polymerases speci®cally
designed for sequencing68±70, cycle sequencing71 and capillary gel
electrophoresis72±74. These studies contributed to substantial
improvements in the automation, quality and throughput of
collecting raw DNA sequence75,76. There were also important
advances in the development of software packages for the analysis
of sequence data. The PHRED software package77,78 introduced the
concept of assigning a `base-quality score' to each base, on the basis
of the probability of an erroneous call. These quality scores make it
possible to monitor raw data quality and also assist in determining
whether two similar sequences truly overlap. The PHRAP computer
package (http://bozeman.mbt.washington.edu/phrap.docs/phrap.
html) then systematically assembles the sequence data using the
base-quality scores. The program assigns `assembly-quality scores'
to each base in the assembled sequence, providing an objective
criterion to guide sequence ®nishing. The quality scores were based
on and validated by extensive experimental data.
Another key innovation for scaling up sequencing was the
development by several centres of automated methods for sample
preparation. This typically involved creating new biochemical
protocols suitable for automation, followed by construction of
appropriate robotic systems.
Coordination and public data sharing
The Human Genome Project adopted two important principles
with regard to human sequencing. The ®rst was that the collabora-
tion would be open to centres from any nation. Although potentially
less ef®cient, in a narrow economic sense, than a centralized
approach involving a few large factories, the inclusive approach
was strongly favoured because we felt that the human genome
sequence is the common heritage of all humanity and the work
should transcend national boundaries, and we believed that
scienti®c progress was best assured by a diversity of approaches.
The collaboration was coordinated through periodic international
meetings (referred to as `Bermuda meetings' after the venue of the
®rst three gatherings) and regular telephone conferences. Work was
shared ¯exibly among the centres, with some groups focusing on
particular chromosomes and others contributing in a genome-wide
fashion.
The second principle was rapid and unrestricted data release. The
centres adopted a policy that all genomic sequence data should be
made publicly available without restriction within 24 hours of
assembly79,80. Pre-publication data releases had been pioneered in
mapping projects in the worm11 and mouse genomes30,81 and were
prominently adopted in the sequencing of the worm, providing a
direct model for the human sequencing efforts. We believed that
scienti®c progress would be most rapidly advanced by immediate
and free availability of the human genome sequence. The explosion
of scienti®c work based on the publicly available sequence data in
both academia and industry has con®rmed this judgement.
Generating the draft genome sequence
Generating a draft sequence of the human genome involved three
steps: selecting the BAC clones to be sequenced, sequencing them
and assembling the individual sequenced clones into an overall draft
genome sequence. A glossary of terms related to genome sequencing
and assembly is provided in Box 1.
The draft genome sequence is a dynamic product, which is
regularly updated as additional data accumulate en route to the
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ultimate goal of a completely ®nished sequence. The results below
are based on the map and sequence data available on 7 October
2000, except as otherwise noted. At the end of this section, we
provide a brief update of key data.
Clone selection
The hierarchical shotgun method involves the sequencing of over-
lapping large-insert clones spanning the genome. For the Human
Genome Project, clones were largely chosen from eight large-insert
libraries containing BAC or P1-derived arti®cial chromosome
(PAC) clones (Table 1; refs 82±88). The libraries were made by
partial digestion of genomic DNA with restriction enzymes.
Together, they represent around 65-fold coverage (redundant sam-
pling) of the genome. Libraries based on other vectors, such as
cosmids, were also used in early stages of the project.
The libraries (Table 1) were prepared from DNA obtained from
anonymous human donors in accordance with US Federal Regu-
lations for the Protection of Human Subjects in Research
(45CFR46) and following full review by an Institutional Review
Board. Brie¯y, the opportunity to donate DNA for this purpose was
broadly advertised near the two laboratories engaged in library
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Raw sequence Individual unassembled sequence reads, produced
by sequencing of clones containing DNA inserts.
Paired-end sequence Raw sequence obtained from both ends of a
cloned insert in any vector, such as a plasmid or bacterial arti®cial
chromosome.
Finished sequence Complete sequence of a clone or genome, with
an accuracy of at least 99.99% and no gaps.
Coverage (or depth) The average number of times a nucleotide is
represented by a high-quality base in a collection of random raw
sequence. Operationally, a `high-quality base' is de®ned as one with an
accuracy of at least 99% (corresponding to a PHRED score of at least 20).
Full shotgun coverage The coverage in random raw sequence
needed from a large-insert clone to ensure that it is ready for ®nishing; this
varies among centres but is typically 8±10-fold. Clones with full shotgun
coverage can usually be assembled with only a handful of gaps per
100 kb.
Half shotgun coverage Half the amount of full shotgun coverage
(typically, 4±5-fold random coverage).
Clones
BAC clone Bacterial arti®cial chromosome vector carrying a genomic
DNA insert, typically 100±200 kb. Most of the large-insert clones
sequenced in the project were BAC clones.
Finished clone A large-insert clone that is entirely represented by
®nished sequence.
Full shotgun clone A large-insert clone for which full shotgun
sequence has been produced.
Draft clone A large-insert clone for which roughly half-shotgun
sequence has been produced. Operationally, the collection of draft
clones produced by each centre was required to have an average
coverage of fourfold for the entire set and a minimum coverage of
threefold for each clone.
Predraft clone A large-insert clone for which some shotgun
sequence is available, but which does not meet the standards for
inclusion in the collection of draft clones.
Contigs and scaffolds
Contig The result of joining an overlapping collection of sequences or
clones.
Scaffold The result of connecting contigs by linking information from
paired-end reads from plasmids, paired-end reads from BACs, known
messenger RNAs or other sources. The contigs in a scaffold are ordered
and oriented with respect to one another.
Fingerprint clone contigs Contigs produced by joining clones
inferred to overlap on the basis of their restriction digest ®ngerprints.
Sequenced-clone layout Assignment of sequenced clones to the
physical map of ®ngerprint clone contigs.
Initial sequence contigs Contigs produced by merging over-
lapping sequence reads obtained from a single clone, in a process called
sequence assembly.
Merged sequence contigs Contigs produced by taking the initial
sequence contigs contained in overlapping clones and merging those
found to overlap. These are also referred to simply as `sequence contigs'
where no confusion will result.
Sequence-contig scaffolds Scaffolds produced by connecting
sequence contigs on the basis of linking information.
Sequenced-clone contigs Contigs produced by merging over-
lapping sequenced clones.
Sequenced-clone-contig scaffolds Scaffolds produced by join-
ing sequenced-clone contigs on the basis of linking information.
Draft genome sequence The sequence produced by combining
the information from the individual sequenced clones (by creating
merged sequence contigs and then employing linking information to
create scaffolds) and positioning the sequence along the physical map of
the chromosomes.
N50 length A measure of the contig length (or scaffold length)
containing a `typical' nucleotide. Speci®cally, it is the maximum length L
such that 50%ofall nucleotides lie incontigs (or scaffolds) of size at leastL.
Computer programs and databases
PHRED A widely used computer program that analyses raw sequence
to produce a `base call' with an associated `quality score' for each
position in the sequence. A PHRED quality score of X corresponds to an
error probability of approximately 10- X/10. Thus, a PHRED quality score of
30 corresponds to 99.9% accuracy for the base call in the raw read.
PHRAP A widely used computer program that assembles raw
sequence into sequence contigs and assigns to each position in the
sequence an associated `quality score', on the basis of the PHRED
scores of the raw sequence reads. A PHRAP quality score of X
corresponds to an error probability of approximately 10- X/10. Thus, a
PHRAP quality score of 30 corresponds to 99.9% accuracy for a base in
the assembled sequence.
GigAssembler A computer program developed during this project
for merging the information from individual sequenced clones into a draft
genome sequence.
Public sequence databases The three coordinated international
sequence databases: GenBank, the EMBL data library and DDBJ.
Map features
STS Sequence tagged site, corresponding to a short (typically less
than 500 bp) unique genomic locus for which a polymerase chain
reaction assay has been developed.
EST Expressed sequence tag, obtained by performing a single raw
sequence read from a random complementary DNA clone.
SSR Simple sequence repeat, a sequence consisting largely of a
tandem repeat of a speci®c k-mer (such as (CA)15). Many SSRs are
polymorphic and have been widely used in genetic mapping.
SNP Single nucleotide polymorphism, or a single nucleotide position in
the genome sequence for which two or more alternative alleles are
present at appreciable frequency (traditionally, at least 1%) in the human
population.
Genetic map A genome map in which polymorphic loci are
positioned relative to one another on the basis of the frequency with
which they recombine during meiosis. The unit of distance is
centimorgans (cM), denoting a 1% chance of recombination.
Radiation hybrid (RH) map A genome map in which STSs are
positioned relative to one another on the basis of the frequency with
which they are separated by radiation-induced breaks. The frequency is
assayed by analysing a panel of human±hamster hybrid cell lines, each
produced by lethally irradiating human cells and fusing them with
recipient hamster cells such that each carries a collection of human
chromosomal fragments. The unit of distance is centirays (cR), denoting
a 1% chance of a break occuring between two loci.
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construction. Volunteers of diverse backgrounds were accepted on a
®rst-come, ®rst-taken basis. Samples were obtained after discussion
with a genetic counsellor and written informed consent. The
samples were made anonymous as follows: the sampling laboratory
stripped all identi®ers from the samples, applied random numeric
labels, and transferred them to the processing laboratory, which
then removed all labels and relabelled the samples. All records of the
labelling were destroyed. The processing laboratory chose samples
at random from which to prepare DNA and immortalized cell lines.
Around 5±10 samples were collected for every one that was
eventually used. Because no link was retained between donor and
DNA sample, the identity of the donors for the libraries is not
known, even by the donors themselves. A more complete descrip-
tion can be found at http://www.nhgri.nih.gov/Grant_info/Fund-
ing/Statements/RFA/human_subjects.html.
During the pilot phase, centres showed that sequence-tagged sites
(STSs) from previously constructed genetic and physical maps
could be used to recover BACs from speci®c regions. As sequencing
expanded, some centres continued this approach, augmented with
additional probes from ¯ow sorting of chromosomes to obtain
long-range coverage of speci®c chromosomes or chromosomal
regions89±94.
For the large-scale sequence production phase, a genome-wide
physical map of overlapping clones was also constructed by sys-
tematic analysis of BAC clones representing 20-fold coverage of the
human genome86. Most clones came from the ®rst three sections of
the RPCI-11 library, supplemented with clones from sections of the
RPCI-13 and CalTech D libraries (Table 1). DNA from each BAC
clone was digested with the restriction enzyme HindIII, and the sizes
of the resulting fragments were measured by agarose gel electro-
phoresis. The pattern of restriction fragments provides a `®nger-
print' for each BAC, which allows different BACs to be distinguished
and the degree of overlaps to be assessed. We used these restriction-
fragment ®ngerprints to determine clone overlaps, and thereby
assembled the BACs into ®ngerprint clone contigs.
The ®ngerprint clone contigs were positioned along the chromo-
somes by anchoring them with STS markers from existing genetic
and physical maps. Fingerprint clone contigs were tied to speci®c
STSs initially by probe hybridization and later by direct search of the
sequenced clones. To localize ®ngerprint clone contigs that did not
contain known markers, new STSs were generated and placed onto
chromosomes95. Representative clones were also positioned by ¯uor-
escence in situ hybridization (FISH) (ref. 86 and C. McPherson,
unpublished).
We selected clones from the ®ngerprint clone contigs for sequen-
cing according to various criteria. Fingerprint data were
reviewed86,90 to evaluate overlaps and to assess clone ®delity (to
bias against rearranged clones83,96). STS content information and
BAC end sequence information were also used91,92. Where possible,
we tried to select a minimally overlapping set spanning a region.
However, because the genome-wide physical map was constructed
concurrently with the sequencing, continuity in many regions was
low in early stages. These small ®ngerprint clone contigs were
nonetheless useful in identifying validated, nonredundant clones
articles
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Sequenced clones used in







Caltech B CTB BAC 987SK cells All HindIII 120 74,496 16 2/1/1 528 518 66.7 0.016
Caltech C CTC BAC Human
sperm
All HindIII 125 263,040 144 21,956/
14,445/
7,255





All HindIII 129 162,432 49,833 403,589/
226,068/
156,631






2,501±2,565 EcoRI 202 24,960
2,566±2,671 EcoRI 182 46,326
3,000±3,253 EcoRI 142 97,536
RPCI-1 RP1 PAC Male, blood All MboI 110 115,200 3,388 1,070 1,053 117.7 0.028
RPCI-3 RP3 PAC Male, blood All MboI 115 75,513 644 638 68.5 0.016
RPCI-4 RP4 PAC Male, blood All MboI 116 105,251 889 881 95.5 0.022
RPCI-5 RP5 PAC Male, blood All MboI 115 142,773 1,042 1,033 116.5 0.027
RPCI-11 RP11 BAC Male, blood All 178 543,797 267,931 379,773/
243,764/
134,110
19,405 19,145 3,165.0 0.743
1 EcoRI 164 108,499
2 EcoRI 168 109,496
3 EcoRI 181 109,657
4 EcoRI 183 109,382






25,580 25,241 3,903.9 0.916
Total all libraries 354,510 812,594/
488,017/
100,775
30,445 29,298 4,260.5 1
...................................................................................................................................................................................................................................................................................................................................................................
* For the CalTech libraries82, see http://www.tree.caltech.edu/lib_status.html; for RPCI libraries83, see http://www.chori.org/bacpac/home.htm.
² For the FPC map and ®ngerprinting84±86, see http://genome.wustl.edu/gsc/human/human_database.shtml.
³ The number of raw BAC end sequences (clones/ends/clones with both ends sequenced) available for use in human genome sequencing. Typically, for clones in which sequence was obtained from both
ends, more than 95% of both end sequences contained at least 100 bp of nonrepetitive sequence. BAC-end sequencing of RPCI-11 and of the CalTech libraries was done at The Institute for Genomic
Research, the California Institute of Technology and the University of Washington High Throughput Sequencing Center. The sources for the Table were http://www.ncbi.nlm.nih.gov/genome/clone/
BESstat.shtml and refs 87, 88.
§ These are the clones in the sequenced-clone layout map (http://genome.wustl.edu/gsc/human/Mapping/index.shtml) that were pre-draft, draft or ®nished.
k The number of sequenced clones used in the assembly. This number is less than that in the previous column owing to removal of a small number of obviously contaminated, combined or duplicated
projects; in addition, not all of the clones from completed chromosomes 21 and 22 were included here because only the available ®nished sequence from those chromosomes was used in the assembly.
¶ The number reported is the total sequence from the clones indicated in the previous column. Potential overlap between clones was not removed here, but Ns were excluded.
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that were used to `seed' the sequencing of new regions. The small
®ngerprint clone contigs were extended or merged with others as
the map matured.
The clones that make up the draft genome sequence therefore do
not constitute a minimally overlapping setÐthere is overlap and
redundancy in places. The cost of using suboptimal overlaps was
justi®ed by the bene®t of earlier availability of the draft genome
sequence data. Minimizing the overlap between adjacent clones
would have required completing the physical map before under-
taking large-scale sequencing. In addition, the overlaps between
BAC clones provide a rich collection of SNPs. More than 1.4 million
SNPs have already been identi®ed from clone overlaps and other
sequence comparisons97.
Because the sequencing project was shared among twenty centres
in six countries, it was important to coordinate selection of clones
across the centres. Most centres focused on particular chromosomes
or, in some cases, larger regions of the genome. We also maintained
a clone registry to track selected clones and their progress. In later
phases, the global map provided an integrated view of the data from
all centres, facilitating the distribution of effort to maximize cover-
age of the genome. Before performing extensive sequencing on a
clone, several centres routinely examined an initial sample of 96 raw
sequence reads from each subclone library to evaluate possible
overlap with previously sequenced clones.
Sequencing
The selected clones were subjected to shotgun sequencing. Although
the basic approach of shotgun sequencing is well established, the
details of implementation varied among the centres. For example,
there were differences in the average insert size of the shotgun
libraries, in the use of single-stranded or double-stranded cloning
vectors, and in sequencing from one end or both ends of each insert.
Centres differed in the ¯uorescent labels employed and in the degree
to which they used dye-primers or dye-terminators. The sequence
detectors included both slab gel- and capillary-based devices.
Detailed protocols are available on the web sites of many of the
individual centres (URLs can be found at www.nhgri.nih.gov/
genome_hub). The extent of automation also varied greatly
among the centres, with the most aggressive automation efforts
resulting in factory-style systems able to process more than 100,000
sequencing reactions in 12 hours (Fig. 3). In addition, centres
differed in the amount of raw sequence data typically obtained for
each clone (so-called half-shotgun, full shotgun and ®nished
sequence). Sequence information from the different centres could
be directly integrated despite this diversity, because the data were
analysed by a common computational procedure. Raw sequence
traces were processed and assembled with the PHRED and PHRAP
software packages77,78 (P. Green, unpublished). All assembled con-
tigs of more than 2 kb were deposited in public databases within
24 hours of assembly.
The overall sequencing output rose sharply during production
(Fig. 4). Following installation of new sequence detectors beginning
in June 1999, sequencing capacity and output rose approximately
eightfold in eight months to nearly 7 million samples processed per
month, with little or no drop in success rate (ratio of useable reads
to attempted reads). By June 2000, the centres were producing raw
sequence at a rate equivalent to onefold coverage of the entire
human genome in less than six weeks. This corresponded to a
continuous throughput exceeding 1,000 nucleotides per second,
24 hours per day, seven days per week. This scale-up resulted in a
concomitant increase in the sequence available in the public
databases (Fig. 4).
A version of the draft genome sequence was prepared on the basis
of the map and sequence data available on 7 October 2000. For this
version, the mapping effort had assembled the ®ngerprinted BACs
into 1,246 ®ngerprint clone contigs. The sequencing effort had
sequenced and assembled 29,298 overlapping BACs and other large-
insert clones (Table 2), comprising a total length of 4.26 gigabases
(Gb). This resulted from around 23 Gb of underlying raw shotgun
sequence data, or about 7.5-fold coverage averaged across the
genome (including both draft and ®nished sequence). The various
contributions to the total amount of sequence deposited in the
HTGS division of GenBank are given in Table 3.
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Figure 3 The automated production line for sample preparation at the Whitehead
Institute, Center for Genome Research. The system consists of custom-designed factory-
style conveyor belt robots that perform all functions from purifying DNA from bacterial



























































































Unfinished (draft and pre-draft)
Month
Figure 4 Total amount of human sequence in the High Throughput Genome Sequence
(HTGS) division of GenBank. The total is the sum of ®nished sequence (red) and un®nished
(draft plus predraft) sequence (yellow).


















Finished 8,277 897 20±25 8±12 9,085
Draft 18,969 3,097 12 4.5 13,395
Predraft 2,052 267 6 2.5 667
Total 23,147
.............................................................................................................................................................................
* The average number of reads per kb was estimated based on information provided by each
sequencing centre. This number differed among sequencing centres, based on the actual protocols
used.
² The average depth in high quality bases ($99% accuracy) was estimated from information
provided by each sequencing centre. The average varies among the centres, and the number may
vary considerably for clones with the same sequencing status. For draft clones in the public
databases (keyword: HTGS_draft), the number can be computed from the quality scores listed in
the database entry.
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By agreement among the centres, the collection of draft clones
produced by each centre was required to have fourfold average
sequence coverage, with no clone below threefold. (For this pur-
pose, sequence coverage was de®ned as the average number of times
that each base was independently read with a base-quality score
corresponding to at least 99% accuracy.) We attained an overall
average of 4.5-fold coverage across the genome for draft clones. A
few of the sequenced clones fell below the minimum of threefold
sequence coverage or have not been formally designated by centres
as meeting draft standards; these are referred to as predraft (Table 2).
Some of these are clones that span remaining gaps in the draft
genome sequence and were in the process of being sequenced on 7
October 2000; a few are old submissions from centres that are no
longer active.
The lengths of the initial sequence contigs in the draft clones vary
as a function of coverage, but half of all nucleotides reside in initial
sequence contigs of at least 21.7 kb (see below). Various properties
of the draft clones can be assessed from instances in which there was
substantial overlap between a draft clone and a ®nished (or nearly
®nished) clone. By examining the sequence alignments in the
overlap regions, we estimated that the initial sequence contigs in a
draft sequence clone cover an average of about 96% of the clone and
are separated by gaps with an average size of about 500 bp.
Although the main emphasis was on producing a draft genome
sequence, the centres also maintained sequence ®nishing activities
during this period, leading to a twofold increase in ®nished
sequence from June 1999 to June 2000 (Fig. 4). The total amount
of human sequence in this ®nal form stood at more than 835 Mb on
7 October 2000, or more than 25% of the human genome. This
includes the ®nished sequences of chromosomes 21 and 22 (refs 93,
94). As centres have begun to shift from draft to ®nished sequencing
in the last quarter of 2000, the production of ®nished sequence has
increased to an annualized rate of 1 Gb per year and is continuing to
rise.
In addition to sequencing large-insert clones, three centres
generated a large collection of random raw sequence reads from
whole-genome shotgun libraries (Table 4; ref. 98). These 5.77
million successful sequences contained 2.4 Gb of high-quality
bases; this corresponds to about 0.75-fold coverage and would be
statistically expected to include about 50% of the nucleotides in the
human genome (data available at http://snp.cshl.org/data). The
primary objective of this work was to discover SNPs, by comparing
these random raw sequences (which came from different individ-
uals) with the draft genome sequence. However, many of these raw
sequences were obtained from both ends of plasmid clones and
thereby also provided valuable `linking' information that was used
in sequence assembly. In addition, the random raw sequences
provide sequence coverage of about half of the nucleotides not yet
represented in the sequenced large-insert clones; these can be used
as probes for portions of the genome not yet recovered.
Assembly of the draft genome sequence
We then set out to assemble the sequences from the individual large-
insert clones into an integrated draft sequence of the human
genome. The assembly process had to resolve problems arising
from the draft nature of much of the sequence, from the variety of
clone sources, and from the high fraction of repeated sequences in
the human genome. This process involved three steps: ®ltering,
layout and merging.
The entire data set was ®ltered uniformly to eliminate contam-
ination from nonhuman sequences and other artefacts that had not
already been removed by the individual centres. (Information about
contamination was also sent back to the centres, which are updating
the individual entries in the public databases.) We also identi®ed
instances in which the sequence data from one BAC clone was
substantially contaminated with sequence data from another
(human or nonhuman) clone. The problems were resolved in
most instances; 231 clones remained unresolved, and these were
eliminated from the assembly reported here. Instances of lower
levels of cross-contamination (for example, a single 96-well micro-
plate misassigned to the wrong BAC) are more dif®cult to detect;
some undoubtedly remain and may give rise to small spurious
sequence contigs in the draft genome sequence. Such issues are
readily resolved as the clones progress towards ®nished sequence,
but they necessitate some caution in certain applications of the
current data.
The sequenced clones were then associated with speci®c clones on
the physical map to produce a `layout'. In principle, sequenced
clones that correspond to ®ngerprinted BACs could be directly
assigned by name to ®ngerprint clone contigs on the ®ngerprint-
based physical map. In practice, however, laboratory mixups occa-
sionally resulted in incorrect assignments. To eliminate such pro-
blems, sequenced clones were associated with the ®ngerprint clone
contigs in the physical map by using the sequence data to calculate a
articles
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Table 3 Total human sequence deposited in the HTGS division of GenBank




Whitehead Institute, Center for Genome Research* 1,196,888 46,560
The Sanger Centre* 970,789 284,353
Washington University Genome Sequencing Center* 765,898 175,279
US DOE Joint Genome Institute 377,998 78,486
Baylor College of Medicine Human Genome Sequencing
Center
345,125 53,418
RIKEN Genomic Sciences Center 203,166 16,971
Genoscope 85,995 48,808
GTC Sequencing Center 71,357 7,014
Department of Genome Analysis, Institute of Molecular
Biotechnology
49,865 17,788
Beijing Genomics Institute/Human Genome Center 42,865 6,297
Multimegabase Sequencing Center; Institute for Systems
Biology
31,241 9,676
Stanford Genome Technology Center 29,728 3,530
The Stanford Human Genome Center and Department of
Genetics
28,162 9,121
University of Washington Genome Center 24,115 14,692
Keio University 17,364 13,058
University of Texas Southwestern Medical Center at Dallas 11,670 7,028
University of Oklahoma Advanced Center for Genome
Technology
10,071 9,155
Max Planck Institute for Molecular Genetics 7,650 2,940
GBF ± German Research Centre for Biotechnology 4,639 2,338






Total human sequence deposited in GenBank by members of the International Human Genome
Sequencing Consortium, as of 8 October 2000.The amount of total sequence (®nished plus draft
plus predraft) is shown in the second column and the amount of ®nished sequence is shown in
the third column. Total sequence differs from totals in Tables 1 and 2 because of inclusion of
padding characters and of some clones not used in assembly. HTGS, high throughput genome
sequence.
*These three centres produced an additional 2.4 Gb of raw plasmid paired-end reads (see Table 4),
consisting of 0.99 Gb from Whitehead Institute, 0.66 Gb from The Sanger Centre and 0.75 Gb from
Washington University.
Table 4 Plasmid paired-end reads
Total reads deposited* Read pairs² Size range of inserts
(kb)
Random-sheared 3,227,685 1,155,284 1.8±6
Enzyme digest 2,539,222 761,010 0.8±4.7
Total 5,766,907 1,916,294
.............................................................................................................................................................................
The plasmid paired-end reads used a mixture of DNA from a set of 24 samples from the DNA
Polymorphism Discovery Resource (http://locus.umdnj.edu/nigms/pdr.html). This set of 24 anon-
ymous US residents contains samples from European-Americans, African-Americans, Mexican-
Americans, Native Americans and Asian-Americans, although the ethnicities of the individual
samples are not identi®ed. Informed consent to contribute samples to the DNA Polymorphism
Discovery Resource was obtained from all 450 individuals who contributed samples. Samples from
the European-American, African-American and Mexican-American individuals came from NHANES
(http://www.cdc.gov/nchs/nhanes.htm); individuals were recontacted to obtain their consent for
the Resource project. New samples were obtained from Asian-Americans whose ancestry was
from a variety of East and South Asian countries. New samples were also obtained for the Native
Americans; tribal permission was obtained ®rst, and then individual consents. See http://
www.nhgri.nih.gov/Grant_info/Funding/RFA/discover_polymorphisms.html and ref. 98.
*Re¯ects data deposited with and released by The SNP Consortium (see http://snp.cshl.org/data).
² Read pairs represents the number of cases in which sequence from both ends of a genomic
cloned fragment was determined and used in this study as linking information.
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partial list of restriction fragments in silico and comparing that list
with the experimental database of BAC ®ngerprints. The compari-
son was feasible because the experimental sizing of restriction
fragments was highly accurate (to within 0.5±1.5% of the true
size, for 95% of fragments from 600 to 12,000 base pairs (bp))84,85.
Reliable matching scores could be obtained for 16,193 of the clones.
The remaining sequenced clones could not be placed on the map by
this method because they were too short, or they contained too
many small initial sequence contigs to yield enough restriction
fragments, or possibly because their sequences were not represented
in the ®ngerprint database.
An independent approach to placing sequenced clones on the
physical map used the database of end sequences from ®ngerprinted
BACs (Table 1). Sequenced clones could typically be reliably
mapped if they contained multiple matches to BAC ends, with all
corresponding to clones from a single genomic region (multiple
matches were required as a safeguard against errors known to exist
in the BAC end database and against repeated sequences). This
approach provided useful placement information for 22,566
sequenced clones.
Altogether, we could assign 25,403 sequenced clones to ®nger-
print clone contigs by combining in silico digestion and BAC end
sequence match data. To place most of the remaining sequenced
clones, we exploited information about sequence overlap or BAC-
end paired links of these clones with already positioned clones. This
left only a few, mostly small, sequenced clones that could not be
placed (152 sequenced clones containing 5.5 Mb of sequence out of
29,298 sequenced clones containing more than 4,260 Mb of
sequence); these are being localized by radiation hybrid mapping
of STSs derived from their sequences.
The ®ngerprint clone contigs were then mapped to chromosomal
locations, using sequence matches to mapped STSs from four
human radiation hybrid maps95,99,100, one YAC and radiation
hybrid map29, and two genetic maps101,102, together with data from
FISH86,90,103. The mapping was iteratively re®ned by comparing the
order and orientation of the STSs in the ®ngerprint clone contigs
and the various STS-based maps, to identify and re®ne discrepan-
cies (Fig. 5). Small ®ngerprint clone contigs (, 1 Mb) were dif®cult
to orient and, sometimes, to order using these methods. In all, 942
®ngerprint clone contigs contained sequenced clones. (An addi-
tional 304 of the 1,246 ®ngerprint clone contigs did not contain
sequenced clones, but these tended to be extremely small and
together contain less than 1% of the mapped clones. About one-
third have been targeted for sequencing. A few derive from the Y
chromosome, for which the map was constructed separately89. Most
of the remainder are fragments of other larger contigs or represent
other artefacts. These are being eliminated in subsequent versions of
the database.) Of these 942 contigs with sequenced clones, 852
(90%, containing 99.2% of the total sequence) were localized to
speci®c chromosome locations in this way. An additional 51
®ngerprint clone contigs, containing 0.5% of the sequence, could
be assigned to a speci®c chromosome but not to a precise position.
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Figure 5 Positions of markers on previous maps of the genome (the Genethon101 genetic
map and Marsh®eld genetic map (http://research.marsh®eldclinic.org/genetics/
genotyping_service/mgsver2.htm), the GeneMap99 radiation hybrid map100, and the
Whitehead YAC and radiation hybrid map29) plotted against their derived position on the
draft sequence for chromosome 2. The horizontal units are Mb but the vertical units of
each map vary (cM, cR and so on) and thus all were scaled so that the entire map spans
the full vertical range. Markers that map to other chromosomes are shown in the
chromosome lines at the top.The data sets generally follow the diagonal, indicating that
order and orientation of the marker sets on the different maps largely agree (note that the
two genetic maps are completely superimposed). In a, there are two segments (bars) that
are inverted in an earlier version draft sequence relative to all the other maps. b, The same





























alignment :  OK
alignment in 
middle only : not OK
Figure 6 The key steps (a±d) in assembling individual sequenced clones into the draft genome sequence. A1±A5 represent initial sequence contigs derived from shotgun sequencing
of clone A, and B1±B6 are from clone B.
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The remaining 39 contigs containing 0.3% of the sequence were not
positioned at all.
We then merged the sequences from overlapping sequenced
clones (Fig. 6), using the computer program GigAssembler104. The
program considers nearby sequenced clones, detects overlaps
between the initial sequence contigs in these clones, merges the
overlapping sequences and attempts to order and orient the
sequence contigs. It begins by aligning the initial sequence contigs
from one clone with those from other clones in the same ®ngerprint
clone contig on the basis of length of alignment, per cent identity of
the alignment, position in the sequenced clone layout and other
factors. Alignments are limited to one end of each initial sequence
contig for partially overlapping contigs or to both ends of an initial
sequence contig contained entirely within another; this eliminates
internal alignments that may re¯ect repeated sequence or possible
misassembly (Fig. 6b). Beginning with the highest scoring pairs,
initial sequence contigs are then integrated to produce `merged
sequence contigs' (usually referred to simply as `sequence contigs').
The program re®nes the arrangement of the clones within the
®ngerprint clone contig on the basis of the extent of sequence
overlap between them and then rebuilds the sequence contigs. Next,
the program selects a sequence path through the sequence contigs
(Fig. 6c). It tries to use the highest quality data by preferring longer
initial sequence contigs and avoiding the ®rst and last 250 bases of
initial sequence contigs where possible. Finally, it attempts to order
and orient the sequence contigs by using additional information,
including sequence data from paired-end plasmid and BAC reads,
known messenger RNAs and ESTs, as well as additional linking
information provided by centres. The sequence contigs are thereby
linked together to create `sequence-contig scaffolds' (Fig. 6d). The
process also joins overlapping sequenced clones into sequenced-
clone contigs and links sequenced-clone contigs to form sequenced-
clone-contig scaffolds. A ®ngerprint clone contig may contain
several sequenced-clone contigs, because bridging clones remain
to be sequenced. The assembly contained 4,884 sequenced-clone
articles
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Order and orient with mRNA, paired end reads, other information
A
B
Figure 7 Levels of clone and sequence coverage. A `®ngerprint clone contig' is
assembled by using the computer program FPC84,451 to analyse the restriction enzyme
digestion patterns of many large-insert clones. Clones are then selected for sequencing to
minimize overlap between adjacent clones. For a clone to be selected, all of its restriction
enzyme fragments (except the two vector-insert junction fragments) must be shared with
at least one of its neighbours on each side in the contig. Once these overlapping clones
have been sequenced, the set is a `sequenced-clone contig'. When all selected clones
from a ®ngerprint clone contig have been sequenced, the sequenced-clone contig will be
the same as the ®ngerprint clone contig. Until then, a ®ngerprint clone contig may contain
several sequenced-clone contigs. After individual clones (for example, A and B) have been
sequenced to draft coverage and the clones have been mapped, the data are analysed by
GigAssembler (Fig. 6), producing merged sequence contigs from initial sequence contigs,
and linking these to form sequence-contig scaffolds (see Box 1).
Table 5 The draft genome sequence
Chromosome Sequence from clones (kb) Sequence from contigs (kb)






All 826,441 1,734,995 131,476 958,922 840,815 893,175
1 50,851 149,027 12,356 61,001 78,773 72,461
2 46,909 167,439 7,210 53,775 81,569 86,214
3 22,350 152,840 11,057 26,959 79,649 79,638
4 15,914 134,973 17,261 19,096 66,165 82,887
5 37,973 129,581 2,160 48,895 61,387 59,431
6 75,312 76,082 6,696 93,458 28,204 36,428
7 94,845 47,328 4,047 103,188 14,434 28,597
8 14,538 102,484 7,236 16,659 47,198 60,400
9 18,401 77,648 10,864 24,030 42,653 40,230
10 16,889 99,181 11,066 21,421 54,054 51,662
11 13,162 111,092 4,352 16,145 65,147 47,314
12 32,156 84,653 7,651 37,519 43,995 42,946
13 16,818 68,983 7,136 22,191 38,319 32,429
14 58,989 27,370 565 78,302 3,267 5,355
15 2,739 67,453 3,211 3,112 34,758 35,533
16 22,987 48,997 1,143 27,751 20,892 24,484
17 29,881 36,349 6,600 33,531 14,671 24,628
18 5,128 65,284 2,352 6,656 40,947 25,160
19 28,481 26,568 369 32,228 7,188 16,003
20 54,217 5,302 976 56,534 1,065 2,896
21 33,824 0 0 33,824 0 0
22 33,786 0 0 33,786 0 0
X 77,630 45,100 4,941 83,796 14,056 29,820
Y 18,169 3,221 363 20,222 333 1,198
NA 2,434 1,858 844 2,446 122 2,568
UL 2,056 6,182 1,020 2,395 1,969 4,894
...................................................................................................................................................................................................................................................................................................................................................................
The table presents summary statistics for the draft genome sequence over the entire genome and by individual chromosome. NA, clones that could not be placed into the sequenced clone layout. UL,
clones that could be placed in the layout, but that could not reliably be placed on a chromosome. First three columns, data from ®nished clones, draft clones and predraft clones. The last three columns
break the data down according to the type of sequence contig. Contigs containing ®nished clones represent sequence contigs that consist of ®nished sequence plus any (small) extensions from merged
sequence contigs that arise from overlap with ¯anking draft clones. Deep coverage sequence contigs include sequence from two or more overlapping un®nished clones; they consist of roughly full shotgun
coverage and thus are longer than the average un®nished sequence contig. Draft/predraft sequence contigs are all of the other sequence contigs in un®nished clones. Thus, the draft genome sequence
consists of approximately one-third ®nished sequence, one-third deep coverage sequence and one-third draft/pre-draft coverage sequence. In all of the statistics, we count only nonoverlapping bases in
the draft genome sequence.
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contigs in 942 ®ngerprint clone contigs.
The hierarchy of contigs is summarized in Fig. 7. Initial sequence
contigs are integrated to create merged sequence contigs, which are
then linked to form sequence-contig scaffolds. These scaffolds reside
within sequenced-clone contigs, which in turn reside within ®nger-
print clone contigs.
The draft genome sequence
The result of the assembly process is an integrated draft sequence of
the human genome. Several features of the draft genome sequence
are reported in Tables 5±7, including the proportion represented by
®nished, draft and predraft categories. The Tables also show the
numbers and lengths of different types of contig, for each chromo-
some and for the genome as a whole.
The contiguity of the draft genome sequence at each level is an
important feature. Two commonly used statistics have signi®cant
drawbacks for describing contiguity. The `average length' of a contig
is de¯ated by the presence of many small contigs comprising only a
small proportion of the genome, whereas the `length-weighted
average length' is in¯ated by the presence of large segments of
®nished sequence. Instead, we chose to describe the contiguity as a
property of the `typical' nucleotide. We used a statistic called the
`N50 length', de®ned as the largest length L such that 50% of all
nucleotides are contained in contigs of size at least L.
The continuity of the draft genome sequence reported here and
the effectiveness of assembly can be readily seen from the following:
half of all nucleotides reside within an initial sequence contig of at
least 21.7 kb, a sequence contig of at least 82 kb, a sequence-contig
scaffold of at least 274 kb, a sequenced-clone contig of at least 826 kb
and a ®ngerprint clone contig of at least 8.4 Mb (Tables 6, 7). The
cumulative distributions for each of these measures of contiguity
are shown in Fig. 8, in which the N50 values for each measure can be
seen as the value at which the cumulative distributions cross 50%.
We have also estimated the size of each chromosome, by estimating
the gap sizes (see below) and the extent of missing heterochromatic
sequence93,94,105±108 (Table 8). This is undoubtedly an oversimpli®ca-
tion and does not adequately take into account the sequence status
of each chromosome. Nonetheless, it provides a useful way to relate
the draft sequence to the chromosomes.
Quality assessment
The draft genome sequence already covers the vast majority of the
genome, but it remains an incomplete, intermediate product that is
regularly updated as we work towards a complete ®nished sequence.
The current version contains many gaps and errors. We therefore
sought to evaluate the quality of various aspects of the current draft
genome sequence, including the sequenced clones themselves, their
assignment to a position in the ®ngerprint clone contigs, and the
assembly of initial sequence contigs from the individual clones into
sequence-contig scaffolds.
Nucleotide accuracy is re¯ected in a PHRAP score assigned to
each base in the draft genome sequence and available to users
through the Genome Browsers (see below) and public database
entries. A summary of these scores for the un®nished portion of the
genome is shown in Table 9. About 91% of the un®nished draft
genome sequence has an error rate of less than 1 per 10,000 bases
(PHRAP score . 40), and about 96% has an error rate of less than 1
in 1,000 bases (PHRAP . 30). These values are based only on the
quality scores for the bases in the sequenced clones; they do not
re¯ect additional con®dence in the sequences that are represented in
overlapping clones. The ®nished portion of the draft genome
sequence has an error rate of less than 1 per 10,000 bases.
Individual sequenced clones. We assessed the frequency of mis-
assemblies, which can occur when the assembly program PHRAP
joins two nonadjacent regions in the clone into a single initial
sequence contig. The frequency of misassemblies depends heavily
on the depth and quality of coverage of each clone and the nature of
the underlying sequence; thus it may vary among genomic regions
and among individual centres. Most clone misassemblies are readily
corrected as coverage is added during ®nishing, but they may have
been propagated into the current version of the draft genome
sequence and they justify caution for certain applications.
We estimated the frequency of misassembly by examining
instances in which there was substantial overlap between a draft
clone and a ®nished clone. We studied 83 Mb of such overlaps,
involving about 9,000 initial sequence contigs. We found 5.3
instances per Mb in which the alignment of an initial sequence
contig to the ®nished sequence failed to extend to within 200 bases
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Table 6 Clone level contiguity of the draft genome sequence
Chromosome Sequenced-clone contigs Sequenced-clone-contig scaffolds Fingerprint clone contigs with sequence
Number N50 length (kb) Number N50 length (kb) Number N50 length (kb)
All 4,884 826 2,191 2,279 942 8,398
1 453 650 197 1,915 106 3,537
2 348 1,028 127 3,140 52 10,628
3 409 672 201 1,550 73 5,077
4 384 606 163 1,659 41 6,918
5 385 623 164 1,642 48 5,747
6 292 814 98 3,292 17 24,680
7 224 1.074 86 3,527 29 20,401
8 292 542 115 1,742 43 6,236
9 143 1,242 78 2,411 21 29,108
10 179 1,097 105 1,952 16 30,284
11 224 887 89 3,024 31 9,414
12 196 1,138 76 2,717 28 9,546
13 128 1,151 56 3,257 13 25,256
14 54 3,079 27 8,489 14 22,128
15 123 797 56 2,095 19 8,274
16 159 620 92 1,317 57 2,716
17 138 831 58 2,138 43 2,816
18 137 709 47 2,572 24 4,887
19 159 569 79 1,200 51 1,534
20 42 2,318 20 6,862 9 23,489
21 5 28,515 5 28,515 5 28,515
22 11 23,048 11 23,048 11 23,048
X 325 572 181 1,082 143 1,436
Y 27 1,539 20 3,290 8 5,135
UL 47 227 40 281 40 281
...................................................................................................................................................................................................................................................................................................................................................................
Number and size of sequenced-clone contigs, sequenced-clone-contig scaffolds and those ®ngerprint clone contigs (see Box 1) that contain sequenced clones; some small ®ngerprint clone contigs do not
as yet have associated sequence. UL, ®ngerprint clone contigs that could not reliably be placed on a chromosome. These length estimates are from the draft genome sequence, in which gaps between
sequence contigs are arbitrarily represented with 100 Ns and gaps between sequence clone contigs with 50,000 Ns for `bridged gaps' and 100,000 Ns for `unbridged gaps'. These arbitrary values differ
minimally from empirical estimates of gap size (see text), and using the empirically derived estimates would change the N50 lengths presented here only slightly. For un®nished chromosomes, the N50 length
ranges from 1.5 to 3 times the arithmetic mean for sequenced-clone contigs, 1.5 to 3 times for sequenced-clone-contig scaffolds, and 1.5 to 6 times for ®ngerprint clone contigs with sequence.
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of the end of the contig, suggesting a possible false join in the
assembly of the initial sequence contig. In about half of these cases,
the potential misassembly involved fewer than 400 bases, suggesting
that a single raw sequence read may have been incorrectly joined. We
found 1.9 instances per Mb in which the alignment showed an
internal gap, again suggesting a possible misassembly; and 0.5
instances per Mb in which the alignment indicated that two initial
sequence contigs that overlapped by at least 150 bp had not been
merged by PHRAP. Finally, there were another 0.9 instances per Mb
with various other problems. This gives a total of 8.6 instances per
Mb of possible misassembly, with about half being relatively small
issues involving a few hundred bases.
Some of the potential problems might not result from misassem-
bly, but might re¯ect sequence polymorphism in the population,
small rearrangements during growth of the large-insert clones,
regions of low-quality sequence or matches between segmental
duplications. Thus, the frequency of misassemblies may be over-
stated. On the other hand, the criteria for recognizing overlap
between draft and ®nished clones may have eliminated some
misassemblies.
Layout of the sequenced clones. We assessed the accuracy of the
layout of sequenced clones onto the ®ngerprinted clone contigs by
calculating the concordance between the positions assigned to a
sequenced clone on the basis of in silico digestion and the position
assigned on the basis of BAC end sequence data. The positions
agreed in 98% of cases in which independent assignments could be
made by both methods. The results were also compared with well
studied regions containing both ®nished and draft genome
sequence. These results indicated that sequenced clone order in
the ®ngerprint map was reliable to within about half of one clone
length (,100 kb).
A direct test of the layout is also provided by the draft genome
sequence assembly itself. With extensive coverage of the genome, a
correctly placed clone should usually (although not always) show
sequence overlap with its neighbours in the map. We found only 421
instances of `singleton' clones that failed to overlap a neighbouring
clone. Close examination of the data suggests that most of these are
correctly placed, but simply do not yet overlap an adjacent
sequenced clone. About 150 clones appeared to be candidates for
being incorrectly placed.
Alignment of the ®ngerprint clone contigs. The alignment of the
®ngerprint clone contigs with the chromosomes was based on the
radiation hybrid, YAC and genetic maps of STSs. The positions of
most of the STSs in the draft genome sequence were consistent with
these previous maps, but the positions of about 1.7% differed from
one or more of them. Some of these disagreements may be due to
errors in the layout of the sequenced clones or in the underlying
articles
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Figure 8 Cumulative distributions of several measures of clone level contiguity and
sequence contiguity. The ®gures represent the proportion of the draft genome sequence
contained in contigs of at most the indicated size. a, Clone level contiguity. The clones
have a tight size distribution with an N50 of , 160 kb (corresponding to 50% on the
cumulative distribution). Sequenced-clone contigs represent the next level of continuity,
and are linked by mRNA sequences or pairs of BAC end sequences to yield the
sequenced-clone-contig scaffolds. The underlying contiguity of the layout of sequenced
clones against the ®ngerprinted clone contigs is only partially shown at this scale.
b, Sequence contiguity. The input fragments have low continuity (N50 = 21.7 kb). After
merging, the sequence contigs grow to an N50 length of about 82 kb. After linking,
sequence-contig scaffolds with an N50 length of about 274 kb are created.
Figure 9 Overview of features of draft human genome. The Figure shows the
occurrences of twelve important types of feature across the human genome. Large
grey blocks represent centromeres and centromeric heterochromatin (size not precisely to
scale). Each of the feature types is depicted in a track, from top to bottom as follows. (1)
Chromosome position in Mb. (2) The approximate positions of Giemsa-stained
chromosome bands at the 800 band resolution. (3) Level of coverage in the draft genome
sequence. Red, areas covered by ®nished clones; yellow, areas covered by predraft
sequence. Regions covered by draft sequenced clones are in orange, with darker shades
re¯ecting increasing shotgun sequence coverage. (4) GC content. Percentage of bases in
a 20,000 base window that are C or G. (5) Repeat density. Red line, density of SINE class
repeats in a 100,000-base window; blue line, density of LINE class repeats in a 100,000-
base window. (6) Density of SNPs in a 50,000-base window. The SNPs were detected by
sequencing and alignments of random genomic reads. Some of the heterogeneity in SNP
density re¯ects the methods used for SNP discovery. Rigorous analysis of SNP density
requires comparing the number of SNPs identi®ed to the precise number of bases
surveyed. (7) Non-coding RNA genes. Brown, functional RNA genes such as tRNAs,
snoRNAs and rRNAs; light orange, RNA pseudogenes. (8) CpG islands. Green ticks
represent regions of , 200 bases with CpG levels signi®cantly higher than in the genome
as a whole, and GC ratios of at least 50%. (9) Exo®sh ecores. Regions of homology with
the puffer®sh T. nigroviridis 292 are blue. (10) ESTs with at least one intron when aligned
against genomic DNA are shown as black tick marks. (11) The starts of genes predicted by
Genie or Ensembl are shown as red ticks. The starts of known genes from the RefSeq
database110 are shown in blue. (12) The names of genes that have been uniquely located
in the draft genome sequence, characterized and named by the HGM Nomenclature
Committee. Known disease genes from the OMIM database are red, other genes blue.
This Figure is based on an earlier version of the draft genome sequence than analysed in
the text, owing to production constraints. We are aware of various errors in the Figure,
including omissions of some known genes and misplacements of others. Some genes are
mapped to more than one location, owing to errors in assembly, close paralogues or
pseudogenes. Manual review was performed to select the most likely location in these
cases and to correct other regions. For updated information, see http://genome.ucsc.edu/
and http://www.ensembl.org/.
Q
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Table 7 Sequence level contiguity of the draft genome sequence
Chromosome Initial sequence contigs Sequence contigs Sequence-contig scaffolds
Number N50 length (kb) Number N50 length (kb) Number N50 length (kb)
All 396,913 21.7 149,821 81.9 87,757 274.3
1 37,656 16.5 12,256 59.1 5,457 278.4
2 32,280 19.9 13,228 57.3 6,959 248.5
3 38,848 15.6 15,098 37.7 8,964 167.4
4 28,600 16.0 13,152 33.0 7,402 158.9
5 30,096 20.4 10,689 72.9 6,378 241.2
6 17,472 43.6 5,547 180.3 2,554 485.0
7 12,733 86.4 4,562 335.7 2,726 591.3
8 19,042 18.1 8,984 38.2 4,631 198.9
9 15,955 20.1 6,226 55.6 3,766 216.2
10 21,762 18.7 9,126 47.9 6,886 133.0
11 29,723 14.3 8,503 40.0 4,684 193.2
12 22,050 19.1 8,422 63.4 5,526 217.0
13 13,737 21.7 5,193 70.5 2,659 300.1
14 4,470 161.4 829 1,371.0 541 2,009.5
15 13,134 15.3 5,840 30.3 3,229 149.7
16 10,297 34.4 4,916 119.5 3,337 356.3
17 10,369 22.9 4,339 90.6 2,616 248.9
18 16,266 15.3 4,461 51.4 2,540 216.1
19 6,009 38.4 2,503 134.4 1,551 375.5
20 2,884 108.6 511 1,346.7 312 813.8
21 103 340.0 5 28,515.3 5 28,515.3
22 526 113.9 11 23,048.1 11 23,048.1
X 11,062 58.8 4,607 218.6 2,610 450.7
Y 557 154.3 140 1,388.6 106 1,439.7
UL 1,282 21.4 613 46.0 297 166.4
...................................................................................................................................................................................................................................................................................................................................................................
This Table is similar to Table 6 but shows the number and N50 length for various types of sequence contig (see Box 1). See legend to Table 6 concerning treatment of gaps. For sequence contigs in the draft
genome sequence, the N50 length ranges from 1.7 to 5.5 times the arithmetic mean for initial sequence contigs, 2.5 to 8.2 times for merged sequence contigs, and 6.1 to 10 times for sequence-contig
scaffolds.
Table 8 Chromosome size estimates
Chromosome* Sequenced
bases² (Mb)




















All 2,692.9 897 152.0 4,076 142.7 145,514 80.6 212 3,289 3,286
1 212.2 104 17.7 347 12.1 11,803 6.5 30 279 263
2 221.6 50 8.5 296 10.4 12,880 7.1 3 251 255
3 186.2 71 12.1 336 11.8 14,689 8.1 3 221 214
4 168.1 39 6.6 343 12.0 12,768 7.1 3 197 203
5 169.7 46 7.8 337 11.8 10,304 5.7 3 198 194
6 158.1 15 2.6 275 9.6 5,225 2.9 3 176 183
7 146.2 27 4.6 195 6.8 4,338 2.4 3 163 171
8 124.3 41 7.0 249 8.7 8,692 4.8 3 148 155
9 106.9 19 3.2 122 4.3 6,083 3.4 22 140 145
10 127.1 14 2.4 163 5.7 8,947 5.0 3 143 144
11 128.6 29 4.9 193 6.8 8,279 4.6 3 148 144
12 124.5 26 4.4 168 5.9 8,226 4.6 3 142 143
13 92.9 12 2.0 115 4.0 5,065 2.8 16 118 114
14 86.9 13 2.2 40 1.4 775 0.4 16 107 109
15 73.4 18 3.1 104 3.6 5,717 3.2 17 100 106
16 73.1 55 9.4 102 3.6 4,757 2.6 15 104 98
17 72.8 41 7.0 95 3.3 4,261 2.4 3 88 92
18 72.9 22 3.7 113 4.0 4,324 2.4 3 86 85
19 55.4 49 8.3 108 3.8 2,344 1.3 3 72 67
20 60.5 7 1.2 33 1.2 469 0.3 3 66 72
21 33.8 4 0.1 0 0.0 0 0.0 11 45 50
22 33.8 10 1.0 0 0.0 0 0.0 13 48 56
X 127.7 141 24.0 182 6.4 4,282 2.4 3 163 164
Y 21.8 6 1.0 19 0.7 113 0.1 27 51 59
NA 5.1 0 0 134 0.0 577 0.3 0 0 0
UL 9.3 38 0 7 0.0 566 0.3 0 0 0
...................................................................................................................................................................................................................................................................................................................................................................
* NA, sequenced clones that could not be associated with ®ngerprint clone contigs. UL, clone contigs that could not be reliably placed on a chromosome.
² Total number of bases in the draft genome sequence, excluding gaps. Total length of scaffold (including gaps contained within clones) is 2.916 Gb.
³ Gaps between those ®ngerprint clone contigs that contain sequenced clones excluding gaps for centromeres.
§ For un®nished chromosomes, we estimate an average size of 0.17 Mb per FCC gap, based on retrospective estimates of the clone coverage of chromosomes 21 and 22. Gap estimates for chromosomes
21 and 22 are taken from refs 93, 94.
kGaps between sequenced-clone contigs within a ®ngerprint clone contig.
¶ For un®nished chromosomes, we estimate sequenced clone gaps at 0.035 Mb each, based on evaluation of a sample of these gaps.
# Gaps between two sequence contigs within a sequenced-clone contig.
I We estimate the average number of bases in sequence gaps from alignments of the initial sequence contigs of un®nished clones (see text) and extrapolation to the whole chromosome.
** Including adjustments for estimates of the sizes of the short arms of the acrocentric chromosomes 13, 14, 15, 21 and 22 (ref. 105), estimates for the centromere and heterochromatic regions of
chromosomes 1, 9 and 16 (refs 106, 107) and estimates of 3 Mb for the centromere and 24 Mb for telomeric heterochromatin for the Y chromosome108.
²² The sum of the ®ve lengths in the preceding columns. This is an overestimate, because the draft genome sequence contains some artefactual sequence owing to inability to correctly to merge all
underlying sequence contigs. The total amount of artefactual duplication varies among chromosomes; the overall amount is estimated by computational analysis to be about 100 Mb, or about 3% of the total
length given, yielding a total estimated size of about 3,200 Mb for the human genome.
³³ Including heterochromatic regions and acrocentric short arm(s)105.
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®ngerprint map. However, many involve STSs that have been
localized on only one or two of the previous maps or that occur
as isolated discrepancies in con¯ict with several ¯anking STSs.
Many of these cases are probably due to errors in the previous
maps (with error rates for individual maps estimated at 1±2%100).
Others may be due to incorrect assignment of the STSs to the draft
genome sequence (by the electronic polymerase chain reaction
(e-PCR) computer program) or to database entries that contain
sequence data from more than one clone (owing to cross-
contamination).
Graphical views of the independent data sets were particularly
useful in detecting problems with order or orientation (Fig. 5).
Areas of con¯ict were reviewed and corrected if supported by the
underlying data. In the version discussed here, there were 41
sequenced clones falling in 14 sequenced-clone contigs with STS
content information from multiple maps that disagreed with the
¯anking clones or sequenced-clone contigs; the placement of these
clones thus remains suspect. Four of these instances suggest errors
in the ®ngerprint map, whereas the others suggest errors in the
layout of sequenced clones. These cases are being investigated and
will be corrected in future versions.
Assembly of the sequenced clones. We assessed the accuracy of the
assembly by using a set of 148 draft clones comprising 22.4 Mb for
which ®nished sequence subsequently became available104. The
initial sequence contigs lack information about order and orienta-
tion, and GigAssembler attempts to use linking data to infer such
information as far as possible104. Starting with initial sequence
contigs that were unordered and unoriented, the program placed
90% of the initial sequence contigs in the correct orientation and
85% in the correct order with respect to one another. In a separate
test, GigAssembler was tested on simulated draft data produced
from ®nished sequence on chromosome 22 and similar results were
obtained.
Some problems remain at all levels. First, errors in the initial
sequence contigs persist in the merged sequence contigs built from
them and can cause dif®culties in the assembly of the draft genome
sequence. Second, GigAssembler may fail to merge some over-
lapping sequences because of poor data quality, allelic differences or
misassemblies of the initial sequence contigs; this may result in
apparent local duplication of a sequence. We have estimated by
various methods the amount of such artefactual duplication in the
assembly from these and other sources to be about 100 Mb. On the
other hand, nearby duplicated sequences may occasionally be incor-
rectly merged. Some sequenced clones remain incorrectly placed on
the layout, as discussed above, and others (, 0.5%) remain unplaced.
The ®ngerprint map has undoubtedly failed to resolve some closely
related duplicated regions, such as the Williams region and several
highly repetitive subtelomeric and pericentric regions (see below).
Detailed examination and sequence ®nishing may be required to
sort out these regions precisely, as has been done with chromosome
Y89. Finally, small sequenced-clone contigs with limited or no STS
landmark content remain dif®cult to place. Full utilization of
the higher resolution radiation hybrid map (the TNG map) may
help in this95. Future targeted FISH experiments and increased map
continuity will also facilitate positioning of these sequences.
Genome coverage
We next assessed the nature of the gaps within the draft genome
sequence, and attempted to estimate the fraction of the human
genome not represented within the current version.
Gaps in draft genome sequence coverage. There are three types of
gap in the draft genome sequence: gaps within un®nished
sequenced clones; gaps between sequenced-clone contigs, but
within ®ngerprint clone contigs; and gaps between ®ngerprint
clone contigs. The ®rst two types are relatively straightforward to
close simply by performing additional sequencing and ®nishing on
already identi®ed clones. Closing the third type may require screen-
ing of additional large-insert clone libraries and possibly new
technologies for the most recalcitrant regions. We consider these
three cases in turn.
We estimated the size of gaps within draft clones by studying
instances in which there was substantial overlap between a draft
clone and a ®nished clone, as described above. The average gap size
in these draft sequenced clones was 554 bp, although the precise
estimate was sensitive to certain assumptions in the analysis.
Assuming that the sequence gaps in the draft genome sequence
are fairly represented by this sample, about 80 Mb or about 3%
(likely range 2±4%) of sequence may lie in the 145,514 gaps within
draft sequenced clones.
The gaps between sequenced-clone contigs but within ®ngerprint
clone contigs are more dif®cult to evaluate directly, because the
draft genome sequence ¯anking many of the gaps is often not
precisely aligned with the ®ngerprinted clones. However, most are
much smaller than a single BAC. In fact, nearly three-quarters of
these gaps are bridged by one or more individual BACs, as indicated
by linking information from BAC end sequences. We measured the
sizes of a subset of gaps directly by examining restriction fragment
®ngerprints of overlapping clones. A study of 157 `bridged' gaps and
55 `unbridged' gaps gave an average gap size of 25 kb. Allowing for the
possibility that these gaps may not be fully representative and that
some restriction fragments are not included in the calculation, a more
conservative estimate of gap size would be 35 kb. This would indicate
that about 150 Mb or 5% of the human genome may reside in the
4,076 gaps between sequenced-clone contigs. This sequence should
be readily obtained as the clones spanning them are sequenced.
The size of the gaps between ®ngerprint clone contigs was
estimated by comparing the ®ngerprint maps to the essentially
completed chromosomes 21 and 22. The analysis shows that the
®ngerprinted BAC clones in the global database cover 97±98% of
the sequenced portions of those chromosomes86. The published
sequences of these chromosomes also contain a few small gaps (5
and 11, respectively) amounting to some 1.6% of the euchromatic
sequence, and do not include the heterochromatic portion. This
suggests that the gaps between contigs in the ®ngerprint map
contain about 4% of the euchromatic genome. Experience with
closure of such gaps on chromosomes 20 and 7 suggests that many
of these gaps are less than one clone in length and will be closed by
clones from other libraries. However, recovery of sequence from
these gaps represents the most challenging aspect of producing a
complete ®nished sequence of the human genome.
As another measure of the representation of the BAC libraries,
Riethman109 has found BAC or cosmid clones that link to telomeric
half-YACs or to the telomeric sequence itself for 40 of the 41 non-
satellite telomeres. Thus, the ®ngerprint map appears to have no
substantial gaps in these regions. Many of the pericentric regions are
also represented, but analysis is less complete here (see below).
Representation of random raw sequences. In another approach to
measuring coverage, we compared a collection of random raw
sequence reads to the existing draft genome sequence. In principle,
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Table 9 Distribution of PHRAP scores in the draft genome sequence













PHRAP scores are a logarithmically based representation of the error probability. A PHRAP score of
X corresponds to an error probability of 10-X/10. Thus, PHRAP scores of 20, 30 and 40 correspond to
accuracy of 99%, 99.9% and 99.99%, respectively. PHRAP scores are derived from quality
scores of the underlying sequence reads used in sequence assembly. See http://www.genome.
washington.edu/UWGC/analysistools/phrap.htm.
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the fraction of reads matching the draft genome sequence should
provide an estimate of genome coverage. In practice, the compar-
ison is complicated by the need to allow for repeat sequences, the
imperfect sequence quality of both the raw sequence and the draft
genome sequence, and the possibility of polymorphism. None-
theless, the analysis provides a reasonable view of the extent to
which the genome is represented in the draft genome sequence and
the public databases.
We compared the raw sequence reads against both the sequences
used in the construction of the draft genome sequence and all of
GenBank using the BLAST computer program. Of the 5,615 raw
sequence reads analysed (each containing at least 100 bp of con-
tiguous non-repetitive sequence), 4,924 had a match of $ 97%
identity with a sequenced clone, indicating that 88 6 1.5% of the
genome was represented in sequenced clones. The estimate is
subject to various uncertainties. Most serious is the proportion of
repeat sequence in the remainder of the genome. If the unsequenced
portion of the genome is unusually rich in repeated sequence,
we would underestimate its size (although the excess would be
comprised of repeated sequence).
We examined those raw sequences that failed to match by
comparing them to the other publicly available sequence resources.
Fifty (0.9%) had matches in public databases containing cDNA
sequences, STSs and similar data. An additional 276 (or 43% of the
remaining raw sequence) had matches to the whole-genome shot-
gun reads discussed above (consistent with the idea that these reads
cover about half of the genome).
We also examined the extent of genome coverage by aligning the
cDNA sequences for genes in the RefSeq dataset110 to the draft
genome sequence. We found that 88% of the bases of these cDNAs
could be aligned to the draft genome sequence at high stringency (at
least 98% identity). (A few of the alignments with either the random
raw sequence reads or the cDNAs may be to a highly similar region
in the genome, but such matches should affect the estimate of
genome coverage by considerably less than 1%, based on the
estimated extent of duplication within the genome (see below).)
These results indicate that about 88% of the human genome is
represented in the draft genome sequence and about 94% in the
combined publicly available sequence databases. The ®gure of 88%
agrees well with our independent estimates above that about 3%,
5% and 4% of the genome reside in the three types of gap in the draft
genome sequence.
Finally, a small experimental check was performed by screening a
large-insert clone library with probes corresponding to 16 of the
whole genome shotgun reads that failed to match the draft genome
sequence. Five hybridized to many clones from different ®ngerprint
clone contigs and were discarded as being repetitive. Of the
remaining eleven, two fell within sequenced clones (presumably
within sequence gaps of the ®rst type), eight fell in ®ngerprint clone
contigs but between sequenced clones (gaps of the second type) and
one failed to identify clones in the ®ngerprint map (gaps of the third
type) but did identify clones in another large-insert library.
Although these numbers are small, they are consistent with the
view that the much of the remaining genome sequence lies within
already identi®ed clones in the current map.
Estimates of genome and chromosome sizes. Informed by this
analysis of genome coverage, we proceeded to estimate the sizes of
the genome and each of the chromosomes (Table 8). Beginning with
the current assigned sequence for each chromosome, we corrected
for the known gaps on the basis of their estimated sizes (see
above). We attempted to account for the sizes of centromeres and
heterochromatin, neither of which are well represented in the draft
sequence. Finally, we corrected for around 100 Mb of artefactual
duplication in the assembly. We arrived at a total human genome
size estimate of around 3,200 Mb, which compares favourably with
previous estimates based on DNA content.
We also independently estimated the size of the euchromatic
portion of the genome by determining the fraction of the 5,615
random raw sequences that matched the ®nished portion of
the human genome (whose total length is known with greater
precision). Twenty-nine per cent of these raw sequences found a
match among 835 Mb of nonredundant ®nished sequence. This
leads to an estimate of the euchromatic genome size of 2.9 Gb. This
agrees reasonably with the prediction above based on the length of
the draft genome sequence (Table 8).
Update. The results above re¯ect the data on 7 October 2000. New
data are continually being added, with improvements being made to
the physical map, new clones being sequenced to close gaps and
draft clones progressing to full shotgun coverage and ®nishing. The
draft genome sequence will be regularly reassembled and publicly
released.
Currently, the physical map has been re®ned such that the
number of ®ngerprint clone contigs has fallen from 1,246 to 965;
this re¯ects the elimination of some artefactual contigs and the
closure of some gaps. The sequence coverage has risen such that
90% of the human genome is now represented in the sequenced
clones and more than 94% is represented in the combined publicly
available sequence databases. The total amount of ®nished sequence
is now around 1 Gb.
Broad genomic landscape
What biological insights can be gleaned from the draft sequence? In
this section, we consider very large-scale features of the draft
genome sequence: the distribution of GC content, CpG islands
and recombination rates, and the repeat content and gene content of
the human genome. The draft genome sequence makes it possible to
integrate these features and others at scales ranging from individual
articles
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Figure 10 Screen shot from UCSC Draft Human Genome Browser. See
http://genome.ucsc.edu/.
Figure 11 Screen shot from the Genome Browser of Project Ensembl. See
http://www.ensembl.org.
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nucleotides to collections of chromosomes. Unless noted, all ana-
lyses were conducted on the assembled draft genome sequence
described above.
Figure 9 provides a high-level view of the contents of the draft
genome sequence, at a scale of about 3.8 Mb per centimetre. Of
course, navigating information spanning nearly ten orders of
magnitude requires computational tools to extract the full value.
We have created and made freely available various `Genome Brow-
sers'. Browsers were developed and are maintained by the University
of California at Santa Cruz (Fig. 10) and the EnsEMBL project of the
European Bioinformatics Institute and the Sanger Centre (Fig. 11).
Additional browsers have been created; URLs are listed at
www.nhgri.nih.gov/genome_hub. These web-based computer
tools allow users to view an annotated display of the draft genome
sequence, with the ability to scroll along the chromosomes and
zoom in or out to different scales. They include: the nucleotide
sequence, sequence contigs, clone contigs, sequence coverage and
®nishing status, local GC content, CpG islands, known STS markers
from previous genetic and physical maps, families of repeat
sequences, known genes, ESTs and mRNAs, predicted genes, SNPs
and sequence similarities with other organisms (currently the
puffer®sh Tetraodon nigroviridis). These browsers will be updated
as the draft genome sequence is re®ned and corrected as additional
annotations are developed.
In addition to using the Genome Browsers, one can download
from these sites the entire draft genome sequence together with the
annotations in a computer-readable format. The sequences of the
underlying sequenced clones are all available through the public
sequence databases. URLs for these and other genome websites are
listed in Box 2. A larger list of useful URLs can be found at
www.nhgri.nih.gov/genome_hub. An introduction to using the
draft genome sequence, as well as associated databases and analy-
tical tools, is provided in an accompanying paper111.
In addition, the human cytogenetic map has been integrated with
the draft genome sequence as part of a related project. The BAC
Resource Consortium103 established dense connections between the
maps using more than 7,500 sequenced large-insert clones that had
been cytogenetically mapped by FISH; the average density of the
map is 2.3 clones per Mb. Although the precision of the integration
is limited by the resolution of FISH, the links provide a powerful
tool for the analysis of cytogenetic aberrations in inherited diseases
and cancer. These cytogenetic links can also be accessed through the
Genome Browsers.
Long-range variation in GC content
The existence of GC-rich and GC-poor regions in the human
genome was ®rst revealed by experimental studies involving density
gradient separation, which indicated substantial variation in aver-
age GC content among large fragments. Subsequent studies have
indicated that these GC-rich and GC-poor regions may have
different biological properties, such as gene density, composition
of repeat sequences, correspondence with cytogenetic bands and
recombination rate112±117. Many of these studies were indirect, owing
to the lack of suf®cient sequence data.
The draft genome sequence makes it possible to explore the
variation in GC content in a direct and global manner. Visual
inspection (Fig. 9) con®rms that local GC content undergoes
substantial long-range excursions from its genome-wide average
of 41%. If the genome were drawn from a uniform distribution of
GC content, the local GC content in a window of size n bp should
be 41 6 Î((41)(59)/n)%. Fluctuations would be modest, with the
standard deviation being halved as the window size is quadrupledÐ
for example, 0.70%, 0.35%, 0.17% and 0.09% for windows of size 5,
20, 80 and 320 kb.
The draft genome sequence, however, contains many regions with
much more extreme variation. There are huge regions (. 10 Mb)
with GC content far from the average. For example, the most distal
48 Mb of chromosome 1p (from the telomere to about STS marker
D1S3279) has an average GC content of 47.1%, and chromosome 13
has a 40-Mb region (roughly between STS marker A005X38 and
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Figure 12 Histogram of GC content of 20-kb windows in the draft genome sequence.
Box 2
Sources of publicly available sequence data and other relevant
genomic information
http://genome.ucsc.edu/
University of California at Santa Cruz




Contains links to clone and accession maps of the human genome
http://www.ensembl.org
EBI/Sanger Centre
Allows access to DNA and protein sequences with automatic baseline annotation
http://www.ncbi.nlm.nih.gov/ genome/guide/
NCBI
Views of chromosomes and maps and loci with links to other NCBI resources
http://www.ncbi.nlm.nih.gov/ genemap99/
Gene map 99: contains data and viewers for radiation hybrid maps of EST-based
STSs
http://compbio.ornl.gov/channel/index.html
Oak Ridge National Laboratory
Java viewers for human genome data
http://hgrep.ims.u-tokyo.ac.jp/
RIKEN and the University of Tokyo
Gives an overview of the entire human genome structure
http://snp.cshl.org/
The SNP Consortium
Includes a variety of ways to query for SNPs in the human genome
http://www.ncbi.nlm.nih.gov/Omim/
Online Mendelian Inheritance in Man
Contain information about human genes and disease
http://www.nhgri.nih.gov/ELSI/ and http://www.ornl.gov/hgmis/elsi/elsi.html
NHGRI and DOE
Contains information, links and articles on a wide range of social, ethical and legal
issues
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stsG30423) with only 36% GC content. There are also examples of
large shifts in GC content between adjacent multimegabase regions.
For example, the average GC content on chromosome 17q is 50%
for the distal 10.3 Mb but drops to 38% for the adjacent 3.9 Mb.
There are regions of less than 300 kb with even wider swings in GC
content, for example, from 33.1% to 59.3%.
Long-range variation in GC content is evident not just from
extreme outliers, but throughout the genome. The distribution of
average GC content in 20-kb windows across the draft genome
sequence is shown in Fig. 12. The spread is 15-fold larger than
predicted by a uniform process. Moreover, the standard deviation
barely decreases as window size increases by successive factors of
fourÐ5.9%, 5.2%, 4.9% and 4.6% for windows of size 5, 20, 80 and
320 kb. The distribution is also notably skewed, with 58% below the
average and 42% above the average of 41%, with a long tail of GC-
rich regions.
Bernardi and colleagues118,119 proposed that the long-range varia-
tion in GC content may re¯ect that the genome is composed of a
mosaic of compositionally homogeneous regions that they dubbed
`isochores'. They suggested that the skewed distribution is com-
posed of ®ve normal distributions, corresponding to ®ve distinct
types of isochore (L1, L2, H1, H2 and H3, with GC contents of
, 38%, 38±42%, 42±47%, 47±52% and . 52%, respectively).
We studied the draft genome sequence to see whether strict
isochores could be identi®ed. For example, the sequence was
divided into 300-kb windows, and each window was subdivided
into 20-kb subwindows. We calculated the average GC content for
each window and subwindow, and investigated how much of the
variance in the GC content of subwindows across the genome can be
statistically `explained' by the average GC content in each window.
About three-quarters of the genome-wide variance among 20-kb
windows can be statistically explained by the average GC content of
300-kb windows that contain them, but the residual variance among
subwindows (standard deviation, 2.4%) is still far too large to be
consistent with a homogeneous distribution. In fact, the hypothesis
of homogeneity could be rejected for each 300-kb window in the
draft genome sequence.
Similar results were obtained with other window and subwindow
sizes. Some of the local heterogeneity in GC content is attributable to
transposable element insertions (see below). Such repeat elements
typically have a higher GC content than the surrounding sequence,
with the effect being strongest for the most recent insertions.
These results rule out a strict notion of isochores as composi-
tionally homogeneous. Instead, there is substantial variation at
many different scales, as illustrated in Fig. 13. Although isochores
do not appear to merit the pre®x `iso', the genome clearly does
contain large regions of distinctive GC content and it is likely to be
worth rede®ning the concept so that it becomes possible rigorously
to partition the genome into regions. In the absence of a precise
de®nition, we will loosely refer to such regions as `GC content
domains' in the context of the discussion below.
Fickett et al.120 have explored a model in which the underlying
preference for a particular GC content drifts continuously through-
out the genome, an approach that bears further examination.
Churchill121 has proposed that the boundaries between GC content
domains can in some cases be predicted by a hidden Markov model,
with one state representing a GC-rich region and one representing
an AT-rich region. We found that this approach tended to identify
only very short domains of less than a kilobase (data not shown),
but variants of this approach deserve further attention.
The correlation between GC content domains and various
biological properties is of great interest, and this is likely to be the
most fruitful route to understanding the basis of variation in GC
content. As described below, we con®rm the existence of strong
correlations with both repeat content and gene density. Using the
integration between the draft genome sequence and the cytogenetic
map described above, it is possible to con®rm a statistically
signi®cant correlation between GC content and Giemsa bands (G-
bands). For example, 98% of large-insert clones mapping to the
darkest G-bands are in 200-kb regions of low GC content (average
37%), whereas more than 80% of clones mapping to the lightest G-
bands are in regions of high GC content (average 45%)103. Estimated
band locations can be seen in Fig. 9 and viewed in the context of
other genome annotation at http://genome.ucsc.edu/goldenPath/
mapPlots/ and http://genome.ucsc.edu/goldenPath/hgTracks.html.
CpG islands
A related topic is the distribution of so-called CpG islands across the
genome. The dinucleotide CpG is notable because it is greatly
under-represented in human DNA, occurring at only about one-
®fth of the roughly 4% frequency that would be expected by simply
multiplying the typical fraction of Cs and Gs (0.21 ´ 0.21). The
de®cit occurs because most CpG dinucleotides are methylated on
the cytosine base, and spontaneous deamination of methyl-C
residues gives rise to T residues. (Spontaneous deamination of
ordinary cytosine residues gives rise to uracil residues that are
readily recognized and repaired by the cell.) As a result, methyl-
CpG dinucleotides steadily mutate to TpG dinucleotides. However,
the genome contains many `CpG islands' in which CpG dinucleo-
tides are not methylated and occur at a frequency closer to that
predicted by the local GC content. CpG islands are of particular
interest because many are associated with the 59 ends of genes122±127.
We searched the draft genome sequence for CpG islands. Ideally,
they should be de®ned by directly testing for the absence of cytosine
methylation, but that was not practical for this report. There are
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Figure 13 Variation in GC content at various scales. The GC content in subregions of a
100-Mb region of chromosome 1 is plotted, starting at about 83 Mb from the beginning of
the draft genome sequence. This region is AT-rich overall. Top, the GC content of the
entire 100-Mb region analysed in non-overlapping 20-kb windows. Middle, GC content of
the ®rst 10 Mb, analysed in 2-kb windows. Bottom, GC content of the ®rst 1 Mb, analysed
in 200-bp windows. At this scale, gaps in the sequence can be seen.
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various computer programs that attempt to identify CpG islands on
the basis of primary sequence alone. These programs differ in some
important respects (such as how aggressively they subdivide long
CpG-containing regions), and the precise correspondence with
experimentally undermethylated islands has not been validated.
Nevertheless, there is a good correlation, and computational ana-
lysis thus provides a reasonable picture of the distribution of CpG
islands in the genome.
To identify CpG islands, we used the de®nition proposed by
Gardiner-Garden and Frommer128 and embodied in a computer
program. We searched the draft genome sequence for CpG islands,
using both the full sequence and the sequence masked to eliminate
repeat sequences. The number of regions satisfying the de®nition of
a CpG island was 50,267 in the full sequence and 28,890 in the
repeat-masked sequence. The difference re¯ects the fact that some
repeat elements (notably Alu) are GC-rich. Although some of these
repeat elements may function as control regions, it seems unlikely
that most of the apparent CpG islands in repeat sequences are
functional. Accordingly, we focused on those in the non-repeated
sequence. The count of 28,890 CpG islands is reasonably close to the
previous estimate of about 35,000 (ref. 129, as modi®ed by ref. 130).
Most of the islands are short, with 60±70% GC content (Table 10).
More than 95% of the islands are less than 1,800 bp long, and more
than 75% are less than 850 bp. The longest CpG island (on
chromosome 10) is 36,619 bp long, and 322 are longer than 3,000
bp. Some of the larger islands contain ribosomal pseudogenes,
although RNA genes and pseudogenes account for only a small
proportion of all islands (, 0.5%). The smaller islands are consis-
tent with their previously hypothesized function, but the role of
these larger islands is uncertain.
The density of CpG islands varies substantially among some of
the chromosomes. Most chromosomes have 5±15 islands per Mb,
with a mean of 10.5 islands per Mb. However, chromosome Y has an
unusually low 2.9 islands per Mb, and chromosomes 16, 17 and 22
have 19±22 islands per Mb. The extreme outlier is chromosome 19,
with 43 islands per Mb. Similar trends are seen when considering the
percentage of bases contained in CpG islands. The relative density of
CpG islands correlates reasonably well with estimates of relative
gene density on these chromosomes, based both on previous
mapping studies involving ESTs (Fig. 14) and on the distribution
of gene predictions discussed below.
Comparison of genetic and physical distance
The draft genome sequence makes it possible to compare genetic
and physical distances and thereby to explore variation in the rate of
recombination across the human chromosomes. We focus here on
large-scale variation. Finer variation is examined in an accompany-
ing paper131.
The genetic and physical maps are integrated by 5,282 poly-
morphic loci from the Marsh®eld genetic map102, whose positions
are known in terms of centimorgans (cM) and Mb along the
chromosomes. Figure 15 shows the comparison of the draft
genome sequence for chromosome 12 with the male, female and
sex-averaged maps. One can calculate the approximate ratio of cM
per Mb across a chromosome (re¯ected in the slopes in Fig. 15) and
the average recombination rate for each chromosome arm.
Two striking features emerge from analysis of these data. First, the
average recombination rate increases as the length of the chromo-
some arm decreases (Fig. 16). Long chromosome arms have an
average recombination rate of about 1 cM per Mb, whereas the
shortest arms are in the range of 2 cM per Mb. A similar trend has
been seen in the yeast genome132,133, despite the fact that the physical
scale is nearly 200 times as small. Moreover, experimental studies
have shown that lengthening or shortening yeast chromosomes
results in a compensatory change in recombination rate132.
The second observation is that the recombination rate tends to be
suppressed near the centromeres and higher in the distal portions
of most chromosomes, with the increase largely in the terminal
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Total 28,890 100 19,818,547 100
.80% 22 0.08 5,916 0.03
70±80% 5,884 20 3,111,965 16
60±70% 18,779 65 13,110,924 66
50±60% 4,205 15 3,589,742 18
.............................................................................................................................................................................
Potential CpG islands were identi®ed by searching the draft genome sequence one base at a time,
scoring each dinucleotide (+17 for GC, -1 for others) and identifying maximally scoring segments.
Each segment was then evaluated to determine GC content ($50%), length (.200) and ratio of
observed proportion of GC dinucleotides to the expected proportion on the basis of the GC content
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Figure 14 Number of CpG islands per Mb for each chromosome, plotted against the
number of genes per Mb (the number of genes was taken from GeneMap98 (ref. 100)).
Chromosomes 16, 17, 22 and particularly 19 are clear outliers, with a density of CpG
islands that is even greater than would be expected from the high gene counts for these
four chromosomes.














































Figure 15 Distance in cM along the genetic map of chromosome 12 plotted against
position in Mb in the draft genome sequence. Female, male and sex-averaged maps are
shown. Female recombination rates are much higher than male recombination rates. The
increased slopes at either end of the chromosome re¯ect the increased rates of
recombination per Mb near the telomeres. Conversely, the ¯atter slope near the
centromere shows decreased recombination there, especially in male meiosis. This is
typical of the other chromosomes as well (see http://genome.ucsc.edu/goldenPath/
mapPlots). Discordant markers may be map, marker placement or assembly errors.
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20±35 Mb. The increase is most pronounced in the male meiotic
map. The effect can be seen, for example, from the higher slope at
both ends of chromosome 12 (Fig. 15). Regional and sex-speci®c
effects have been observed for chromosome 21 (refs 110, 134).
Why is recombination higher on smaller chromosome arms? A
higher rate would increase the likelihood of at least one crossover
during meiosis on each chromosome arm, as is generally observed
in human chiasmata counts135. Crossovers are believed to be
necessary for normal meiotic disjunction of homologous chromo-
some pairs in eukaryotes. An extreme example is the pseudoauto-
somal regions on chromosomes Xp and Yp, which pair during male
meiosis; this physical region of only 2.6 Mb has a genetic length of
50 cM (corresponding to 20 cM per Mb), with the result that a
crossover is virtually assured.
Mechanistically, the increased rate of recombination on shorter
chromosome arms could be explained if, once an initial recombina-
tion event occurs, additional nearby events are blocked by positive
crossover interference on each arm. Evidence from yeast mutants in
which interference is abolished shows that interference plays a key
role in distributing a limited number of crossovers among the
various chromosome arms in yeast136. An alternative possibility is
that a checkpoint mechanism scans for and enforces the presence of
at least one crossover on each chromosome arm.
Variation in recombination rates along chromosomes and
between the sexes is likely to re¯ect variation in the initiation of
meiosis-induced double-strand breaks (DSBs) that initiate recom-
bination. DSBs in yeast have been associated with open
chromatin137,138, rather than with speci®c DNA sequence motifs.
With the availability of the draft genome sequence, it should be
possible to explore in an analogous manner whether variation
in human recombination rates re¯ects systematic differences in
chromosome accessibility during meiosis.
Repeat content of the human genome
A puzzling observation in the early days of molecular biology was
that genome size does not correlate well with organismal complex-
ity. For example, Homo sapiens has a genome that is 200 times as
large as that of the yeast S. cerevisiae, but 200 times as small as that of
Amoeba dubia139,140. This mystery (the C-value paradox) was largely
resolved with the recognition that genomes can contain a large
quantity of repetitive sequence, far in excess of that devoted to
protein-coding genes (reviewed in refs 140, 141).
In the human, coding sequences comprise less than 5% of the
genome (see below), whereas repeat sequences account for at least
50% and probably much more. Broadly, the repeats fall into ®ve
classes: (1) transposon-derived repeats, often referred to as inter-
spersed repeats; (2) inactive (partially) retroposed copies of cellular
genes (including protein-coding genes and small structural RNAs),
usually referred to as processed pseudogenes; (3) simple sequence
repeats, consisting of direct repetitions of relatively short k-mers
such as (A)n, (CA)n or (CGG)n; (4) segmental duplications, con-
sisting of blocks of around 10±300 kb that have been copied from
one region of the genome into another region; and (5) blocks of
tandemly repeated sequences, such as at centromeres, telomeres,
the short arms of acrocentric chromosomes and ribosomal gene
clusters. (These regions are intentionally under-represented in the
draft genome sequence and are not discussed here.)
Repeats are often described as `junk' and dismissed as uninterest-
ing. However, they actually represent an extraordinary trove of
information about biological processes. The repeats constitute a
rich palaeontological record, holding crucial clues about evolu-
tionary events and forces. As passive markers, they provide assays
for studying processes of mutation and selection. It is possible to
recognize cohorts of repeats `born' at the same time and to follow
their fates in different regions of the genome or in different species.
As active agents, repeats have reshaped the genome by causing
ectopic rearrangements, creating entirely new genes, modifying and
reshuf¯ing existing genes, and modulating overall GC content. They
also shed light on chromosome structure and dynamics, and
provide tools for medical genetic and population genetic studies.
The human is the ®rst repeat-rich genome to be sequenced, and
so we investigated what information could be gleaned from this
majority component of the human genome. Although some of the
general observations about repeats were suggested by previous
studies, the draft genome sequence provides the ®rst comprehensive
view, allowing some questions to be resolved and new mysteries to
emerge.
Transposon-derived repeats
Most human repeat sequence is derived from transposable
elements142,143. We can currently recognize about 45% of the
genome as belonging to this class. Much of the remaining
`unique' DNA must also be derived from ancient transposable
element copies that have diverged too far to be recognized as
such. To describe our analyses of interspersed repeats, it is necessary
brie¯y to review the relevant features of human transposable
elements.
Classes of transposable elements. In mammals, almost all trans-
posable elements fall into one of four types (Fig. 17), of which three
transpose through RNA intermediates and one transposes directly
as DNA. These are long interspersed elements (LINEs), short
interspersed elements (SINEs), LTR retrotransposons and DNA
transposons.
LINEs are one of the most ancient and successful inventions in
eukaryotic genomes. In humans, these transposons are about 6 kb
long, harbour an internal polymerase II promoter and encode two
open reading frames (ORFs). Upon translation, a LINE RNA
assembles with its own encoded proteins and moves to the nucleus,
where an endonuclease activity makes a single-stranded nick and
the reverse transcriptase uses the nicked DNA to prime reverse
transcription from the 39 end of the LINE RNA. Reverse transcrip-
tion frequently fails to proceed to the 59 end, resulting in many
truncated, nonfunctional insertions. Indeed, most LINE-derived
repeats are short, with an average size of 900 bp for all LINE1 copies,
and a median size of 1,070 bp for copies of the currently active
LINE1 element (L1Hs). New insertion sites are ¯anked by a small
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Figure 16 Rate of recombination averaged across the euchromatic portion of each
chromosome arm plotted against the length of the chromosome arm in Mb. For large
chromosomes, the average recombination rates are very similar, but as chromosome arm
length decreases, average recombination rates rise markedly.
© 2001 Macmillan Magazines Ltd
target site duplication of 7±20 bp. The LINE machinery is believed
to be responsible for most reverse transcription in the genome,
including the retrotransposition of the non-autonomous SINEs144
and the creation of processed pseudogenes145,146. Three distantly
related LINE families are found in the human genome: LINE1,
LINE2 and LINE3. Only LINE1 is still active.
SINEs are wildly successful freeloaders on the backs of LINE
elements. They are short (about 100±400 bp), harbour an internal
polymerase III promoter and encode no proteins. These non-
autonomous transposons are thought to use the LINE machinery
for transposition. Indeed, most SINEs `live' by sharing the 39 end
with a resident LINE element144. The promoter regions of all known
SINEs are derived from tRNA sequences, with the exception of a
single monophyletic family of SINEs derived from the signal
recognition particle component 7SL. This family, which also does
not share its 39 end with a LINE, includes the only active SINE in the
human genome: the Alu element. By contrast, the mouse has both
tRNA-derived and 7SL-derived SINEs. The human genome con-
tains three distinct monophyletic families of SINEs: the active Alu,
and the inactive MIR and Ther2/MIR3.
LTR retroposons are ¯anked by long terminal direct repeats that
contain all of the necessary transcriptional regulatory elements. The
autonomous elements (retrotransposons) contain gag and pol
genes, which encode a protease, reverse transcriptase, RNAse H
and integrase. Exogenous retroviruses seem to have arisen from
endogenous retrotransposons by acquisition of a cellular envelope
gene (env)147. Transposition occurs through the retroviral mechan-
ism with reverse transcription occurring in a cytoplasmic virus-like
particle, primed by a tRNA (in contrast to the nuclear location and
chromosomal priming of LINEs). Although a variety of LTR retro-
transposons exist, only the vertebrate-speci®c endogenous retro-
viruses (ERVs) appear to have been active in the mammalian
genome. Mammalian retroviruses fall into three classes (I±III),
each comprising many families with independent origins. Most
(85%) of the LTR retroposon-derived `fossils' consist only of an
isolated LTR, with the internal sequence having been lost by
homologous recombination between the ¯anking LTRs.
DNA transposons resemble bacterial transposons, having term-
inal inverted repeats and encoding a transposase that binds near the
inverted repeats and mediates mobility through a `cut-and-paste'
mechanism. The human genome contains at least seven major
classes of DNA transposon, which can be subdivided into many
families with independent origins148 (see RepBase, http://www.
girinst.org/,server/repbase.html). DNA transposons tend to have
short life spans within a species. This can be explained by contrast-
ing the modes of transposition of DNA transposons and LINE
elements. LINE transposition tends to involve only functional
elements, owing to the cis-preference by which LINE proteins
assemble with the RNA from which they were translated. By
contrast, DNA transposons cannot exercise a cis-preference: the
encoded transposase is produced in the cytoplasm and, when it
returns to the nucleus, it cannot distinguish active from inactive
elements. As inactive copies accumulate in the genome, transposi-
tion becomes less ef®cient. This checks the expansion of any DNA
transposon family and in due course causes it to die out. To survive,
DNA transposons must eventually move by horizontal transfer
to virgin genomes, and there is considerable evidence for such
transfer149±153.
Transposable elements employ different strategies to ensure their
evolutionary survival. LINEs and SINEs rely almost exclusively on
vertical transmission within the host genome154 (but see refs 148,
155). DNA transposons are more promiscuous, requiring relatively
frequent horizontal transfer. LTR retroposons use both strategies,
with some being long-term active residents of the human genome
(such as members of the ERVL family) and others having only short
residence times.
articles
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Classes of interspersed repeat in the human genome
Figure 17 Almost all transposable elements in mammals fall into one of four classes. See text for details.














SINEs 1,558 359.6 13.14
Alu 1,090 290.1 10.60 1 (,20)
MIR 393 60.1 2.20 1 (1)
MIR3 75 9.3 0.34 1 (1)
LINEs 868 558.8 20.42
LINE1 516 462.1 16.89 1 (,55)
LINE2 315 88.2 3.22 1 (2)
LINE3 37 8.4 0.31 1 (2)
LTR elements 443 227.0 8.29
ERV-class I 112 79.2 2.89 72 (132)
ERV(K)-class II 8 8.5 0.31 10 (20)
ERV (L)-class III 83 39.5 1.44 21 (42)
MaLR 240 99.8 3.65 1 (31)
DNA elements 294 77.6 2.84
hAT group
MER1-Charlie 182 38.1 1.39 25 (50)
Zaphod 13 4.3 0.16 4 (10)
Tc-1 group
MER2-Tigger 57 28.0 1.02 12 (28)
Tc2 4 0.9 0.03 1 (5)
Mariner 14 2.6 0.10 4 (5)
PiggyBac-like 2 0.5 0.02 10 (20)
Unclassi®ed 22 3.2 0.12 7 (7)





The number of copies and base pair contributions of the major classes and subclasses of
transposable elements in the human genome. Data extracted from a RepeatMasker analysis of
the draft genome sequence (RepeatMasker version 09092000, sensitive settings, using RepBase
Update 5.08). In calculating percentages, RepeatMasker excluded the runs of Ns linking the contigs
in the draft genome sequence. In the last column, separate consensus sequences in the repeat
databases are considered subfamilies, rather than families, when the sequences are closely related
or related through intermediate subfamilies.
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Census of human repeats. We began by taking a census of the
transposable elements in the draft genome sequence, using a
recently updated version of the RepeatMasker program (version
09092000) run under sensitive settings (see http://repeatmasker.
genome.washington.edu). This program scans sequences to identify
full-length and partial members of all known repeat families
represented in RepBase Update (version 5.08; see http://www.
girinst.org/,server/repbase.html and ref. 156). Table 11 shows the
number of copies and fraction of the draft genome sequence
occupied by each of the four major classes and the main subclasses.
The precise count of repeats is obviously underestimated because
the genome sequence is not ®nished, but their density and other
properties can be stated with reasonable con®dence. Currently
recognized SINEs, LINEs, LTR retroposons and DNA transposon
copies comprise 13%, 20%, 8% and 3% of the sequence, respec-
tively. We expect these densities to grow as more repeat families are
recognized, among which will be lower copy number LTR elements
and DNA transposons, and possibly high copy number ancient
(highly diverged) repeats.
Age distribution. The age distribution of the repeats in the human
genome provides a rich `fossil record' stretching over several
hundred million years. The ancestry and approximate age of each
fossil can be inferred by exploiting the fact that each copy is derived
from, and therefore initially carried the sequence of, a then-active
transposon and, being generally under no functional constraint, has
accumulated mutations randomly and independently of other
copies. We can infer the sequence of the ancestral active elements
by clustering the modern derivatives into phylogenetic trees and
building a consensus based on the multiple sequence alignment of a
cluster of copies. Using available consensus sequences for known
repeat subfamilies, we calculated the per cent divergence from the
inferred ancestral active transposon for each of three million
interspersed repeats in the draft genome sequence.
The percentage of sequence divergence can be converted into an
approximate age in millions of years (Myr) on the basis of evolu-
tionary information. Care is required in calibrating the clock,
because the rate of sequence divergence may not be constant over
time or between lineages139. The relative-rate test157 can be used to
calculate the sequence divergence that accumulated in a lineage after
a given timepoint, on the basis of comparison with a sibling species
that diverged at that time and an outgroup species. For example, the
substitution rate over roughly the last 25 Myr in the human lineage
can be calculated by using old world monkeys (which diverged
about 25 Myr ago) as a sibling species and new world monkeys as an
outgroup. We have used currently available calibrations for the
human lineage, but the issue should be revisited as sequence
information becomes available from different mammals.
Figure 18a shows the representation of various classes of trans-
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Figure 18 Age distribution of interspersed repeats in the human and mouse genomes.
Bases covered by interspersed repeats were sorted by their divergence from their
consensus sequence (which approximates the repeat's original sequence at the time of
insertion). The average number of substitutions per 100 bp (substitution level, K ) was
calculated from the mismatch level p assuming equal frequency of all substitutions (the
one-parameter Jukes±Cantor model, K = -3/4ln(1 - 4/3p )). This model tends to
underestimate higher substitution levels. CpG dinucleotides in the consensus were
excluded from the substitution level calculations because the C!T transition rate in CpG
pairs is about tenfold higher than other transitions and causes distortions in comparing
transposable elements with high and low CpG content. a, The distribution, for the human
genome, in bins corresponding to 1% increments in substitution levels. b, The data
grouped into bins representing roughly equal time periods of 25 Myr. c,d, Equivalent data
for available mouse genomic sequence. There is a different correspondence between
substitution levels and time periods owing to different rates of nucleotide substitution in
the two species. The correspondence between substitution levels and time periods was
largely derived from three-way species comparisons (relative rate test139,157 ) with the age
estimates based on fossil data. Human divergence from gibbon 20±30 Myr; old world
monkey 25±35 Myr; prosimians 55±80 Myr; eutherian mammalian radiation ,100 Myr.
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posable elements in categories re¯ecting equal amounts of sequence
divergence. In Fig. 18b the data are grouped into four bins
corresponding to successive 25-Myr periods, on the basis of an
approximate clock. Figure 19 shows the mean ages of various
subfamilies of DNA transposons. Several facts are apparent from
these graphs. First, most interspersed repeats in the human genome
predate the eutherian radiation. This is a testament to the extremely
slow rate with which nonfunctional sequences are cleared from
vertebrate genomes (see below concerning comparison with the ¯y).
Second, LINE and SINE elements have extremely long lives. The
monophyletic LINE1 and Alu lineages are at least 150 and 80 Myr
old, respectively. In earlier times, the reigning transposons were
LINE2 and MIR148,158. The SINE MIR was perfectly adapted for
reverse transcription by LINE2, as it carried the same 50-base
sequence at its 39 end. When LINE2 became extinct 80±100 Myr
ago, it spelled the doom of MIR.
Third, there were two major peaks of DNA transposon activity
(Fig. 19). The ®rst involved Charlie elements and occurred long
before the eutherian radiation; the second involved Tigger elements
and occurred after this radiation. Because DNA transposons can
produce large-scale chromosome rearrangements159±162, it is possible
that widespread activity could be involved in speciation events.
Fourth, there is no evidence for DNA transposon activity in the
past 50 Myr in the human genome. The youngest two DNA
transposon families that we can identify in the draft genome
sequence (MER75 and MER85) show 6±7% divergence from their
respective consensus sequences representing the ancestral element
(Fig. 19), indicating that they were active before the divergence of
humans and new world monkeys. Moreover, these elements were
relatively unsuccessful, together contributing just 125 kb to the draft
genome sequence.
Finally, LTR retroposons appear to be teetering on the brink of
extinction, if they have not already succumbed. For example, the
most proli®c elements (ERVL and MaLRs) ¯ourished for more than
100 Myr but appear to have died out about 40 Myr ago163,164. Only a
single LTR retroposon family (HERVK10) is known to have trans-
posed since our divergence from the chimpanzee 7 Myr ago, with
only one known copy (in the HLA region) that is not shared
between all humans165. In the draft genome sequence, we can
identify only three full-length copies with all ORFs intact (the
®nal total may be slightly higher owing to the imperfect state of
the draft genome sequence).
More generally, the overall activity of all transposons has declined
markedly over the past 35±50 Myr, with the possible exception of
LINE1 (Fig. 18). Indeed, apart from an exceptional burst of activity
of Alus peaking around 40 Myr ago, there would appear to have
been a fairly steady decline in activity in the hominid lineage since
the mammalian radiation. The extent of the decline must be even
greater than it appears because old repeats are gradually removed by
random deletion and because old repeat families are harder to
recognize and likely to be under-represented in the repeat databases.
(We con®rmed that the decline in transposition is not an artefact
arising from errors in the draft genome sequence, which, in
principle, could increase the divergence level in recent elements.
First, the sequence error rate (Table 9) is far too low to have a
signi®cant effect on the apparent age of recent transposons; and
second, the same result is seen if one considers only ®nished
sequence.)
What explains the decline in transposon activity in the lineage
leading to humans? We return to this question below, in the context
of the observation that there is no similar decline in the mouse
genome.
Comparison with other organisms. We compared the complement
of transposable elements in the human genome with those of the
other sequenced eukaryotic genomes. We analysed the ¯y, worm
and mustard weed genomes for the number and nature of repeats
(Table 12) and the age distribution (Fig. 20). (For the ¯y, we
analysed the 114 Mb of un®nished `large' contigs produced by the
whole-genome shotgun assembly166, which are reported to represent
euchromatic sequence. Similar results were obtained by analysing
30 Mb of ®nished euchromatic sequence.) The human genome
stands in stark contrast to the genomes of the other organisms.
(1) The euchromatic portion of the human genome has a much
higher density of transposable element copies than the euchromatic
DNA of the other three organisms. The repeats in the other
organisms may have been slightly underestimated because the
repeat databases for the other organisms are less complete than
for the human, especially with regard to older elements; on the other
hand, recent additions to these databases appear to increase the
repeat content only marginally.
(2) The human genome is ®lled with copies of ancient transposons,
whereas the transposons in the other genomes tend to be of more
recent origin. The difference is most marked with the ¯y, but is clear
for the other genomes as well. The accumulation of old repeats is
likely to be determined by the rate at which organisms engage in
`housecleaning' through genomic deletion. Studies of pseudogenes
articles
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Table 12 Number and nature of interspersed repeats in eukaryotic genomes





















LINE/SINE 33.40% 6 0.70% 20 0.40% 10 0.50% 10
LTR 8.10% 100 1.50% 50 0.00% 4 4.80% 70
DNA 2.80% 60 0.70% 20 5.30% 80 5.10% 80
Total 44.40% 170 3.10% 90 6.50% 90 10.50% 160
...................................................................................................................................................................................................................................................................................................................................................................
The complete genomes of ¯y, worm, and chromosomes 2 and 4 of mustard weed (as deposited at ncbi.nlm.nih.gov/genbank/genomes) were screened against the repeats in RepBase Update 5.02
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Figure 19 Median ages and per cent of the genome covered by subfamilies of DNA
transposons. The Charlie and Zaphod elements were hobo-Activator-Tam3 (hAT) DNA
transposons; Mariner, Tc2 and Tigger were Tc1-like elements. Unlike retroposons, DNA
transposons are thought to have a short life span in a genome. Thus, the average or
median divergence of copies from the consensus is a particularly accurate measure of the
age of the DNA transposon copies.
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have suggested that small deletions occur at a rate that is 75-fold
higher in ¯ies than in mammals; the half-life of such nonfunctional
DNA is estimated at 12 Myr for ¯ies and 800 Myr for mammals167.
The rate of large deletions has not been systematically compared,
but seems likely also to differ markedly.
(3) Whereas in the human two repeat families (LINE1 and Alu)
account for 60% of all interspersed repeat sequence, the other
organisms have no dominant families. Instead, the worm, ¯y and
mustard weed genomes all contain many transposon families, each
consisting of typically hundreds to thousands of elements. This
difference may be explained by the observation that the vertically
transmitted, long-term residential LINE and SINE elements repre-
sent 75% of interspersed repeats in the human genome, but only 5±
25% in the other genomes. In contrast, the horizontally transmitted
and shorter-lived DNA transposons represent only a small portion
of all interspersed repeats in humans (6%) but a much larger
fraction in ¯y, mustard weed and worm (25%, 49% and 87%,
respectively). These features of the human genome are probably
general to all mammals. The relative lack of horizontally transmitted
elements may have its origin in the well developed immune system
of mammals, as horizontal transfer requires infectious vectors, such
as viruses, against which the immune system guards.
We also looked for differences among mammals, by comparing
the transposons in the human and mouse genomes. As with the
human genome, care is required in calibrating the substitution clock
for the mouse genome. There is considerable evidence that the rate
of substitution per Myr is higher in rodent lineages than in the
hominid lineages139,168,169. In fact, we found clear evidence for
different rates of substitution by examining families of transposable
elements whose insertions predate the divergence of the human and
mouse lineages. In an analysis of 22 such families, we found that the
substitution level was an average of 1.7-fold higher in mouse than
human (not shown). (This is likely to be an underestimate because
of an ascertainment bias against the most diverged copies.) The
faster clock in mouse is also evident from the fact that the ancient
LINE2 and MIR elements, which transposed before the mammalian
radiation and are readily detectable in the human genome, cannot
be readily identi®ed in available mouse genomic sequence (Fig. 18).
We used the best available estimates to calibrate substitution
levels and time169. The ratio of substitution rates varied from about
1.7-fold higher over the past 100 Myr to about 2.6-fold higher over
the past 25 Myr.
The analysis shows that, although the overall density of the four
transposon types in human and mouse is similar, the age distribu-
tion is strikingly different (Fig. 18). Transposon activity in the
mouse genome has not undergone the decline seen in humans and
proceeds at a much higher rate. In contrast to their possible
extinction in humans, LTR retroposons are alive and well in the
mouse with such representatives as the active IAP family and
putatively active members of the long-lived ERVL and MaLR
families. LINE1 and a variety of SINEs are quite active. These
evolutionary ®ndings are consistent with the empirical observations
that new spontaneous mutations are 30 times more likely to be
caused by LINE insertions in mouse than in human (,3% versus
0.1%)170 and 60 times more likely to be caused by transposable
elements in general. It is estimated that around 1 in 600 mutations
in human are due to transpositions, whereas 10% of mutations in
mouse are due to transpositions (mostly IAP insertions).
The contrast between human and mouse suggests that the
explanation for the decline of transposon activity in humans may
lie in some fundamental difference between hominids and rodents.
Population structure and dynamics would seem to be likely sus-
pects. Rodents tend to have large populations, whereas hominid
populations tend to be small and may undergo frequent bottle-
necks. Evolutionary forces affected by such factors include inbreed-
ing and genetic drift, which might affect the persistence of active
transposable elements171. Studies in additional mammalian lineages
may shed light on the forces responsible for the differences in the
activity of transposable elements172.
Variation in the distribution of repeats. We next explored varia-
tion in the distribution of repeats across the draft genome sequence,
by calculating the repeat density in windows of various sizes across
the genome. There is striking variation at smaller scales.
Some regions of the genome are extraordinarily dense in repeats.
The prizewinner appears to be a 525-kb region on chromosome
Xp11, with an overall transposable element density of 89%. This
region contains a 200-kb segment with 98% density, as well as a
segment of 100 kb in which LINE1 sequences alone comprise 89% of
the sequence. In addition, there are regions of more than 100 kb
with extremely high densities of Alu (. 56% at three loci, including
one on 7q11 with a 50-kb stretch of . 61% Alu) and the ancient
transposons MIR (. 15% on chromosome 1p36) and LINE2
(. 18% on chromosome 22q12).
In contrast, some genomic regions are nearly devoid of repeats.
The absence of repeats may be a sign of large-scale cis-regulatory
elements that cannot tolerate being interrupted by insertions. The
four regions with the lowest density of interspersed repeats in the
human genome are the four homeobox gene clusters, HOXA,
HOXB, HOXC and HOXD (Fig. 21). Each locus contains regions
of around 100 kb containing less than 2% interspersed repeats.
Ongoing sequence analysis of the four HOX clusters in mouse, rat
and baboon shows a similar absence of transposable elements, and
reveals a high density of conserved noncoding elements (K. Dewar
and B. Birren, manuscript in preparation). The presence of a
complex collection of regulatory regions may explain why indivi-
dual HOX genes carried in transgenic mice fail to show proper
regulation.
It may be worth investigating other repeat-poor regions, such as a
region on chromosome 8q21 (1.5% repeat over 63 kb) containing a
gene encoding a homeodomain zinc-®nger protein (homologous to
mouse pID 9663936), a region on chromosome 1p36 (5% repeat
over 100 kb) with no obvious genes and a region on chromosome
18q22 (4% over 100 kb) containing three genes of unknown func-
tion (among which is KIAA0450). It will be interesting to see
whether the homologous regions in the mouse genome have
articles
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100 kb HoxD cluster
chr 22
chr 2
Figure 21 Two regions of about 1 Mb on chromosomes 2 and 22. Red bars, interspersed
repeats; blue bars, exons of known genes. Note the de®cit of repeats in the HoxD cluster,



















































Figure 20 Comparison of the age of interspersed repeats in eukaryotic genomes. The
copies of repeats were pooled by their nucleotide substitution level from the consensus.
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similarly resisted the insertion of transposable elements during
rodent evolution.
Distribution by GC content. We next focused on the correlation
between the nature of the transposons in a region and its GC
content. We calculated the density of each repeat type as a function
of the GC content in 50-kb windows (Fig. 22). As has been
reported142,173±176, LINE sequences occur at much higher density in
AT-rich regions (roughly fourfold enriched), whereas SINEs (MIR,
Alu) show the opposite trend (for Alu, up to ®vefold lower in AT-
rich DNA). LTR retroposons and DNA transposons show a more
uniform distribution, dipping only in the most GC-rich regions.
The preference of LINEs for AT-rich DNA seems like a reasonable
way for a genomic parasite to accommodate its host, by targeting
gene-poor AT-rich DNA and thereby imposing a lower mutational
burden. Mechanistically, selective targeting is nicely explained by
the fact that the preferred cleavage site of the LINE endonuclease is
TTTT/A (where the slash indicates the point of cleavage), which is
used to prime reverse transcription from the poly(A) tail of LINE
RNA177.
The contrary behaviour of SINEs, however, is baf¯ing. How do
SINEs accumulate in GC-rich DNA, particularly if they depend on
the LINE transposition machinery178? Notably, the same pattern is
seen for the Alu-like B1 and the tRNA-derived SINEs in mouse and
for MIR in human142. One possibility is that SINEs somehow target
GC-rich DNA for insertion. The alternative is that SINEs initially
insert with the same proclivity for AT-rich DNA as LINEs, but that
the distribution is subsequently reshaped by evolutionary
forces142,179.
We used the draft genome sequence to investigate this mystery by
comparing the proclivities of young, adolescent, middle-aged and
old Alus (Fig. 23). Strikingly, recent Alus show a preference for AT-
rich DNA resembling that of LINEs, whereas progressively older
Alus show a progressively stronger bias towards GC-rich DNA.
These results indicate that the GC bias must result from strong
pressure: Fig. 23 shows that a 13-fold enrichment of Alus in GC-rich
DNA has occurred within the last 30 Myr, and possibly more
recently.
These results raise a new mystery. What is the force that produces
the great and rapid enrichment of Alus in GC-rich DNA? One
explanation may be that deletions are more readily tolerated in
gene-poor AT-rich regions than in gene-rich GC-rich regions,
resulting in older elements being enriched in GC-rich regions.
Such an enrichment is seen for transposable elements such as
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AluY < 1%  (<1 Myr)
AluY 1–4%  (1–5 Myr)
AluY > 4%  (5–30 Myr)
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Figure 23 Alu elements target AT-rich DNA, but accumulate in GC-rich DNA. This graph
shows the relative distribution of various Alu cohorts as a function of local GC content. The
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Figure 24 DNA transposon copies in AT-rich DNA tend to be younger than those in more
GC-rich DNA. DNA transposon families were grouped into ®ve age categories by their
median substitution level (see Fig. 19). The proportion attributed to each age class is
shown as a function of GC content. Similar patterns are seen for LINE1 and LTR elements.
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DNA transposons (Fig. 24). However, this effect seems too slow and
too small to account for the observed remodelling of the Alu
distribution. This can be seen by performing a similar analysis for
LINE elements (Fig. 25). There is no signi®cant change in the LINE
distribution over the past 100 Myr, in contrast to the rapid change
seen for Alu. There is an eventual shift after more than 100 Myr,
although its magnitude is still smaller than seen for Alus.
These observations indicate that there may be some force acting
particularly on Alus. This could be a higher rate of random loss of
Alus in AT-rich DNA, negative selection against Alus in AT-rich
DNA or positive selection in favour of Alus in GC-rich DNA.
The ®rst two possibilities seem unlikely because AT-rich DNA is
gene-poor and tolerates the accumulation of other transposable
elements. The third seems more feasible, in that it involves selecting
in favour of the minority of Alus in GC-rich regions rather than
against the majority that lie in AT-rich regions. But positive
selection for Alus in GC-rich regions would imply that they bene®t
the organism.
Schmid180 has proposed such a function for SINEs. This hypoth-
esis is based on the observation that in many species SINEs are
transcribed under conditions of stress, and the resulting RNAs
speci®cally bind a particular protein kinase (PKR) and block its
ability to inhibit protein translation181±183. SINE RNAs would thus
promote protein translation under stress. SINE RNA may be well
suited to such a role in regulating protein translation, because it can
be quickly transcribed in large quantities from thousands of
elements and it can function without protein translation. Under
this theory, there could be positive selection for SINEs in readily
transcribed open chromatin such as is found near genes. This could
explain the retention of Alus in gene-rich GC-rich regions. It is also
consistent with the observation that SINE density in AT-rich DNA is
higher near genes142.
Further insight about Alus comes from the relationship between
Alu density and GC content on individual chromosomes (Fig. 26).
There are two outliers. Chromosome 19 is even richer in Alus than
predicted by its (high) GC content; the chromosome comprises 2%
of the genome, but contains 5% of Alus. On the other hand,
chromosome Y shows the lowest density of Alus relative to its GC
content, being higher than average for GC content less than 40%
and lower than average for GC content over 40%. Even in AT-rich
DNA, Alus are under-represented on chromosome Y compared
with other young interspersed repeats (see below). These phenom-
ena may be related to an unusually high gene density on chromo-
some 19 and an unusually low density of somatically active genes on
chromosome Y (both relative to GC content). This would be
consistent with the idea that Alu correlates not with GC content
but with actively transcribed genes.
Our results may support the controversial idea that SINEs
actually earn their keep in the genome. Clearly, much additional
work will be needed to prove or disprove the hypothesis that SINEs
are genomic symbionts.
Biases in human mutation. Indirect studies have suggested
that nucleotide substitution is not uniform across mammalian
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Figure 25 Distribution of various LINE cohorts as a function of local GC content. The
divergence levels and ages of the cohorts are shown in the key. (The divergence levels
were measured for the 39 UTR of the LINE1 element only, which is best characterized
evolutionarily. This region contains almost no CpG sites, and thus 1% divergence level
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Figure 26 Comparison of the Alu density of each chromosome as a function of local GC
content. At higher GC levels, the Alu density varies widely between chromosomes, with
chromosome 19 being a particular outlier. In contrast, the LINE1 density pattern is quite
uniform for most chromosomes, with the exception of a 1.5 to 2-fold over-representation
in AT-rich regions of the X and Y chromosomes (not shown).
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genomes184±187. By studying sets of repeat elements belonging to a
common cohort, one can directly measure nucleotide substitution
rates in different regions of the genome. We ®nd strong evidence
that the pattern of neutral substitution differs as a function of local
GC content (Fig. 27). Because the results are observed in repetitive
elements throughout the genome, the variation in the pattern of
nucleotide substitution seems likely to be due to differences in the
underlying mutational process rather than to selection.
The effect can be seen most clearly by focusing on the substitution
process g $ a, where g denotes GC or CG base pairs and a denotes
ATor TA base pairs. If K is the equilibrium constant in the direction
of a base pairs (de®ned by the ratio of the forward and reverse
rates), then the equilibrium GC content should be 1/(1 + K). Two
observations emerge.
First, there is a regional bias in substitution patterns. The
equilibrium constant varies as a function of local GC content: g
base pairs are more likely to mutate towards a base pairs in AT-rich
regions than in GC-rich regions. For the analysis in Fig. 27, the
equilibrium constant K is 2.5, 1.9 and 1.2 when the draft genome
sequence is partitioned into three bins with average GC content of
37, 43 and 50%, respectively. This bias could be due to a reported
tendency for GC-rich regions to replicate earlier in the cell cycle
than AT-rich regions and for guanine pools, which are limiting for
DNA replication, to become depleted late in the cell cycle, thereby
resulting in a small but signi®cant shift in substitution towards a
base pairs186,188. Another theory proposes that many substitutions
are due to differences in DNA repair mechanisms, possibly related
to transcriptional activity and thereby to gene density and GC
content185,189,190.
There is also an absolute bias in substitution patterns resulting in
directional pressure towards lower GC content throughout the
human genome. The genome is not at equilibrium with respect to
the pattern of nucleotide substitution: the expected equilibrium GC
content corresponding to the values of K above is 29, 35 and 44% for
regions with average GC contents of 37, 43 and 50%, respectively.
Recent observations on SNPs190 con®rm that the mutation pattern
in GC-rich DNA is biased towards a base pairs; it should be possible
to perform similar analyses throughout the genome with the
availability of 1.4 million SNPs97,191. On the basis solely of nucleotide
substitution patterns, the GC content would be expected to be about
7% lower throughout the genome.
What accounts for the higher GC content? One possible explana-
tion is that in GC-rich regions, a considerable fraction of the
nucleotides is likely to be under functional constraint owing to
the high gene density. Selection on coding regions and regulatory
CpG islands may maintain the higher-than-predicted GC content.
Another is that throughout the rest of the genome, a constant in¯ux
of transposable elements tends to increase GC content (Fig. 28).
Young repeat elements clearly have a higher GC content than their
surrounding regions, except in extremely GC-rich regions. More-
over, repeat elements clearly shift with age towards a lower GC
content, closer to that of the neighbourhood in which they reside.
Much of the `non-repeat' DNA in AT-rich regions probably consists
of ancient repeats that are not detectable by current methods and
that have had more time to approach the local equilibrium value.
The repeats can also be used to study how the mutation process is
affected by the immediately adjacent nucleotide. Such `context
effects' will be discussed elsewhere (A. Kas and A. F. A. Smit,
unpublished results).
Fast living on chromosome Y. The pattern of interspersed repeats
can be used to shed light on the unusual evolutionary history of
chromosome Y. Our analysis shows that the genetic material on
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Figure 27 Substitution patterns in interspersed repeats differ as a function of GC content.
We collected all copies of ®ve DNA transposons (Tigger1, Tigger2, Charlie3, MER1 and
HSMAR2), chosen for their high copy number and well de®ned consensus sequences.
DNA transposons are optimal for the study of neutral substitutions: they do not segregate
into subfamilies with diagnostic differences, presumably because they are short-lived and
new active families do not evolve in a genome (see text). Duplicates and close paralogues
resulting from duplication after transposition were eliminated. The copies were grouped
on the basis of GC content of the ¯anking 1,000 bp on both sides and aligned to the
consensus sequence (representing the state of the copy at integration). Recursive efforts
using parameters arising from this study did not change the alignments signi®cantly.
Alignments were inspected by hand, and obvious misalignments caused by insertions and
duplications were eliminated. Substitutions (n  80; 000) were counted for each position
in the consensus, excluding those in CpG dinucleotides, and a substitution frequency
matrix was de®ned. From the matrices for each repeat (which corresponded to different
ages), a single rate matrix was calculated for these bins of GC content (, 40% GC, 40±
47% GC and . 47% GC). Data are shown for a repeat with an average divergence (in
non-CpG sites) of 18% in 43% GC content (the repeat has slightly higher divergence in
AT-rich DNA and lower in GC-rich DNA). From the rate matrix, we calculated log-likelihood
matrices with different entropies (divergence levels), which are theoretically optimal for
alignments of neutrally diverged copies to their common ancestral state (A. Kas and
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Figure 28 Interspersed repeats tend to diminish the differences between GC bins, despite
the fact that GC-rich transposable elements (speci®cally Alu) accumulate in GC-rich DNA,
and AT-rich elements (LINE1) in AT-rich DNA. The GC content of particular components of
the sequence (repeats, young repeats and non-repeat sequence) was calculated as a
function of overall GC content.
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chromosome Y is unusually young, probably owing to a high
tolerance for gain of new material by insertion and loss of old
material by deletion. Several lines of evidence support this picture.
For example, LINE elements on chromosome Yare on average much
younger than those on autosomes (not shown). Similarly, MaLR-
family retroposons on chromosome Y are younger than those on
autosomes, with the representation of subfamilies showing a strong
inverse correlation with the age of the subfamily. Moreover, chro-
mosome Y has a relative over-representation of the younger retro-
viral class II (ERVK) and a relative under-representation of the
primarily older class III (ERVL) compared with other chromo-
somes. Overall, chromosome Y seems to maintain a youthful
appearance by rapid turnover.
Interspersed repeats on chromosome Y can also be used to
estimate the relative mutation rates, am and af, in the male and
female germlines. Chromosome Y always resides in males, whereas
chromosome X resides in females twice as often as in males. The
substitution rates, mY and mX, on these two chromosomes should
thus be in the ratio mY:mX = (am):(am + 2af)/3, provided that one
considers equivalent neutral sequences. Several authors have esti-
mated the mutation rate in the male germline to be ®vefold higher
than in the female germline, by comparing the rates of evolution of
X- and Y-linked genes in humans and primates. However, Page and
colleagues192 have challenged these estimates as too high. They
studied a 39-kb region that is apparently devoid of genes and resides
within a large segmental duplication from X to Y that occurred 3±4
Myr ago in the human lineage. On the basis of phylogenetic analysis
of the sequence on human Y and human, chimp and gorilla X, they
obtained a much lower estimate of mY:mX = 1.36, corresponding to
am:af = 1.7. They suggested that the other estimates may have been
higher because they were based on much longer evolutionary
periods or because the genes studied may have been under selection.
Our database of human repeats provides a powerful resource for
addressing this question. We identi®ed the repeat elements from
recent subfamilies (effectively, birth cohorts dating from the past
50 Myr) and measured the substitution rates for subfamily members
on chromosomes X and Y (Fig. 29). There is a clear linear relation-
ship with a slope of mY:mX = 1.57 corresponding to am:af = 2.1. The
estimate is in reasonable agreement with that of Page et al., although
it is based on much more total sequence (360 kb on Y, 1.6 Mb on X)
and a much longer time period. In particular, the discrepancy with
earlier reports is not explained by recent changes in the human
lineage. Various theories have been proposed for the higher muta-
tion rate in the male germline, including the greater number of cell
divisions in the formation of sperm than eggs and different repair
mechanisms in sperm and eggs.
Active transposons. We were interested in identifying the youngest
retrotransposons in the draft genome sequence. This set should
contain the currently active retrotransposons, as well as the inser-
tion sites that are still polymorphic in the human population.
The youngest branch in the phylogenetic tree of human LINE1
elements is called L1Hs (ref. 158); it differs in its 39 untranslated
region (UTR) by 12 diagnostic substitutions from the next oldest
subfamily (L1PA2). Within the L1Hs family, there are two
subsets referred to as Ta and pre-Ta, de®ned by a diagnostic
trinucleotide193,194. All active L1 elements are thought to belong to
these two subsets, because they account for all 14 known cases of
human disease arising from new L1 transposition (with 13 belong-
ing to the Ta subset and one to the pre-Ta subset)195,196. These
subsets are also of great interest for population genetics because at
least 50% are still segregating as polymorphisms in the human
population194,197; they provide powerful markers for tracing
population history because they represent unique (non-recurrent
and non-revertible) genetic events that can be used (along with
similarly polymorphic Alus) for reconstructing human migrations.
LINE1 elements that are retrotransposition-competent should
consist of a full-length sequence and should have both ORFs intact.
Eleven such elements from the Ta subset have been identi®ed,
including the likely progenitors of mutagenic insertions into the
factor VIII and dystrophin genes198±202. A cultured cell retrotrans-
position assay has revealed that eight of these elements remain
retrotransposition-competent200,202,203.
We searched the draft genome sequence and identi®ed 535 LINEs
belonging to the Ta subset and 415 belonging to the pre-Ta subset.
These elements provide a large collection of tools for probing
human population history. We also identi®ed those consisting of
full-length elements with intact ORFs, which are candidate active
LINEs. We found 39 such elements belonging to the Ta subset and
22 belonging to the pre-Ta subset; this substantially increases the
number in the ®rst category and provides the ®rst known examples
in the second category. These elements can now be tested for
retrotransposition competence in the cell culture assay. Preliminary
analysis resulted in the identi®cation of two of these elements as the
likely progenitors of mutagenic insertions into the b-globin and
RP2 genes (R. Badge and J. V. Moran, unpublished data). Similar
analyses should allow the identi®cation of the progenitors of most,
if not all, other known mutagenic L1 insertions.
L1 elements can carry extra DNA if transcription extends through
the native transcriptional termination site into ¯anking genomic
DNA. This process, termed L1-mediated transduction, provides a
means for the mobilization of DNA sequences around the genome
and may be a mechanism for `exon shuf¯ing'204. Twenty-one per
cent of the 71 full-length L1s analysed contained non-L1-derived
sequences before the 39 target-site duplication site, in cases in which
the site was unambiguously recognizable. The length of the trans-
duced sequence was 30±970 bp, supporting the suggestion that 0.5±
1.0% of the human genome may have arisen by LINE-based
transduction of 39 ¯anking sequences205,206.
Our analysis also turned up two instances of 59 transduction
(145 bp and 215 bp). Although this possibility had been suggested
on the basis of cell culture models195,203, these are the ®rst docu-
mented examples. Such events may arise from transcription initiat-
ing in a cellular promoter upstream of the L1 elements. L1
transcription is generally con®ned to the germline207,208, but
transcription from other promoters could explain a somatic L1
retrotransposition event that resulted in colon cancer206.
Transposons as a creative force. The primary force for the origin
and expansion of most transposons has been selection for their
ability to create progeny, and not a selective advantage for the host.
However, these sel®sh pieces of DNA have been responsible for
important innovations in many genomes, for example by contri-
buting regulatory elements and even new genes.
Twenty human genes have been recognized as probably derived
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Figure 29 Higher substitution rate on chromosome Y than on chromosome X. We
calculated the median substitution level (excluding CpG sites) for copies of the most recent
L1 subfamilies (L1Hs±L1PA8) on the X and Y chromosomes. Only the 39 UTR of the L1
element was considered because its consensus sequence is best established.
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from transposons142,209. These include the RAG1 and RAG2 recom-
binases and the major centromere-binding protein CENPB. We
scanned the draft genome sequence and identi®ed another 27 cases,
bringing the total to 47 (Table 13; refs 142, 209). All but four are
derived from DNA transposons, which give rise to only a small
proportion of the interspersed repeats in the genome. Why there are
so many DNA transposase-like genes, many of which still contain
the critical residues for transposase activity, is a mystery.
To illustrate this concept, we describe the discovery of one of the
new examples. We searched the draft genome sequence to identify
the autonomous DNA transposon responsible for the distribution
of the non-autonomous MER85 element, one of the most recently
(40±50 Myr ago) active DNA transposons. Most non-autonomous
elements are internal deletion products of a DNA transposon. We
identi®ed one instance of a large (1,782 bp) ORF ¯anked by the 59
and 39 halves of a MER85 element. The ORF encodes a novel protein
(partially published as pID 6453533) whose closest homologue is
the transposase of the piggyBac DNA transposon, which is found in
insects and has the same characteristic TTAA target-site
duplications210 as MER85. The ORF is actively transcribed in fetal
brain and in cancer cells. That it has not been lost to mutation in
40±50 Myr of evolution (whereas the ¯anking, noncoding, MER85-
like termini show the typical divergence level of such elements) and
is actively transcribed provides strong evidence that it has been
adopted by the human genome as a gene. Its function is unknown.
LINE1 activity clearly has also had fringe bene®ts. We mentioned
above the possibility of exon reshuf¯ing by cotranscription of
neighbouring DNA. The LINE1 machinery can also cause reverse
transcription of genic mRNAs, which typically results in nonfunc-
tional processed pseudogenes but can, occasionally, give rise to
functional processed genes. There are at least eight human and
eight mouse genes for which evidence strongly supports such an
origin211 (see http://www-i®.uni-muenster.de/exapted-retrogenes/
tables.html). Many other intronless genes may have been created
in the same way.
Transposons have made other creative contributions to the
genome. A few hundred genes, for example, use transcriptional
terminators donated by LTR retroposons (data not shown). Other
genes employ regulatory elements derived from repeat elements211.
Simple sequence repeats
Simple sequence repeats (SSRs) are a rather different type of
repetitive structure that is common in the human genomeÐperfect
or slightly imperfect tandem repeats of a particular k-mer. SSRs with
a short repeat unit (n = 1±13 bases) are often termed microsa-
articles
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Table 13 Human genes derived from transposable elements
GenBank ID* Gene name Related transposon family² Possible fusion gene§ Newly recognized derivationk
nID 3150436 BC200 FLAM Alu³
pID 2330017 Telomerase non-LTR retrotransposon
pID 1196425 HERV-3 env Retroviridae/HERV-R³
pID 4773880 Syncytin Retroviridae/HERV-W³
pID 131827 RAG1 and 2 Tc1-like
pID 29863 CENP-B Tc1/Pogo
EST 2529718 Tc1/Pogo +
PID 10047247 Tc1/Pogo/Pogo +
EST 4524463 Tc1/Pogo/Pogo +
pID 4504807 Jerky Tc1/Pogo/Tigger
pID 7513096 JRKL Tc1/Pogo/Tigger
EST 5112721 Tc1/Pogo/Tigger +
EST 11097233 Tc1/Pogo/Tigger +
EST 6986275 Sancho Tc1/Pogo/Tigger
EST 8616450 Tc1/Pogo/Tigger +
EST 8750408 Tc1/Pogo/Tigger +
EST 5177004 Tc1/Pogo/Tigger +
PID 3413884 KIAA0461 Tc1/Pogo/Tc2 +
PID 7959287 KIAA1513 Tc1/Pogo/Tc2 +
PID 2231380 Tc1/Mariner/Hsmar1³ +
EST 10219887 hAT/Hobo + +
PID 6581095 Buster1 hAT/Charlie +
PID 7243087 Buster2 hAT/Charlie +
PID 6581097 Buster3 hAT/Charlie
PID 7662294 KIAA0766 hAT/Charlie +
PID 10439678 hAT/Charlie +
PID 7243087 KIAA1353 hAT/Charlie +
PID 7021900 hAT/Charlie/Charlie3³ +
PID 4263748 hAT/Charlie/Charlie8³ +
EST 8161741 hAT/Charlie/Charlie9³ +
pID 4758872 DAP4,pP52rIPK hAT/Tip100/Zaphod
EST 10990063 hAT/Tip100/Zaphod +
EST 10101591 hAT/Tip100/Zaphod +
pID 7513011 KIAA0543 hAT/Tip100/Tip100 +
pID 10439744 hAT/Tip100/Tip100 +
pID 10047247 KIAA1586 hAT/Tip100/Tip100 +
pID 10439762 hAT/Tip100 + +
EST 10459804 hAT/Tip100 +
pID 4160548 Tramp hAT/Tam3 +
BAC 3522927 hAT/Tam3 +
pID 3327088 KIAA0637 hAT/Tam3 +
EST 1928552 hAT/Tam3 +
pID 6453533 piggyBac/MER85³ +
EST 3594004 piggyBac/MER85³ +
BAC 4309921 piggyBac/MER85³ +
EST 4073914 piggyBac/MER75³ +
EST 1963278 piggyBac +
...................................................................................................................................................................................................................................................................................................................................................................
The Table lists 47 human genes, with a likely origin in up to 38 different transposon copies.
* Where available, the GenBank ID numbers are given for proteins, otherwise a representative EST or a clone name is shown. Six groups (two or three genes each) have similarity at the DNA level well beyond
that observed between different DNA transposon families in the genome; they are indicated in italics, with all but the initial member of each group indented. This could be explained if the genes were
paralogous (derived from a single inserted transposon and subsequently duplicated).
² Classi®cation of the transposon.
³ Indicates that the transposon from which the gene is derived is precisely known.
§ Proteins probably formed by fusion of a cellular and transposon gene; many have acquired zinc-®nger domains.
kNot previously reported as being derived from transposable element genes. The remaining genes can be found in refs 142, 209.
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tellites, whereas those with longer repeat units (n = 14±500 bases)
are often termed minisatellites. With the exception of poly(A) tails
from reverse transcribed messages, SSRs are thought to arise by
slippage during DNA replication212,213.
We compiled a catalogue of all SSRs over a given length in the
human draft genome sequence, and studied their properties
(Table 14). SSRs comprise about 3% of the human genome, with
the greatest single contribution coming from dinucleotide repeats
(0.5%). (The precise criteria for the number of repeat units and the
extent of divergence allowed in an SSR affect the exact census, but
not the qualitative conclusions.)
There is approximately one SSR per 2 kb (the number of non-
overlapping tandem repeats is 437 per Mb). The catalogue con®rms
various properties of SSRs that have been inferred from sampling
approaches (Table 15). The most frequent dinucleotide repeats are
AC and AT (50 and 35% of dinucleotide repeats, respectively),
whereas AG repeats (15%) are less frequent and GC repeats (0.1%)
are greatly under-represented. The most frequent trinucleotides are
AAT and AAC (33% and 21%, respectively), whereas ACC (4.0%),
AGC (2.2%), ACT (1.4%) and ACG (0.1%) are relatively rare.
Overall, trinucleotide SSRs are much less frequent than dinucleotide
SSRs214.
SSRs have been extremely important in human genetic studies,
because they show a high degree of length polymorphism in the
human population owing to frequent slippage by DNA polymerase
during replication. Genetic markers based on SSRsÐparticularly
(CA)n repeatsÐhave been the workhorse of most human disease-
mapping studies101,102. The availability of a comprehensive catalogue
of SSRs is thus a boon for human genetic studies.
The SSR catalogue also allowed us to resolve a mystery regarding
mammalian genetic maps. Such genetic maps in rat, mouse and
human have a de®cit of polymorphic (CA)n repeats on chromosome
X30,101. There are two possible explanations for this de®cit. There
may simply be fewer (CA)n repeats on chromosome X; or (CA)n
repeats may be as dense on chromosome X but less polymorphic in
the population. In fact, analysis of the draft genome sequence shows
that chromosome X has the same density of (CA)n repeats per Mb as
the autosomes (data not shown). Thus, the de®cit of polymorphic
markers relative to autosomes results from population genetic
forces. Possible explanations include that chromosome X has a
smaller effective population size, experiences more frequent selec-
tive sweeps reducing diversity (owing to its hemizygosity in males),
or has a lower mutation rate (owing to its more frequent passage
through the less mutagenic female germline). The availability of the
draft genome sequence should provide ways to test these alternative
explanations.
Segmental duplications
A remarkable feature of the human genome is the segmental
duplication of portions of genomic sequence215±217. Such duplica-
tions involve the transfer of 1±200-kb blocks of genomic sequence
to one or more locations in the genome. The locations of both
donor and recipient regions of the genome are often not tandemly
arranged, suggesting mechanisms other than unequal crossing-over
for their origin. They are relatively recent, inasmuch as strong
sequence identity is seen in both exons and introns (in contrast to
regions that are considered to show evidence of ancient duplica-
tions, characterized by similarities only in coding regions). Indeed,
many such duplications appear to have arisen in very recent
evolutionary time, as judged by high sequence identity and by
their absence in closely related species.
Segmental duplications can be divided into two categories. First,
interchromosomal duplications are de®ned as segments that are
duplicated among nonhomologous chromosomes. For example, a
9.5-kb genomic segment of the adrenoleukodystrophy locus from
Xq28 has been duplicated to regions near the centromeres of
chromosomes 2, 10, 16 and 22 (refs 218, 219). Anecdotal observations
suggest that many interchromosomal duplications map near the
centromeric and telomeric regions of human chromosomes218±233.
The second category is intrachromosomal duplications, which
occur within a particular chromosome or chromosomal arm. This
category includes several duplicated segments, also known as low
copy repeat sequences, that mediate recurrent chromosomal struc-
tural rearrangements associated with genetic disease215,217. Examples
on chromosome 17 include three copies of a roughly 200-kb repeat
separated by around 5 Mb and two copies of a roughly 24-kb repeat
separated by 1.5 Mb. The copies are so similar (99% identity) that
paralogous recombination events can occur, giving rise to contig-
uous gene syndromes: Smith±Magenis syndrome and Charcot±
Marie±Tooth syndrome 1A, respectively34,234. Several other exam-
ples are known and are also suspected to be responsible for recurrent
microdeletion syndromes (for example, Prader±Willi/Angelman,
articles
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Table 15 SSRs by repeat unit
















SSRs were identi®ed as in Table 14.
Table 14 SSR content of the human genome














SSRs were identi®ed by using the computer program Tandem Repeat Finder with the following
parameters: match score 2, mismatch score 3, indel 5, minimum alignment 50, maximum repeat
length 500, minimum repeat length 1.
Figure 30 Duplication landscape of chromosome 22. The size and location of
intrachromosomal (blue) and interchromosomal (red) duplications are depicted for
chromosome 22q, using the PARASIGHT computer program (Bailey and Eichler,
unpublished). Each horizontal line represents 1 Mb (ticks, 100-kb intervals). The
chromosome sequence is oriented from centromere (top left) to telomere (bottom right).
Pairwise alignments with . 90% nucleotide identity and . 1 kb long are shown. Gaps
within the chromosomal sequence are of known size and shown as empty space.
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velocardiofacial/DiGeorge and Williams' syndromes215,235±240).
Until now, the identi®cation and characterization of segmental
duplications have been based on anecdotal reportsÐfor example,
®nding that certain probes hybridize to multiple chromosomal sites
or noticing duplicated sequence at certain recurrent chromosomal
breakpoints. The availability of the entire genomic sequence will
make it possible to explore the nature of segmental duplications
more systematically. This analysis can begin with the current state of
the draft genome sequence, although caution is required because
some apparent duplications may arise from a failure to merge
sequence contigs from overlapping clones. Alternatively, erroneous
assembly of closely related sequences from nonoverlapping clones
may underestimate the true frequency of such features, particularly
among those segments with the highest sequence similarity. Accord-
ingly, we adopted a conservative approach for estimating such
duplication from the available draft genome sequence.
Pericentromeres and subtelomeres. We began by re-evaluating the
®nished sequences of chromosomes 21 and 22. The initial papers on
these chromosomes93,94 noted some instances of interchromosomal
duplication near each centromere. With the ability now to compare
these chromosomes to the vast majority of the genome, it is
apparent that the regions near the centromeres consist almost
entirely of interchromosomal duplicated segments, with little
or no unique sequence. Smaller regions of interchromosomal
duplication are also observed near the telomeres.
Chromosome 22 contains a region of 1.5 Mb adjacent to the
centromere in which 90% of sequence can now be recognized to
consist of interchromosomal duplication (Fig. 30). Conversely, 52%
of the interchromosomal duplications on chromosome 22 were
located in this region, which comprises only 5% of the chromo-
some. Also, the subtelomeric end consists of a 50-kb region con-
sisting almost entirely of interchromosomal duplications.
Chromosome 21 presents a similar landscape (Fig. 31). The ®rst
1 Mb after the centromere is composed of interchromosomal
repeats, as well as the largest (. 200 kb) block of intrachromoso-
mally duplicated material. Again, most interchromosomal duplica-
tions on the chromosome map to this region and the most
subtelomeric region (30 kb) shows extensive duplication among
nonhomologous chromosomes.
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Figure 32 Mosaic patterns of duplications. Panels depict various patterns of duplication
within the human genome (PARASIGHT). For each region, a segment of draft genome
sequence (100±500 kb) is shown with both interchromosomal (red) and intrachromo-
somal (blue) duplications displayed along the horizontal line. Below the line, each separate
sequence duplication is indicated (with a distinct colour) relative to per cent nucleotide
identity for the duplicated segment (y axis). Black bars show the relative locations of large
blocks of heterochromatic sequences (alpha, gamma and HSAT sequence). a, An active
pericentromeric region on chromosome 21. b, An ancestral region from Xq28 that has
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Figure 31 Duplication landscape of chromosome 21. The size and location of
intrachromosomal (blue) and interchromosomal (red) duplications are depicted along the
sequence of the long arm of chromosome 21. Gaps between ®nished sequence are
denoted by empty space but do not represent actual gap size.
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The pericentromeric regions are structurally very complex, as
illustrated for chromosome 21 in Fig. 32a. The pericentromeric
regions appear to have been bombarded by successive insertions of
duplications; the insertion events must be fairly recent because the
degree of sequence conservation with the genomic source loci is
fairly high (90±100%, with an apparent peak around 96%). Distinct
insertions are typically separated by AT-rich or GC-rich minisatel-
lite-like repeats that have been hypothesized to have a functional
role in targeting duplications to these regions233,241.
A single genomic source locus often gives rise to pericentromeric
copies on multiple chromosomes, with each having essentially the
same breakpoints and the same degree of divergence. An example of
such a source locus on Xq28 is shown in Fig. 32b. Phylogenetic
analysis has suggested a two-step mechanism for the origin and
dispersal of these segments, whereby an initial segmental duplica-
tion in the pericentromeric region of one chromosome occurs and is
then redistributed as part of a larger cassette to other such regions242.
A comprehensive analysis for all chromosomes will have to await
complete sequencing of the genome, but the evidence from the draft
genome sequence indicates that the same picture is likely to be seen
throughout the genome. Several papers have analysed ®nished
segments within pericentromeric regions of chromosomes 2
(160 kb), 10 (400 kb) and 16 (300 kb), all of which show extensive
interchromosomal segmental duplication215,219,232,233. An example
from another pericentromeric region on chromosome 11 is
shown in Fig. 32c. Interchromosomal duplications in subtelomeric
regions also appear to be a fairly general phenomenon, as illustrated
by a large tract (,500 kb) of complex duplication on chromosome 7
(Fig. 32d).
The explanation for the clustering of segmental duplications may
be that the genome has a damage-control mechanism whereby
chromosomal breakage products are preferentially inserted into
pericentromeric and, to a lesser extent, subtelomeric regions. The
possibility of a speci®c mechanism for the insertion of these
sequences has been suggested on the basis of the unusual sequences
found ¯anking the insertions. Although it is also possible that these
regions simply have greater tolerance for large insertions, many
large gene-poor `deserts' have been identi®ed93 and there is no
accumulation of duplicated segments within these regions. Along
with the fact that transitions between duplicons (from different
regions of the genome) occur at speci®c sequences, this suggests that
active recruitment of duplications to such regions may occur. In any
case, the duplicated regions are in general young (with many
duplications showing ,6% nucleotide divergence from their
source loci) and in constant ¯ux, both through additional duplica-
tions and by large-scale exchange among similar chromosomal
environments. There is evidence of structural polymorphism in
the human population, such as the presence or absence of olfactory
receptor segments located within the telomeric regions of several
human chromosomes226,227.
Genome-wide analysis of segmental duplications. We also per-
formed a global genome-wide analysis to characterize the amount
of segmental duplication in the genome. We `repeat-masked' the
known interspersed repeats in the draft genome sequence and
compared the remaining draft genomic sequence with itself in a
massive all-by-all BLASTN similarity search. We excluded matches
in which the sequence identity was so high that it might re¯ect
artefactual duplications resulting from a failure to overlap sequence
contigs correctly in assembling the draft genome sequence. Speci-
®cally, we considered only matches with less than 99.5% identity for
®nished sequence and less than 98% identity for un®nished
sequence.
We took several approaches to avoid counting artefactual dupli-
cations in the sequence. In the ®rst approach, we studied only
®nished sequence. We compared the ®nished sequence with itself,
to identify segments of at least 1 kb and 90±99.5% sequence
identity. This analysis will underestimate the extent of segmental
duplication, because it requires that at least two copies of the
segment are present in the ®nished sequence and because some
true duplications have over 99.5% identity.
The ®nished sequence consists of at least 3.3% segmental dupli-
cation (Table 16). Interchromosomal duplication accounts for
about 1.5% and intrachromosomal duplication for about 2%,
with some overlap (0.2%) between these categories. We analysed
the lengths and divergence of the segmental duplications (Fig. 33).
The duplications tend to be large (10±50 kb) and highly homo-
logous, especially for the interchromosomal segments. The
sequence divergence for the interchromosomal duplications
appears to peak between 96.5% and 97.5%. This may indicate
that interchromosomal duplications occurred in a punctuated
manner. It will be intriguing to investigate whether such genomic
upheaval has a role in speciation events.
In a second approach, we compared the entire human draft
genome sequence (®nished and un®nished) with itself to identify
duplications with 90±98% sequence identity (Table 17). The draft
genome sequence contains at least 3.6% segmental duplication. The
actual proportion will be signi®cantly higher, because we excluded
many true matches with more than 98% sequence identity (at least
1.1% of the ®nished sequence). Although exact measurement must
await a ®nished sequence, the human genome seems likely to
contain about 5% segmental duplication, with most of this
sequence in large blocks (. 10 kb). Such a high proportion of
large duplications clearly distinguishes the human genome from
other sequenced genomes, such as the ¯y and worm (Table 18).
The structure of large highly paralogous regions presents one of
the `serious and unanticipated challenges' to producing a ®nished
sequence of the genome46. The absence of unique STS or ®ngerprint
signatures over large genomic distances (,1 Mb) and the high
degree of sequence similarity makes the distinction between para-
logous sequence variation and allelic polymorphism problematic.
Furthermore, the fact that such regions frequently harbour intron±
exon structures of genuine unique sequence will complicate efforts
to generate a genome-wide SNP map. The data indicate that a
modest portion of the human genome may be relatively recalcitrant
to genomic-based methods for SNP detection. Owing to their
repetitive nature and their location in the genome, segmental
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Table 16 Fraction of ®nished sequence in inter- and intrachromosomal
duplications
Chromosome Intrachromosomal (%) Interchromosomal (%) All (%)
1 1.4 0.5 1.9
2 0.1 0.6 0.7
3 0.3 1.1 1.1
4 0.0 1.0 1.0
5 0.6 0.3 0.9
6 0.8 0.4 1.1
7 3.4 1.3 4.1
8 0.3 0.1 0.3
9 0.8 2.9 3.7
10 2.1 0.8 2.9
11 1.2 2.1 2.3
12 1.5 0.3 1.8
13 0.0 0.5 0.5
14 0.6 0.4 1.0
15 3.0 6.9 6.9
16 4.5 2.0 5.8
17 1.6 0.3 1.8
18 0.0 0.7 0.7
19 3.6 0.3 3.8
20 0.2 0.3 0.5
21 1.4 1.6 3.0
22 6.1 2.6 7.5
X 1.8 3.2 5.0
Y 12.1 16.0 27.4
Un 0.0 0.5 0.5
Total 2.0 1.5 3.3
.............................................................................................................................................................................
Excludes duplications with identities .99.5% to avoid artefactual duplication due to incomplete
merger in the assembly process. Calculation was performed on the ®nished sequence available in
September 2000 and re¯ects the duplications found within the total amount of ®nished sequence
then. Note that there is some overlap between the interchromosomal and intrachromosomal sets.
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duplications may well be underestimated by the current analysis. An
understanding of the biology, pathology and evolution of these
duplications will require specialized efforts within these exceptional
regions of the human genome. The presence and distribution of
such segments may provide evolutionary fodder for processes of
exon shuf¯ing and a general increase in protein diversity associated
with domain accretion. It will be important to consider both
genome-wide duplication events and more restricted punctuated
events of genome duplication as forces in the evolution of vertebrate
genomes.
Gene content of the human genome
Genes (or at least their coding regions) comprise only a tiny fraction
of human DNA, but they represent the major biological function of
the genome and the main focus of interest by biologists. They are
also the most challenging feature to identify in the human genome
sequence.
The ultimate goal is to compile a complete list of all human genes
and their encoded proteins, to serve as a `periodic table' for
biomedical research243. But this is a dif®cult task. In organisms
with small genomes, it is straightforward to identify most genes by
the presence of long ORFs. In contrast, human genes tend to have
small exons (encoding an average of only 50 codons) separated by
long introns (some exceeding 10 kb). This creates a signal-to-noise
problem, with the result that computer programs for direct gene
prediction have only limited accuracy. Instead, computational
prediction of human genes must rely largely on the availability of
cDNA sequences or on sequence conservation with genes and
proteins from other organisms. This approach is adequate for
strongly conserved genes (such as histones or ubiquitin), but may
be less sensitive to rapidly evolving genes (including many crucial to
speciation, sex determination and fertilization).
Here we describe our efforts to recognize both the RNA genes and
protein-coding genes in the human genome. We also study the
properties of the predicted human protein set, attempting to discern
how the human proteome differs from those of invertebrates such as
worm and ¯y.
Noncoding RNAs
Although biologists often speak of a tight coupling between `genes
articles
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Table 18 Cross-species comparison for large, highly homologous segmen-
tal duplications
Percentage of genome (%)
Fly Worm Human (®nished)*
. 1 kb 1.2 4.25 3.25
. 5 kb 0.37 1.50 2.86
. 10 kb 0.08 0.66 2.52
.............................................................................................................................................................................
* This is an underestimate of the total amount of segmental duplication in the human genome
because it only re¯ects duplication detectable with available ®nished sequence. The proportion of
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Figure 33 a±d, Sequence properties of segmental duplications. Distributions of length
and per cent nucleotide identity for segmental duplications are shown as a function of the
number of aligned bp, for the subset of ®nished genome sequence. Intrachromosomal,
red; interchromosomal, blue.
Table 17 Fraction of the draft genome sequence in inter- and intrachromo-
somal duplications
Chromosome Intrachromosomal (%) Interchromosomal (%) All (%)
1 2.1 1.7 3.4
2 1.6 1.6 2.6
3 1.8 1.4 2.7
4 1.5 2.2 3.0
5 1.0 0.9 1.8
6 1.5 1.4 2.7
7 3.6 1.8 4.5
8 1.2 1.5 2.1
9 2.1 2.3 3.8
10 3.3 2.0 4.7
11 2.7 1.4 3.7
12 2.1 1.2 2.8
13 1.7 1.6 3.0
14 0.6 0.6 1.2
15 4.1 4.4 6.7
16 3.4 3.4 5.5
17 4.4 1.7 5.7
18 0.9 1.0 1.9
19 5.4 1.6 6.3
20 0.8 1.4 2.0
21 1.9 4.0 4.8
22 6.8 7.7 11.9
X 1.2 1.1 2.2
Y 10.9 13.1 20.8
NA 2.3 7.8 8.3
UL 11.6 20.8 22.2
Total 2.3 2.0 3.6
.............................................................................................................................................................................
Excludes duplications with identities .98% to avoid artefactual duplication due to incomplete
merger in the assembly process. Calculation was performed on an earlier version of the draft
genome sequence based on data available in July 2000 and re¯ects the duplications found within
the total amount of ®nished sequence then. Note that there is some overlap between the
interchromosomal and intrachromosomal sets.
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and their encoded protein products', it is important to remember
that thousands of human genes produce noncoding RNAs
(ncRNAs) as their ultimate product244. There are several major
classes of ncRNA. (1) Transfer RNAs (tRNAs) are the adapters that
translate the triplet nucleic acid code of RNA into the amino-acid
sequence of proteins; (2) ribosomal RNAs (rRNAs) are also central
to the translational machinery, and recent X-ray crystallography
results strongly indicate that peptide bond formation is catalysed by
rRNA, not protein245,246; (3) small nucleolar RNAs (snoRNAs) are
required for rRNA processing and base modi®cation in the
nucleolus247,248; and (4) small nuclear RNAs (snRNAs) are critical
components of spliceosomes, the large ribonucleoprotein (RNP)
complexes that splice introns out of pre-mRNAs in the nucleus.
Humans have both a major, U2 snRNA-dependent spliceosome that
splices most introns, and a minor, U12 snRNA-dependent spliceo-
some that splices a rare class of introns that often have AT/AC
dinucleotides at the splice sites instead of the canonical GT/AG
splice site consensus249.
Other ncRNAs include both RNAs of known biochemical func-
tion (such as telomerase RNA and the 7SL signal recognition
particle RNA) and ncRNAs of enigmatic function (such as the
large Xist transcript implicated in X dosage compensation250, or the
small vault RNAs found in the bizarre vault ribonucleoprotein
complex251, which is three times the mass of the ribosome but has
unknown function).
ncRNAs do not have translated ORFs, are often small and are not
polyadenylated. Accordingly, novel ncRNAs cannot readily be
found by computational gene-®nding techniques (which search
for features such as ORFs) or experimental sequencing of cDNA or
EST libraries (most of which are prepared by reverse transcription
using a primer complementary to a poly(A) tail). Even if the
complete ®nished sequence of the human genome were available,
discovering novel ncRNAs would still be challenging. We can,
however, identify genomic sequences that are homologous to
known ncRNA genes, using BLASTN or, in some cases, more
specialized methods.
It is sometimes dif®cult to tell whether such homologous genes
are orthologues, paralogues or closely related pseudogenes (because
inactivating mutations are much less obvious than for protein-
coding genes). For tRNA, there is suf®ciently detailed information
about the cloverleaf secondary structure to allow true genes and
pseudogenes to be distinguished with high sensitivity. For many
other ncRNAs, there is much less structural information and so we
employ an operational criterion of high sequence similarity (. 95%
sequence identity and . 95% full length) to distinguish true genes
from pseudogenes. These assignments will eventually need to be
reconciled with experimental data.
Transfer RNA genes. The classical experimental estimate of the
number of human tRNA genes is 1,310 (ref. 252). In the draft
genome sequence, we ®nd only 497 human tRNA genes (Tables 19,
20). How do we account for this discrepancy? We believe that the
original estimate is likely to have been in¯ated in two respects. First,
it came from a hybridization experiment that probably counted
closely related pseudogenes; by analysis of the draft genome
sequence, there are in fact 324 tRNA-derived putative pseudogenes
(Table 20). Second, the earlier estimate assumed too high a value for
the size of the human genome; repeating the calculation using the
correct value yields an estimate of about 890 tRNA-related loci,
which is in reasonable accord with our count of 821 tRNA genes and
pseudogenes in the draft genome sequence.
The human tRNA gene set predicted from the draft genome
sequence appears to include most of the known human tRNA
species. The draft genome sequence contains 37 of 38 human
tRNA species listed in a tRNA database253, allowing for up to one
mismatch. This includes one copy of the known gene for a
specialized selenocysteine tRNA, one of several components of a
baroque translational mechanism that reads UGA as a selenocys-
teine codon in certain rare mRNAs that carry a speci®c cis-acting
RNA regulatory site (a so-called SECIS element) in their 39 UTRs.
The one tRNA gene in the database not found in the draft genome
sequence is DE9990, a tRNAGlu species, which differs in two
positions from the most related tRNA gene in the human
genome. Possible explanations are that the database version of
this tRNA contains two errors, the gene is polymorphic or this is
a genuine functional tRNA that is missing from the draft genome
sequence. (The database also lists one additional tRNA gene
(DS9994), but this is apparently a contaminant, most similar to
bacterial tRNAs; the parent entry (Z13399) was withdrawn from the
DNA database, but the tRNA entry has not yet been removed from
the tRNA database.) Although the human set appears substantially
complete by this test, the tRNA gene numbers in Table 19 should be
considered tentative and used with caution. The human and ¯y (but
not the worm) are known to be missing signi®cant amounts of
heterochromatic DNA, and additional tRNA genes could be located
there.
With this caveat, the results indicate that the human has fewer
tRNA genes than the worm, but more than the ¯y. This may seem
surprising, but tRNA gene number in metazoans is thought to be
related not to organismal complexity, but more to idiosyncrasies of
the demand for tRNA abundance in certain tissues or stages of
embryonic development. For example, the frog Xenopus laevis,
which must load each oocyte with a remarkable 40 ng of tRNA,
has thousands of tRNA genes254.
The degeneracy of the genetic code has allowed an inspired
economy of tRNA anticodon usage. Although 61 sense codons
need to be decoded, not all 61 different anticodons are present in
tRNAs. Rather, tRNAs generally follow stereotyped and conserved
wobble rules255±257. Wobble reduces the number of required anti-
codons substantially, and provides a connection between the genetic
code and the hybridization stability of modi®ed and unmodi®ed
RNA bases. In eukaryotes, the rules proposed by Guthrie and
Abelson256 predict that about 46 tRNA species will be suf®cient to
read the 61 sense codons (counting the initiator and elongator
methionine tRNAs as two species). According to these rules, in the
codon's third (wobble) position, U and C are generally decoded by a
single tRNA species, whereas A and G are decoded by two separate
tRNA species.
In `two-codon boxes' of the genetic code (where codons ending
with U/C encode a different amino acid from those ending with
A/G), the U/C wobble position should be decoded by a G at position
34 in the tRNA anticodon. Thus, in the top left of Fig. 34, there is no
tRNA with an AAA anticodon for Phe, but the GAA anticodon can
recognize both UUU and UUC codons in the mRNA. In `four-
codon boxes' of the genetic code (where U, C, A and G in the wobble
position all encode the same amino acid), the U/C wobble position
is almost always decoded by I34 (inosine) in the tRNA, where the
inosine is produced by post-transcriptional modi®cation of an
adenine (A). In the bottom left of Fig. 34, for example, the GUU
and GUC codons of the four-codon Val box are decoded by a tRNA
with an anticodon of AAC, which is no doubt modi®ed to IAC.
Presumably this pattern, which is strikingly conserved in eukar-
yotes, has to do with the fact that IA base pairs are also possible; thus
articles
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Table 19 Number of tRNA genes in various organisms





Methanococcus jannaschii 36 1
Escherichia coli 86 1
.............................................................................................................................................................................
Number of tRNA genes in each of six genome sequences, according to analysis by the computer
program tRNAscan-SE . Canonical tRNAs read one of the standard 61 sense codons; this category
excludes pseudogenes, undetermined anticodons, putative supressors and selenocysteine tRNAs.
Most organisms have a selenocysteine (SeCys) tRNA species, but some unicellular eukaryotes do
not (such as the yeast S. cerevisiae).
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the IAC anticodon for a Val tRNA could recognize GUU, GUC and
even GUA codons. Were this same I34 to be utilized in two-codon
boxes, however, misreading of the NNA codon would occur, result-
ing in translational havoc. Eukaryotic glycine tRNAs represent a
conserved exception to this last rule; they use a GCC anticodon to
decode GGU and GGC, rather than the expected ICC anticodon.
Satisfyingly, the human tRNA set follows these wobble rules
almost perfectly (Fig. 34). Only three unexpected tRNA species
are found: single genes for a tRNATyr-AUA, tRNAIle-GAU, and
tRNAAsn-AUU. Perhaps these are pseudogenes, but they appear to
be plausible tRNAs. We also checked the possibility of sequencing
errors in their anticodons, but each of these three genes is in a region
of high sequence accuracy, with PHRAP quality scores higher
than 70 for every base in their anticodons.
As in all other organisms, human protein-coding genes show
codon biasÐpreferential use of one synonymous codon over
another258 (Fig. 34). In less complex organisms, such as yeast or
bacteria, highly expressed genes show the strongest codon bias.
Cytoplasmic abundance of tRNA species is correlated with both
codon bias and overall amino-acid frequency (for example, tRNAs
for preferred codons and for more common amino acids are more
abundant). This is presumably driven by selective pressure for
ef®cient or accurate translation259. In many organisms, tRNA
abundance in turn appears to be roughly correlated with tRNA
gene copy number, so tRNA gene copy number has been used as a
proxy for tRNA abundance260. In vertebrates, however, codon bias is
not so obviously correlated with gene expression level. Differing
codon biases between human genes is more a function of their
location in regions of different GC composition261. In agreement
with the literature, we see only a very rough correlation of human
tRNA gene number with either amino-acid frequency or codon bias
(Fig. 34). The most obvious outliers in these weak correlations are
the strongly preferred CUG leucine codon, with a mere six tRNA-
Leu-CAG genes producing a tRNA to decode it, and the relatively
rare cysteine UGU and UGC codons, with 30 tRNA genes to decode
them.
The tRNA genes are dispersed throughout the human genome.
However, this dispersal is nonrandom. tRNA genes have sometimes
been seen in clusters at small scales262,263 but we can now see striking
clustering on a genome-wide scale. More than 25% of the tRNA
genes (140) are found in a region of only about 4 Mb on chromo-
some 6. This small region, only about 0.1% of the genome, contains
an almost suf®cient set of tRNA genes all by itself. The 140 tRNA
genes contain a representative for 36 of the 49 anticodons found in
the complete set; and of the 21 isoacceptor types, only tRNAs to
decode Asn, Cys, Glu and selenocysteine are missing. Many of these
tRNA genes, meanwhile, are clustered elsewhere; 18 of the 30 Cys
tRNAs are found in a 0.5-Mb stretch of chromosome 7 and many of
the Asn and Glu tRNA genes are loosely clustered on chromosome 1.
More than half of the tRNA genes (280 out of 497) reside on either
chromosome 1 or chromosome 6. Chromosomes 3, 4, 8, 9, 10, 12,
18, 20, 21 and X appear to have fewer than 10 tRNA genes each; and
chromosomes 22 and Y have none at all (each has a single
pseudogene).
Ribosomal RNA genes. The ribosome, the protein synthetic
machine of the cell, is made up of two subunits and contains four
rRNA species and many proteins. The large ribosomal subunit
contains 28S and 5.8S rRNAs (collectively called `large subunit'
(LSU) rRNA) and also a 5S rRNA. The small ribosomal subunit
contains 18S rRNA (`small subunit' (SSU) rRNA). The genes for
LSU and SSU rRNA occur in the human genome as a 44-kb tandem
repeat unit264. There are thought to be about 150±200 copies of this
repeat unit arrayed on the short arms of acrocentric chromosomes
13, 14, 15, 21 and 22 (refs 254, 264). There are no true complete
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Figure 34 The human genetic code and associated tRNA genes. For each of the 64
codons, we show: the corresponding amino acid; the observed frequency of the codon per
10,000 codons; the codon; predicted wobble pairing to a tRNA anticodon (black lines); an
unmodi®ed tRNA anticodon sequence; and the number of tRNA genes found with this
anticodon. For example, phenylalanine is encoded by UUU or UUC; UUC is seen more
frequently, 203 to 171 occurrences per 10,000 total codons; both codons are expected to
be decoded by a single tRNA anticodon type, GAA, using a G/U wobble; and there are 14
tRNA genes found with this anticodon. The modi®ed anticodon sequence in the mature
tRNA is not shown, even where post-transcriptional modi®cations can be con®dently
predicted (for example, when an A is used to decode a U/C third position, the A is almost
certainly an inosine in the mature tRNA). The Figure also does not show the number of
distinct tRNA species (such as distinct sequence families) for each anticodon; often there
is more than one species for each anticodon.
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copies of the rDNA tandem repeats in the draft genome sequence,
owing to the deliberate bias in the initial phase of the sequencing
effort against sequencing BAC clones whose restriction fragment
®ngerprints showed them to contain primarily tandemly repeated
sequence. Sequence similarity analysis with the BLASTN computer
program does, however, detect hundreds of rDNA-derived sequence
fragments dispersed throughout the complete genome, including
one `full-length' copy of an individual 5.8S rRNA gene not asso-
ciated with a true tandem repeat unit (Table 20).
The 5S rDNA genes also occur in tandem arrays, the largest of
which is on chromosome 1 between 1q41.11 and 1q42.13, close to
the telomere265,266. There are 200±300 true 5S genes in these
arrays265,267. The number of 5S-related sequences in the genome,
including numerous dispersed pseudogenes, is classically cited as
2,000 (refs 252, 254). The long tandem array on chromosome 1 is
not yet present in the draft genome sequence because there are no
EcoRI or HindIII sites present, and thus it was not cloned in the
most heavily utilized BAC libraries (Table 1). We expect to recover it
during the ®nishing stage. We do detect four individual copies of 5S
rDNA by our search criteria ($ 95% identity and $ 95% full
length). We also ®nd many more distantly related dispersed
sequences (520 at P # 0.001), which we interpret as probable
pseudogenes (Table 20).
Small nucleolar RNA genes. Eukaryotic rRNA is extensively pro-
cessed and modi®ed in the nucleolus. Much of this activity is
directed by numerous snoRNAs. These come in two families: C/D
box snoRNAs (mostly involved in guiding site-speci®c 29-O-ribose
methylations of other RNAs) and H/ACA snoRNAs (mostly
involved in guiding site-speci®c pseudouridylations)247,248. We
compiled a set of 97 known human snoRNA gene sequences; 84
of these (87%) have at least one copy in the draft genome sequence
(Table 20), almost all as single-copy genes.
It is thought that all 29-O-ribose methylations and pseudouri-
dylations in eukaryotic rRNA are guided by snoRNAs. There are
105±107 methylations and around 95 pseudouridylations in human
rRNA268. Only about half of these have been tentatively assigned to
known guide snoRNAs. There are also snoRNA-directed
modi®cations on other stable RNAs, such as U6 (ref. 269), and
the extent of this is just beginning to be explored. Sequence
similarity has so far proven insuf®cient to recognize all snoRNA
genes. We therefore expect that there are many unrecognized
snoRNA genes that are not detected by BLAST queries.
Spliceosomal RNAs and other ncRNA genes. We also looked for
copies of other known ncRNA genes. We found at least one copy of
21 (95%) of 22 known ncRNAs, including the spliceosomal
snRNAs. There were multiple copies for several ncRNAs, as
expected; for example, we ®nd 44 dispersed genes for U6 snRNA,
and 16 for U1 snRNA (Table 20).
For some of these RNA genes, homogeneous multigene families
that occur in tandem arrays are again under-represented owing to
the restriction enzymes used in constructing the BAC libraries and,
in some instances, the decision to delay the sequencing of BAC
clones with low complexity ®ngerprints indicative of tandemly
repeated DNA. The U2 RNA genes are located at the RNU2 locus,
a tandem array of 10±20 copies of nearly identical 6.1-kb units at
17q21±q22 (refs 270±272). Similarly, the U3 snoRNA genes
(included in the aggregate count of C/D snoRNAs in Table 20) are
clustered at the RNU3 locus at 17p11.2, not in a tandem array, but in
a complex inverted repeat structure of about 5±10 copies per
haploid genome273. The U1 RNA genes are clustered with about
30 copies at the RNU1 locus at 1p36.1, but this cluster is thought to
be loose and irregularly organized; no two U1 genes have been
cloned on the same cosmid271. In the draft genome sequence, we see
six copies of U2 RNA that meet our criteria for true genes, three of
which appear to be in the expected position on chromosome 17. For
U3, so far we see one true copy at the correct place on chromosome
17p11.2. For U1, we see 16 true genes, 6 of which are loosely
clustered within 0.6 Mb at 1p36.1 and another 6 are elsewhere on
chromosome 1. Again, these and other clusters will be a matter for
the ®nishing process.
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Table 20 Known non-coding RNA genes in the draft genome sequence
RNA gene* Number expected² Number found³ Number of
related genes§
Function
tRNA 1,310 497 324 Protein synthesis
SSU (18S) rRNA 150±200 0 40 Protein synthesis
5.8S rRNA 150±200 1 11 Protein synthesis
LSU (28S) rRNA 150±200 0 181 Protein synthesis
5S rRNA 200±300 4 520 Protein synthesis
U1 ,30 16 134 Spliceosome component
U2 10±20 6 94 Spliceosome component
U4 ?? 4 87 Spliceosome component
U4atac ?? 1 20 Component of minor (U11/U12) spliceosome
U5 ?? 1 31 Spliceosome component
U6 ?? 44 1,135 Spliceosome component
U6atac ?? 4 32 Component of minor (U11/U12) spliceosome
U7 1 1 3 Histone mRNA 39 processing
U11 1 0 6 Component of minor (U11/U12) spliceosome
U12 1 1 0 Component of minor (U11/U12) spliceosome
SRP (7SL) RNA 4 3 773 Component of signal recognition particle (protein secretion)
RNAse P 1 1 2 tRNA 59 end processing
RNAse MRP 1 1 6 rRNA processing
Telomerase RNA 1 1 4 Template for addition of telomeres
hY1 1 1 353 Component of Ro RNP, function unknown
hY3 1 25 414 Component of Ro RNP, function unknown
hY4 1 3 115 Component of Ro RNP, function unknown
hY5 (4.5S RNA) 1 1 9 Component of Ro RNP, function unknown
Vault RNAs 3 3 1 Component of 13-MDa vault RNP, function unknown
7SK 1 1 330 Unknown
H19 1 1 2 Unknown
Xist 1 1 0 Initiation of X chromosome inactivation (dosage compensation)
Known C/D snoRNAs 81 69 558 Pre-rRNA processing or site-speci®c ribose methylation of rRNA
Known H/ACA snoRNAs 16 15 87 Pre-rRNA processing or site-speci®c pseudouridylation of rRNA
...................................................................................................................................................................................................................................................................................................................................................................
* Known ncRNA genes (or gene families, such as the C/D and H/ACA snoRNA families); reference sequences were extracted from GenBank and used to probe the draft genome sequence.
² Number of genes that were expected in the human genome, based on previous literature (note that earlier experimental techniques probably tend to overestimate copy number, by counting closely related
pseudogenes).
³ The copy number of `true' full-length genes identi®ed in the draft genome sequence.
§ The copy number of other signi®cantly related copies (pseudogenes, fragments, paralogues) found. Except for the 497 true tRNA genes, all sequence similarities were identi®ed by WashU BLASTN 2.0MP
(W. Gish, unpublished; http://blast.wustl.edu), with parameters `-kap wordmask = seg B = 50000 W = 8' and the default +5/-4 DNA scoring matrix. True genes were operationally de®ned as BLAST hits
with $ 95% identity over $ 95% of the length of the query. Related sequences were operationally de®ned as all other BLAST hits with P-values # 0.001.
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Our observations also con®rm the striking proliferation of
ncRNA-derived pseudogenes (Table 20). There are hundreds or
thousands of sequences in the draft genome sequence related to
some of the ncRNA genes. The most proli®c pseudogene counts
generally come from RNA genes transcribed by RNA polymerase III
promoters, including U6, the hY RNAs and SRP-RNA. These
ncRNA pseudogenes presumably arise through reverse transcrip-
tion. The frequency of such events gives insight into how ncRNA
genes can evolve into SINE retroposons, such as the tRNA-derived
SINEs found in many vertebrates and the SRP-RNA-derived Alu
elements found in humans.
Protein-coding genes
Identifying the protein-coding genes in the human genome is one of
the most important applications of the sequence data, but also one
of the most dif®cult challenges. We describe below our efforts to
create an initial human gene and protein index.
Exploring properties of known genes. Before attempting to
identify new genes, we explored what could be learned by aligning
the cDNA sequences of known genes to the draft genome sequence.
Genomic alignments allow one to study exon±intron structure and
local GC content, and are valuable for biomedical studies because
they connect genes with the genetic and cytogenetic map, link them
with regulatory sequences and facilitate the development of poly-
merase chain reaction (PCR) primers to amplify exons. Until now,
genomic alignment was available for only about a quarter of known
genes.
The `known' genes studied were those in the RefSeq database110, a
manually curated collection designed to contain nonredundant
representatives of most full-length human mRNA sequences in
GenBank (RefSeq intentionally contains some alternative splice
forms of the same genes). The version of RefSeq used contained
10,272 mRNAs.
The RefSeq genes were aligned with the draft genome sequence,
using both the Spidey (S. Wheelan, personal communication) and
Acembly (D. Thierry-Mieg and J. Thierry-Mieg, unpublished;
http://www.acedb.org) computer programs. Because this sequence
is incomplete and contains errors, not all genes could be fully
aligned and some may have been incorrectly aligned. More than
92% of the RefSeq entries could be aligned at high stringency over at
least part of their length, and 85% could be aligned over more than
half of their length. Some genes (16%) had high stringency align-
ments to more than one location in the draft genome sequence
owing, for example, to paralogues or pseudogenes. In such cases, we
considered only the best match. In a few of these cases, the assign-
ment may not be correct because the true matching region has not
yet been sequenced. Three per cent of entries appeared to be
alternative splice products of the same gene, on the basis of their
alignment to the same location in the draft genome sequence. In all,
we obtained at least partial genomic alignments for 9,212 distinct
known genes and essentially complete alignment for 5,364 of
them.
Previous efforts to study human gene structure116,274,275 have been
hampered by limited sample sizes and strong biases in favour of
compact genes. Table 21 gives the mean and median values of some
basic characteristics of gene structures. Some of the values may be
underestimates. In particular, the UTRs given in the RefSeq data-
base are likely to be incomplete; they are considerably shorter, for
example, than those derived from careful reconstructions on chro-
mosome 22. Intron sizes were measured only for genes in ®nished
genomic sequence, to mitigate the bias arising from the fact that
articles
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Table 21 Characteristics of human genes
Median Mean Sample (size)
Internal exon 122 bp 145 bp RefSeq alignments to draft genome sequence, with
con®rmed intron boundaries (43,317 exons)
Exon number 7 8.8 RefSeq alignments to ®nished sequence (3,501 genes)
Introns 1,023 bp 3,365 bp RefSeq alignments to ®nished sequence (27,238 introns)
39 UTR 400 bp 770 bp Con®rmed by mRNA or EST on chromosome 22 (689)







Selected RefSeq entries (1,804)
Genomic extent 14 kb 27 kb Selected RefSeq entries (1,804)
...................................................................................................................................................................................................................................................................................................................................................................









































































Figure 35 Size distributions of exons, introns and short introns, in sequenced genomes.
a, Exons; b, introns; c, short introns (enlarged from b). Con®rmed exons and introns for
the human were taken from RefSeq alignments and for worm and ¯y from Acembly
alignments of ESTs (J. and D. Thierry-Mieg and, for worm, Y. Kohara, unpublished).
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long introns are more likely than short introns to be interrupted by
gaps in the draft genome sequence. Nonetheless, there may be some
residual bias against long genes and long introns.
There is considerable variation in overall gene size and intron size,
with both distributions having very long tails. Many genes are over
100 kb long, the largest known example being the dystrophin gene
(DMD) at 2.4 Mb. The variation in the size distribution of coding
sequences and exons is less extreme, although there are still some
remarkable outliers. The titin gene276 has the longest currently
known coding sequence at 80,780 bp; it also has the largest
number of exons (178) and longest single exon (17,106 bp).
It is instructive to compare the properties of human genes with
those from worm and ¯y. For all three organisms, the typical length
of a coding sequence is similar (1,311 bp for worm, 1,497 bp for ¯y
and 1,340 bp for human), and most internal exons fall within a
common peak between 50 and 200 bp (Fig. 35a). However, the
worm and ¯y exon distributions have a fatter tail, resulting in a
larger mean size for internal exons (218 bp for worm versus 145 bp
for human). The conservation of preferred exon size across all three
species supports suggestions of a conserved exon-based component
of the splicing machinery277. Intriguingly, the few extremely short
human exons show an unusual base composition. In 42 detected
human exons of less than 19 bp, the nucleotide frequencies of A, G,
T and C are 39, 33, 15 and 12%, respectively, showing a strong
purine bias. Purine-rich sequences may enhance splicing278,279, and it
is possible that such sequences are required or strongly selected for
to ensure correct splicing of very short exons. Previous studies have
shown that short exons require intronic, but not exonic, splicing
enhancers280.
In contrast to the exons, the intron size distributions differ
substantially among the three species (Fig. 35b, c). The worm and
¯y each have a reasonably tight distribution, with most introns near
the preferred minimum intron length (47 bp for worm, 59 bp for
¯y) and an extended tail (overall average length of 267 bp for worm
and 487 bp for ¯y). Intron size is much more variable in humans,
with a peak at 87 bp but a very long tail resulting in a mean of more
than 3,300 bp. The variation in intron size results in great variation
in gene size.
The variation in gene size and intron size can partly be explained
by the fact that GC-rich regions tend to be gene-dense with many
compact genes, whereas AT-rich regions tend to be gene-poor with
many sprawling genes containing large introns. The correlation of
gene density with GC content is shown in Fig. 36a, b; the relative
density increases more than tenfold as GC content increases from
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Figure 36 GC content. a, Distribution of GC content in genes and in the genome. For
9,315 known genes mapped to the draft genome sequence, the local GC content was
calculated in a window covering either the whole alignment or 20,000 bp centred around
the midpoint of the alignment, whichever was larger. Ns in the sequence were not
counted. GC content for the genome was calculated for adjacent nonoverlapping 20,000-
bp windows across the sequence. Both the gene and genome distributions have been
normalized to sum to one. b, Gene density as a function of GC content, obtained by taking
the ratio of the data in a. Values are less accurate at higher GC levels because the
denominator is small. c, Dependence of mean exon and intron lengths on GC content. For
exons and introns, the local GC content was derived from alignments to ®nished sequence
only, and were calculated from windows covering the feature or 10,000 bp centred on the
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30% to 50%. The correlation appears to be due primarily to intron
size, which drops markedly with increasing GC content (Fig. 36c).
In contrast, coding properties such as exon length (Fig. 36c) or exon
number (data not shown) vary little. Intergenic distance is also
probably lower in high-GC areas, although this is hard to prove
directly until all genes have been identi®ed.
The large number of con®rmed human introns allows us to
analyse variant splice sites, con®rming and extending recent
reports281. Intron positions were con®rmed by applying a stringent
criterion that EST or mRNA sequence show an exact match of 8 bp
in the ¯anking exonic sequence on each side. Of 53,295 con®rmed
introns, 98.12% use the canonical dinucleotides GT at the 59 splice
site and AG at the 39 site (GT±AG pattern). Another 0.76% use the
related GC±AG. About 0.10% use AT±AC, which is a rare alter-
native pattern primarily recognized by the variant U12 splicing
machinery282. The remaining 1% belong to 177 types, some of which
undoubtedly re¯ect sequencing or alignment errors.
Finally, we looked at alternative splicing of human genes. Alter-
native splicing can allow many proteins to be produced from a
single gene and can be used for complex gene regulation. It appears
to be prevalent in humans, with lower estimates of about 35% of
human genes being subject to alternative splicing283±285. These
studies may have underestimated the prevalence of alternative
splicing, because they examined only EST alignments covering
only a portion of a gene.
To investigate the prevalence of alternative splicing, we analysed
reconstructed mRNA transcripts covering the entire coding regions
of genes on chromosome 22 (omitting small genes with coding
regions of less than 240 bp). Potential transcripts identi®ed by
alignments of ESTs and cDNAs to genomic sequence were veri®ed
by human inspection. We found 642 transcripts, covering 245 genes
(average of 2.6 distinct transcripts per gene). Two or more alter-
natively spliced transcripts were found for 145 (59%) of these genes.
A similar analysis for the gene-rich chromosome 19 gave 1,859
transcripts, corresponding to 544 genes (average 3.2 distinct tran-
scripts per gene). Because we are sampling only a subset of all
transcripts, the true extent of alternative splicing is likely to be
greater. These ®gures are considerably higher than those for worm,
in which analysis reveals alternative splicing for 22% of genes for
which ESTs have been found, with an average of 1.34 (12,816/9,516)
splice variants per gene. (The apparently higher extent of alternative
splicing seen in human than in worm was not an artefact resulting
from much deeper coverage of human genes by ESTs and mRNAs.
Although there are many times more ESTs available for human than
worm, these ESTs tend to have shorter average length (because many
were the product of early sequencing efforts) and many match no
human genes. We calculated the actual coverage per bp used in the
analysis of the human and worm genes; the coverage is only
modestly higher (about 50%) for the human, with a strong bias
towards 39 UTRs which tend to show much less alternative splicing.
We also repeated the analysis using equal coverage for the two
organisms and con®rmed that higher levels of alternative splicing
were still seen in human.)
Seventy per cent of alternative splice forms found in the genes on
chromosomes 19 and 22 affect the coding sequence, rather than
merely changing the 39 or 59 UTR. (This estimate may be affected by
the incomplete representation of UTRs in the RefSeq database and
in the transcripts studied.) Alternative splicing of the terminal exon
was seen for 20% of 6,105 mRNAs that were aligned to the draft
genome sequence and correspond to con®rmed 39 EST clusters. In
addition to alternative splicing, we found evidence of the terminal
exon employing alternative polyadenylation sites (separated by
. 100 bp) in 24% of cases.
Towards a complete index of human genes. We next focused on
creating an initial index of human genes and proteins. This index is
quite incomplete, owing to the dif®culty of gene identi®cation in
human DNA and the imperfect state of the draft genome sequence.
Nonetheless, it is valuable for experimental studies and provides
important insights into the nature of human genes and proteins.
The challenge of identifying genes from genomic sequence varies
greatly among organisms. Gene identi®cation is almost trivial in
bacteria and yeast, because the absence of introns in bacteria and
their paucity in yeast means that most genes can be readily
recognized by ab initio analysis as unusually long ORFs. It is not
as simple, but still relatively straightforward, to identify genes in
animals with small genomes and small introns, such as worm and
¯y. A major factor is the high signal-to-noise ratioÐcoding
sequences comprise a large proportion of the genome and a large
proportion of each gene (about 50% for worm and ¯y), and exons
are relatively large.
Gene identi®cation is more dif®cult in human DNA. The signal-
to-noise ratio is lower: coding sequences comprise only a few per
cent of the genome and an average of about 5% of each gene;
internal exons are smaller than in worms; and genes appear to have
more alternative splicing. The challenge is underscored by the work
on human chromosomes 21 and 22. Even with the availability of
®nished sequence and intensive experimental work, the gene con-
tent remains uncertain, with upper and lower estimates differing by
as much as 30%. The initial report of the ®nished sequence of
chromosome 22 (ref. 94) identi®ed 247 previously known genes,
298 predicted genes con®rmed by sequence homology or ESTs and
325 ab initio predictions without additional support. Many of the
con®rmed predictions represented partial genes. In the past year,
440 additional exons (10%) have been added to existing gene
annotations by the chromosome 22 annotation group, although
the number of con®rmed genes has increased by only 17 and some
previously identi®ed gene predictions have been merged286.
Before discussing the gene predictions for the human genome, it
is useful to consider background issues, including previous esti-
mates of the number of human genes, lessons learned from worms
and ¯ies and the representativeness of currently `known' human
genes.
Previous estimates of human gene number. Although direct enumera-
tion of human genes is only now becoming possible with the advent
of the draft genome sequence, there have been many attempts in the
past quarter of a century to estimate the number of genes indirectly.
Early estimates based on reassociation kinetics estimated the mRNA
complexity of typical vertebrate tissues to be 10,000±20,000, and
were extrapolated to suggest around 40,000 for the entire genome287.
In the mid-1980s, Gilbert suggested that there might be about
100,000 genes, based on the approximate ratio of the size of a typical
gene (,3 ´ 104 bp) to the size of the genome (3 ´ 109 bp). Although
this was intended only as a back-of-the-envelope estimate, the
pleasing roundness of the ®gure seems to have led to it being
widely quoted and adopted in many textbooks. (W. Gilbert,
personal communication; ref. 288). An estimate of 70,000±80,000
genes was made by extrapolating from the number of CpG islands
and the frequency of their association with known genes129.
As human sequence information has accumulated, it has been
possible to derive estimates on the basis of sampling techniques289.
Such studies have sought to extrapolate from various types of data,
including ESTs, mRNAs from known genes, cross-species genome
comparisons and analysis of ®nished chromosomes. Estimates
based on ESTs290 have varied widely, from 35,000 (ref. 130) to
120,000 genes291. Some of the discrepancy lies in differing estimates
of the amount of contaminating genomic sequence in the EST
collection and the extent to which multiple distinct ESTs corre-
spond to a single gene. The most rigorous analyses130 exclude as
spurious any ESTs that appear only once in the data set and carefully
calibrate sensitivity and speci®city. Such calculations consistently
produce low estimates, in the region of 35,000.
Comparison of whole-genome shotgun sequence from the puf-
fer®sh T. nigroviridis with the human genome292 can be used to
estimate the density of exons (detected as conserved sequences
articles
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between ®sh and human). These analyses also suggest around
30,000 human genes.
Extrapolations have also been made from the gene counts for
chromosomes 21 and 22 (refs 93, 94), adjusted for differences
in gene densities on these chromosomes, as inferred from EST
mapping. These estimates are between 30,500 and 35,500, depend-
ing on the precise assumptions used286.
Insights from invertebrates. The worm and ¯y genomes contain a
large proportion of novel genes (around 50% of worm genes and
30% of ¯y genes), in the sense of showing no signi®cant similarity to
organisms outside their phylum293±295. Such genes may have been
present in the original eukaryotic ancestor, but were subsequently
lost from the lineages of the other eukaryotes for which sequence is
available; they may be rapidly diverging genes, so that it is dif®cult to
recognize homologues solely on the basis of sequence; they may
represent true innovations developed within the lineage; or they
may represent acquisitions by horizontal transfer. Whatever their
origin, these genes tend to have different biological properties from
highly conserved genes. In particular, they tend to have low expres-
sion levels as assayed both by direct studies and by a paucity of
corresponding ESTs, and are less likely to produce a visible pheno-
type in loss-of-function genetic experiments294,296.
Gene prediction. Current gene prediction methods employ combi-
nations of three basic approaches: direct evidence of transcription
provided by ESTs or mRNAs297±299; indirect evidence based on
sequence similarity to previously identi®ed genes and proteins300,301;
and ab initio recognition of groups of exons on the basis of hidden
Markov models (HMMs) that combine statistical information
about splice sites, coding bias and exon and intron lengths (for
example, Genscan275, Genie302,303 and FGENES304).
The ®rst approach relies on direct experimental data, but is
subject to artefacts arising from contaminating ESTs derived from
unspliced mRNAs, genomic DNA contamination and nongenic
transcription (for example, from the promoter of a transposable
element). The ®rst two problems can be mitigated by comparing
transcripts with the genomic sequence and using only those that
show clear evidence of splicing. This solution, however, tends to
discard evidence from genes with long terminal exons or single
exons. The second approach tends correctly to identify gene-derived
sequences, although some of these may be pseudogenes. However, it
obviously cannot identify truly novel genes that have no sequence
similarity to known genes. The third approach would suf®ce alone if
one could accurately de®ne the features used by cells for gene
recognition, but our current understanding is insuf®cient to do
so. The sensitivity and speci®city of ab initio predictions are greatly
affected by the signal-to-noise ratio. Such methods are more
accurate in the ¯y and worm than in human. In ¯y, ab initio
methods can correctly predict around 90% of individual exons and
can correctly predict all coding exons of a gene in about 40% of
cases303. For human, the comparable ®gures are only about 70% and
20%, respectively94,305. These estimates may be optimistic, owing to
the design of the tests used.
In any collection of gene predictions, we can expect to see various
errors. Some gene predictions may represent partial genes, because
of inability to detect some portions of a gene (incomplete sensitiv-
ity) or to connect all the components of a gene (fragmentation);
some may be gene fusions; and others may be spurious predictions
(incomplete speci®city) resulting from chance matches or pseudo-
genes.
Creating an initial gene index. We set out to create an initial
integrated gene index (IGI) and an associated integrated protein
index (IPI) for the human genome. We describe the results obtained
from a version of the draft genome sequence based on the sequence
data available in July 2000, to allow time for detailed analysis of the
gene and protein content. The additional sequence data that has
since become available will affect the results quantitatively, but are
unlikely to change the conclusions qualitatively.
We began with predictions produced by the Ensembl system306.
Ensembl starts with ab initio predictions produced by Genscan275
and then attempts to con®rm them by virtue of similarity to
proteins, mRNAs, ESTs and protein motifs (contained in the
Pfam database307) from any organism. In particular, it con®rms
introns if they are bridged by matches and exons if they are ¯anked
by con®rmed introns. It then attempts to extend protein matches
using the GeneWise computer program308. Because it requires
con®rmatory evidence to support each gene component, it fre-
quently produces partial gene predictions. In addition, when there
is evidence of alternative splicing, it reports multiple overlapping
transcripts. In total, Ensembl produced 35,500 gene predictions
with 44,860 transcripts.
To reduce fragmentation, we next merged Ensembl-based gene
predictions with overlapping gene predictions from another
program, Genie302. Genie starts with mRNA or EST matches and
employs an HMM to extend these matches by using ab initio
statistical approaches. To avoid fragmentation, it attempts to link
information from 59 and 39 ESTs from the same cDNA clone and
thereby to produce a complete coding sequence from an initial ATG
to a stop codon. As a result, it may generate complete genes more
accurately than Ensembl in cases where there is extensive EST
support. (Genie also generates potential alternative transcripts,
but we used only the longest transcript in each group.) We
merged 15,437 Ensembl predictions into 9,526 clusters, and the
longest transcript in each cluster (from either Genie or Ensembl)
was taken as the representative.
Next, we merged these results with known genes contained in the
RefSeq (version of 29 September 2000), SWISSPROT (release 39.6
of 30 August 2000) and TrEMBL databases (TrEMBL release 14.17
of 1 October 2000, TrEMBL_new of 1 October 2000). Incorporating
these sequences gave rise to overlapping sequences because of
alternative splice forms and partial sequences. To construct a
nonredundant set, we selected the longest sequence from each
overlapping set by using direct protein comparison and by mapping
the gene predictions back onto the genome to construct the over-
lapping sets. This may occasionally remove some close paralogues in
the event that the correct genomic location has not yet been
sequenced, but this number is expected to be small.
Finally, we searched the set to eliminate any genes derived from
contaminating bacterial sequences, recognized by virtue of near
identity to known bacterial plasmids, transposons and chromoso-
mal genes. Although most instances of such contamination had
been removed in the assembly process, a few cases had slipped
through and were removed at this stage.
The process resulted in version 1 of the IGI (IGI.1). The
composition of the corresponding IPI.1 protein set, obtained by
translating IGI.1, is given in Table 22. There are 31,778 protein
predictions, with 14,882 from known genes, 4,057 predictions from
Ensembl merged with Genie and 12,839 predictions from Ensembl
alone. The average lengths are 469 amino acids for the known
proteins, 443 amino acids for protein predictions from the
Ensembl±Genie merge, and 187 amino acids for those from
Ensembl alone. (The smaller average size for the predictions from
Ensembl alone re¯ects its tendency to predict partial genes where
there is supporting evidence for only part of the gene; the remainder
of the gene will often not be predicted at all, rather than included as
part of another prediction. Accordingly, the smaller size cannot be
used to estimate the rate of fragmentation in such predictions.)
The set corresponds to fewer than 31,000 actual genes, because
some genes are fragmented into more than one partial prediction
and some predictions may be spurious or correspond to pseudo-
genes. As discussed below, our best estimate is that IGI.1 includes
about 24,500 true genes.
Evaluation of IGI/IPI. We used several approaches to evaluate the
sensitivity, speci®city and fragmentation of the IGI/IPI set.
Comparison with `new' known genes. One approach was to examine
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newly discovered genes arising from independent work that were
not used in our gene prediction effort. We identi®ed 31 such genes:
22 recent entries to RefSeq and 9 from the Sanger Centre's gene
identi®cation program on chromosome X. Of these, 28 were
contained in the draft genome sequence and 19 were represented
in the IGI/IPI. This suggests that the gene prediction process has a
sensitivity of about 68% (19/28) for the detection of novel genes in
the draft genome sequence and that the current IGI contains about
61% (19/31) of novel genes in the human genome. On average, 79%
of each gene was detected. The extent of fragmentation could also be
estimated: 14 of the genes corresponded to a single prediction in the
IGI/IPI, three genes corresponded to two predictions, one gene to
three predictions and one gene to four predictions. This corre-
sponds to a fragmentation rate of about 1.4 gene predictions per
true gene.
Comparison with RIKEN mouse cDNAs. In a less direct but larger-
scale approach, we compared the IGI gene set to a set of mouse
cDNAs sequenced by the Genome Exploration Group of the RIKEN
Genomic Sciences Center309. This set of 15,294 cDNAs, subjected to
full-insert sequencing, was enriched for novel genes by selecting
cDNAs with novel 39 ends from a collection of nearly one million
ESTs from diverse tissues and developmental timepoints. We
determined the proportion of the RIKEN cDNAs that showed
sequence similarity to the draft genome sequence and the propor-
tion that showed sequence similarity to the IGI/IPI. Around 81% of
the genes in the RIKEN mouse set showed sequence similarity to the
human genome sequence, whereas 69% showed sequence similarity
to the IGI/IPI. This suggests a sensitivity of 85% (69/81). This is
higher than the sensitivity estimate above, perhaps because some of
the matches may be due to paralogues rather than orthologues. It is
consistent with the IGI/IPI representing a substantial fraction of the
human proteome.
Conversely, 69% (22,013/31,898) of the IGI matches the RIKEN
cDNA set. Table 22 shows the breakdown of these matches among
the different components of the IGI. This is lower than the
proportion of matches among known proteins, although this is
expected because known proteins tend to be more highly conserved
(see above) and because the predictions are on average shorter than
known proteins. Table 22 also shows the numbers of matches to the
RIKEN cDNAs among IGI members that do not match known
proteins. The results indicate that both the IGI and the RIKEN set
contain a signi®cant number of genes that are novel in the sense of
not having known protein homologues.
Comparison with genes on chromosome 22. We also compared the
IGI/IPI with the gene annotations on chromosome 22, to assess the
proportion of gene predictions corresponding to pseudogenes and to
estimate the rate of overprediction. We compared 477 IGI gene
predictions to 539 con®rmed genes and 133 pseudogenes on chro-
mosome 22 (with the immunoglobulin lambda locus excluded owing
to its highly atypical gene structure). Of these, 43 hit 36 annotated
pseudogenes. This suggests that 9% of the IGI predictions may
correspond to pseudogenes and also suggests a fragmentation rate
of 1.2 gene predictions per gene. Of the remaining hits, 63 did not
overlap with any current annotations. This would suggest a rate of
spurious predictions of about 13% (63/477), although the true rate
is likely to be much lower because many of these may correspond to
unannotated portions of existing gene predictions or to currently
unannotated genes (of which there are estimated to be about 100 on
this chromosome94).
Chromosomal distribution. Finally, we examined the chromosomal
distribution of the IGI gene set. The average density of gene
predictions is 11.1 per Mb across the genome, with the extremes
being chromosome 19 at 26.8 per Mb and chromosome Yat 6.4 per
Mb. It is likely that a signi®cant number of the predictions on
chromosome Y are pseudogenes (this chromosome is known to be
rich in pseudogenes) and thus that the density for chromosome Y is
an overestimate. The density of both genes and Alus on chromo-
some 19 is much higher than expected, even accounting for the high
GC content of the chromosome; this supports the idea that Alu
density is more closely correlated with gene density than with GC
content itself.
Summary. We are clearly still some way from having a complete set
of human genes. The current IGI contains signi®cant numbers of
partial genes, fragmented and fused genes, pseudogenes and spur-
ious predictions, and it also lacks signi®cant numbers of true genes.
This re¯ects the current state of gene prediction methods in
vertebrates even in ®nished sequence, as well as the additional
challenges related to the current state of the draft genome sequence.
Nonetheless, the gene predictions provide a valuable starting point
for a wide range of biological studies and will be rapidly re®ned in
the coming year.
The analysis above allows us to estimate the number of distinct
genes in the IGI, as well as the number of genes in the human
genome. The IGI set contains about 15,000 known genes and about
17,000 gene predictions. Assuming that the gene predictions are
subject to a rate of overprediction (spurious predictions and
pseudogenes) of 20% and a rate of fragmentation of 1.4, the IGI
would be estimated to contain about 24,500 actual human genes.
Assuming that the gene predictions contain about 60% of
previously unknown human genes, the total number of genes in
the human genome would be estimated to be about 31,000. This is
consistent with most recent estimates based on sampling, which
suggest a gene number of 30,000±35,000. If there are 30,000±35,000
genes, with an average coding length of about 1,400 bp and average
genomic extent of about 30 kb, then about 1.5% of the human
genome would consist of coding sequence and one-third of the
genome would be transcribed in genes.
The IGI/IPI was constructed primarily on the basis of gene
predictions from Ensembl. However, we also generated an expanded
set (IGI+) by including additional predictions from two other gene
prediction programs, Genie and GenomeScan (C. Burge, personal
communication). These predictions were not included in the core
IGI set, because of the concern that each additional set will provide
diminishing returns in identifying true genes while contributing its
own false positives (increased sensitivity at the expense of speci®-
city). Genie produced an additional 2,837 gene predictions not
overlapping the IGI, and GenomeScan produced 6,534 such gene
predictions. If all of these gene predictions were included in the IGI,
the number of the 31 new `known' genes (see above) contained in
the IGI would rise from 19 to 24. This would amount to an increase
of about 26% in sensitivity, at the expense of increasing the number
of predicted genes (excluding knowns) by 55%. Allowing a higher
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Table 22 Properties of the IGI/IPI human protein set
Source Number Average length (amino acids) Matches to nonhuman
proteins
Matches to RIKEN mouse
cDNA set
Matches to RIKEN mouse cDNA
set but not to nonhuman proteins
RefSeq/SwissProt/TrEMBL 14,882 469 12,708 (85%) 11,599 (78%) 776 (36%)
Ensembl±Genie 4,057 443 2,989 (74%) 3,016 (74%) 498 (47%)
Ensembl 12,839 187 81,126 (63%) 7,372 (57%) 1,449 (31%)
Total 31,778 352 23,813 (75%) 219,873 (69%) 2,723 (34%)
...................................................................................................................................................................................................................................................................................................................................................................
The matches to nonhuman proteins were obtained by using Smith-Waterman sequence alignment with an E-value threshold of 10-3 and the matches to the RIKEN mouse cDNAs by using TBLASTN with an
E-value threshold of 10-6. The last column shows that a signi®cant number of the IGI members that do not have nonhuman protein matches do match sequences in the RIKEN mouse cDNA set, suggesting
that both the IGI and the RIKEN sets contain a signi®cant number of novel proteins.
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overprediction rate of 30% for gene predictions in this expanded set,
the analysis above suggests that IGI+ set contains about 28,000 true
genes and yields an estimate of about 32,000 human genes. We are
investigating ways to ®lter the expanded set, to produce an IGI with
the advantage of the increased sensitivity resulting from combining
multiple gene prediction programs without the corresponding loss
of speci®city. Meanwhile, the IGI+ set can be used by researchers
searching for genes that cannot be found in the IGI.
Some classes of genes may have been missed by all of the gene-
®nding methods. Genes could be missed if they are expressed at low
levels or in rare tissues (being absent or very under-represented in
EST and mRNA databases) and have sequences that evolve rapidly
(being hard to detect by protein homology and genome compar-
ison). Both the worm and ¯y gene sets contain a substantial number
of such genes293,294. Single-exon genes encoding small proteins may
also have been missed, because EST evidence that supports them
cannot be distinguished from genomic contamination in the EST
dataset and because homology may be hard to detect for small
proteins310.
The human thus appears to have only about twice as many genes
as worm or ¯y. However, human genes differ in important respects
from those in worm and ¯y. They are spread out over much larger
regions of genomic DNA, and they are used to construct more
alternative transcripts. This may result in perhaps ®ve times as many
primary protein products in the human as in the worm or ¯y.
The predicted gene and protein sets described here are clearly far
from ®nal. Nonetheless, they provide a valuable starting point for
experimental and computational research. The predictions will
improve progressively as the sequence is ®nished, as further
con®rmatory evidence becomes available (particularly from
other vertebrate genome sequences, such as those of mouse and
T. nigroviridis), and as computational methods improve. We intend
to create and release updated versions of the IGI and IPI regularly,
until they converge to a ®nal accurate list of every human gene. The
gene predictions will be linked to RefSeq, HUGO and SWISSPROT
identi®ers where available, and tracking identi®ers between versions
will be included, so that individual genes under study can be traced
forwards as the human sequence is completed.
Comparative proteome analysis
Knowledge of the human proteome will provide unprecedented
opportunities for studies of human gene function. Often clues will
be provided by sequence similarity with proteins of known function
in model organisms. Such initial observations must then be fol-
lowed up by detailed studies to establish the actual function of these
molecules in humans.
For example, 35 proteins are known to be involved in the vacuolar
protein-sorting machinery in yeast. Human genes encoding homo-
logues can be found in the draft human sequence for 34 of these
yeast proteins, but precise relationships are not always clear. In nine
cases there appears to be a single clear human orthologue (a gene
that arose as a consequence of speciation); in 12 cases there are
matches to a family of human paralogues (genes that arose owing to
intra-genome duplication); and in 13 cases there are matches
to speci®c protein domains311±314. Hundreds of similar stories
emerge from the draft sequence, but each merits a detailed inter-
pretation in context. To treat these subjects properly, there will be
many following studies, the ®rst of which appear in accompanying
papers315±323.
Here, we aim to take a more global perspective on the content of
the human proteome by comparing it with the proteomes of yeast,
worm, ¯y and mustard weed. Such comparisons shed useful light on
the commonalities and differences among these eukaryotes294,324,325.
The analysis is necessarily preliminary, because of the imperfect
nature of the human sequence, uncertainties in the gene and protein
sets for all of the multicellular organisms considered and our
incomplete knowledge of protein structures. Nonetheless, some
general patterns emerge. These include insights into fundamental
mechanisms that create functional diversity, including invention of
protein domains, expansion of protein and domain families, evolu-
tion of new protein architectures and horizontal transfer of genes.
Other mechanisms, such as alternative splicing, post-translational
modi®cation and complex regulatory networks, are also crucial in
generating diversity but are much harder to discern from the
primary sequence. We will not attempt to consider the effects of
alternative splicing on proteins; we will consider only a single splice
form from each gene in the various organisms, even when multiple
splice forms are known.
Functional and evolutionary classi®cation. We began by classify-
ing the human proteome on the basis of functional categories and
evolutionary conservation. We used the InterPro annotation pro-
tocol to identify conserved biochemical and cellular processes.
InterPro is a tool for combining sequence-pattern information
from four databases. The ®rst two databases (PRINTS326 and
Prosite327) primarily contain information about motifs correspond-
ing to speci®c family subtypes, such as type II receptor tyrosine
kinases (RTK-II) in particular or tyrosine kinases in general. The
second two databases (Pfam307 and Prosite Pro®le327) contain
information (in the form of pro®les or HMMs) about families of
structural domainsÐfor example, protein kinase domains. Inter-
Pro integrates the motif and domain assignments into a hierarchical
classi®cation system; so a protein might be classi®ed at the most
detailed level as being an RTK-II, at a more general level as being a
kinase speci®c for tyrosine, and at a still more general level as
being a protein kinase. The complete hierarchy of InterPro entries
is described at http://www.ebi.ac.uk/interpro/. We collapsed the
InterPro entries into 12 broad categories, each re¯ecting a set of
cellular functions.
The InterPro families are partly the product of human judgement
and re¯ect the current state of biological and evolutionary knowl-
edge. The system is a valuable way to gain insight into large
collections of proteins, but not all proteins can be classi®ed at
present. The proportions of the yeast, worm, ¯y and mustard weed
protein sets that are assigned to at least one InterPro family is, for
each organism, about 50% (Table 23; refs 307, 326, 327).
About 40% of the predicted human proteins in the IPI could be
assigned to InterPro entries and functional categories. On the basis
of these assignments, we could compare organisms according to the
number of proteins in each category (Fig. 37). Compared with the
two invertebrates, humans appear to have many proteins involved
in cytoskeleton, defence and immunity, and transcription and
translation. These expansions are clearly related to aspects of
vertebrate physiology. Humans also have many more proteins that
are classi®ed as falling into more than one functional category (426
in human versus 80 in worm and 57 in ¯y, data not shown).
Interestingly, 32% of these are transmembrane receptors.
We obtained further insight into the evolutionary conservation of
proteins by comparing each sequence to the complete nonredun-
dant database of protein sequences maintained at NCBI, using the
BLASTP computer program328 and then breaking down the matches
according to organismal taxonomy (Fig. 38). Overall, 74% of the
proteins had signi®cant matches to known proteins.
Such classi®cations are based on the presence of clearly detectable
homologues in existing databases. Many of these genes have surely
evolved from genes that were present in common ancestors but have
since diverged substantially. Indeed, one can detect more distant
relationships by using sensitive computer programs that can recog-
nize weakly conserved features. Using PSI-BLAST, we can recognize
probable nonvertebrate homologues for about 45% of the `verte-
brate-speci®c' set. Nonetheless, the classi®cation is useful for gain-
ing insights into the commonalities and differences among the
proteomes of different organisms.
Probable horizontal transfer. An interesting category is a set of 223
proteins that have signi®cant similarity to proteins from bacteria,
but no comparable similarity to proteins from yeast, worm, ¯y and
articles
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mustard weed, or indeed from any other (nonvertebrate) eukaryote.
These sequences should not represent bacterial contamination in
the draft human sequence, because we ®ltered the sequence to
eliminate sequences that were essentially identical to known bacter-
ial plasmid, transposon or chromosomal DNA (such as the host
strains for the large-insert clones). To investigate whether these were
genuine human sequences, we designed PCR primers for 35 of these
genes and con®rmed that most could be readily detected directly in
human genomic DNA (Table 24). Orthologues of many of these
genes have also been detected in other vertebrates (Table 24).
A more detailed computational analysis indicated that at least 113
of these genes are widespread among bacteria, but, among eukar-
yotes, appear to be present only in vertebrates. It is possible that the
genes encoding these proteins were present in both early prokar-
yotes and eukaryotes, but were lost in each of the lineages of yeast,
worm, ¯y, mustard weed and, possibly, from other nonvertebrate
eukaryote lineages. A more parsimonious explanation is that these
genes entered the vertebrate (or prevertebrate) lineage by horizontal
transfer from bacteria. Many of these genes contain introns, which
presumably were acquired after the putative horizontal transfer
event. Similar observations indicating probable lineage-speci®c
horizontal gene transfers, as well as intron insertion in the acquired
genes, have been made in the worm genome329.
We cannot formally exclude the possibility that gene transfer
occurred in the opposite directionÐthat is, that the genes were
invented in the vertebrate lineage and then transferred to bacteria.
However, we consider this less likely. Under this scenario, the broad
distribution of these genes among bacteria would require extensive
horizontal dissemination after their initial acquisition. In addition,
the functional repertoire of these genes, which largely encode
intracellular enzymes (Table 24), is uncharacteristic of vertebrate-
speci®c evolutionary innovations (which appear to be primarily
extracellular proteins; see below).
We did not identify a strongly preferred bacterial source for the
putative horizontally transferred genes, indicating the likelihood
of multiple independent gene transfers from different bacteria
(Table 24). Notably, several of the probable recent acquisitions
have established (or likely) roles in metabolism of xenobiotics or
stress response. These include several hydrolases of different
speci®cities, including epoxide hydrolase, and several dehydro-
genases (Table 24). Of particular interest is the presence of two
paralogues of monoamine oxidase (MAO), an enzyme of the
mitochondrial outer membrane that is central in the metabolism
of neuromediators and is a target of important psychiatric
drugs330±333. This example shows that at least some of the genes
thought to be horizontally transferred into the vertebrate lineage
appear to be involved in important physiological functions and so
probably have been ®xed and maintained during evolution because
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Figure 37 Functional categories in eukaryotic proteomes. The classi®cation categories
were derived from functional classi®cation systems, including the top-level biological

















Figure 38 Distribution of the homologues of the predicted human proteins. For each
protein, a homologue to a phylogenetic lineage was considered present if a search of the
NCBI nonredundant protein sequence database, using the gapped BLASTP program, gave
a random expectation (E ) value of # 0.001. Additional searches for probable homologues
with lower sequence conservation were performed using the PSI-BLAST program, run for
three iterations using the same cut-off for inclusion of sequences into the pro®le328.
Table 23 Properties of genome and proteome in essentially completed eukaryotic proteomes
Human Fly Worm Yeast Mustard weed
Number of identi®ed genes ,32,000* 13,338 18,266 6,144 25,706
% with InterPro matches 51 56 50 50 52
Number of annotated domain families 1,262 1,035 1,014 851 1,010
Number of InterPro entries per gene 0.53 0.84 0.63 0.6 0.62
Number of distinct domain architectures 1,695 1,036 1,018 310 ±
Percentage of 1-1-1-1 1.40 4.20 3.10 9.20 ±
% Signal sequences 20 20 24 11 ±
% Transmembrane proteins 20 25 28 15 ±
% Repeat-containing 10 11 9 5 ±
% Coiled-coil 11 13 10 9 ±
...................................................................................................................................................................................................................................................................................................................................................................
The numbers of distinct architectures were calculated using SMART339 and the percentages of repeat-containing proteins were estimated using Prospero452 and a P-value threshold of 10-5. The protein sets
used in the analysis were taken from http://www.ebi.ac.uk/proteome/ for yeast, worm and ¯y. The proteins from mustard weed were taken from the TAIR website (http:// www.arabidopsis.org/) on 5
September 2000. The protein set was searched against the InterPro database (http://www.ebi.ac.uk/interpro/) using the InterProscan software. Comparison of protein sequences with the InterPro
database allows prediction of protein families, domain and repeat families and sequence motifs. The searches used Pfam release 5.2307, Prints release 26.1326, Prosite release 16327 and Prosite preliminary
pro®les. InterPro analysis results are available as Supplementary Information. The fraction of 1-1-1-1 is the percentage of the genome that falls into orthologous groups composed of only one member each
in human, ¯y, worm and yeast.
* The gene number for the human is still uncertain (see text). Table is based on 31,778 known genes and gene predictions.
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of the increased selective advantage(s) they provide.
Genes shared with ¯y, worm and yeast. IPI.1 contains apparent
homologues of 61% of the ¯y proteome, 43% of the worm
proteome and 46% of the yeast proteome. We next considered the
groups of proteins containing likely orthologues and paralogues
(genes that arose from intragenome duplication) in human, ¯y,
worm and yeast.
Brie¯y, we performed all-against-all sequence comparison334 for
the combined protein sets of human, yeast, ¯y and worm. Pairs of
sequences that were one another's best matches in their respective
genomes were considered to be potential orthologues. These were
then used to identify orthologous groups across three organisms335.
Recent species-speci®c paralogues were de®ned by using the all-
against-all sequence comparison to cluster the protein set for each
organism. For each sequence found in an orthologous group, the
recent paralogues were de®ned to be the largest species-speci®c
cluster including it. The set of paralogues may be in¯ated by
unrecognized splice variants and by fragmentation.
We identi®ed 1,308 groups of proteins, each containing at least
one predicted orthologue in each species and many containing
additional paralogues. The 1,308 groups contained 3,129 human
proteins, 1,445 ¯y proteins, 1,503 worm proteins and 1,441 yeast
proteins. These 1,308 groups represent a conserved core of proteins
that are mostly responsible for the basic `housekeeping' functions of
the cell, including metabolism, DNA replication and repair, and
translation.
In 564 of the 1,308 groups, one orthologue (and no additional
paralogues) could be unambiguously assigned for each of human,
¯y, worm and yeast. These groups will be referred to as 1-1-1-1
groups. More than half (305) of these groups could be assigned to
the functional categories shown in Fig. 37. Within these functional
categories, the numbers of groups containing single orthologues
in each of the four proteomes was: 19 for cellular processes, 66
for metabolism, 31 for DNA replication and modi®cation, 106
for transcription/translation, 13 for intracellular signalling, 24
for protein folding and degradation, 38 for transport, 5 for
articles
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Table 24 Probable vertebrate-speci®c acquisitions of bacterial genes
Human protein (accession) Predicted function Known orthologues in
other vertebrates





Pig, rat, chicken Thermotoga, Thermoplasma,
Methylobacter
Thermotoga maritima Yes





BAA1143.21 Epoxide hydrolase (a/b-hydrolase) Mouse, Danio, fugu
®sh
Most bacteria Pseudomonas aeruginosa Yes
CAB59628.1 Protein-methionine-S-oxide reductase Cow Most bacteria Synechocystis sp. Yes
BAA91273.1 Hypertension-associated protein SA/
acetate-CoA ligase
Mouse, rat, cow Most bacteria Bacillus halodurans NT*
CAA75608.1 Glucose-6-phosphate transporter/
glycogen storage disease type 1b
protein
Mouse, rat Most bacteria Chlamydophila pneumoniae Yes




Mouse, rat, pig Most bacteria P. aeruginosa Yes
AAA51565.1
IGI_M1_ctg19153_147 Aldose-1-epimerase Pig (also found in
plants)
Streptomyces, Bacillus Streptomyces coelicolor Yes
BAA92632.1 Predicted carboxylase (C-terminal




BAA34458.1 Uncharacterized protein None Gamma-proteobacteria Escherichia coli Yes
AAF24044.1 Uncharacterized protein None Most bacteria T. maritima Yes
BAA34458.1 b-Lactamase superfamily hydrolase None Most bacteria Synechocystis sp. Yes
BAA91839.1 Oxidoreductase (Rossmann fold)





more distant homologues in
other bacteria
S. coelicolor Yes
BAA92073.1 Oxidoreductase (Rossmann fold) None Synechocystis, Pseudomonas Synechocystis sp. Yes
BAA92133.1 a/b-hydrolase None Rickettsia; more distant
homologues in other bacteria
Rickettsia prowazekii Yes






None Most bacteria Bacillus stearothermophilus Yes
BAA86552.1 Ribosomal protein S6-glutamic acid
ligase
None Most bacteria and archaea Haemophilus in¯uenzae Yes
IGI_M1_ctg12741_7 Ribosomal protein S6-glutamic acid
ligase (paralogue of the above)
None Most bacteria and archaea H. in¯uenzae Yes
IGI_M1_ctg13238_61 Hydratase None Synechocystis,
Sphingomonas
Synechocystis sp. Yes







coli, more distant homologues
in other bacteria
T. maritima Yes
IGI_M1_ctg14420_10 Sugar transporter None Most bacteria Synechocystis sp. Yes
IGI_M1_ctg16010_18 Predicted metal-binding protein None Most bacteria Borrelia burgdorferi Yes
IGI_M1_ctg16227_58 Pseudouridine synthase None Most bacteria Zymomonas mobilis Yes





* NT, not tested.
Representative genes con®rmed by PCR to be present in the human genome. The similarity to a bacterial homologue was considered to be `signi®cantly' greater than that to eukaryotic homologues if the
difference in alignment scores returned by BLASTP was greater than 30 bits (,9 orders of magnitude in terms of E-value). A complete, classi®ed and annotated list of probable vertebrate-speci®c horizontal
gene transfers detected in this analysis is available as Supplementary Information. cDNA sequences for each protein were searched, using the SSAHA algorithm, against the draft genome sequence.
Primers were designed and PCR was performed using three human genomic samples and a random BAC clone. The predicted genes were considered to be present in the human genome if a band of the
expected size was found in all three human samples but not in the control clone.
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multifunctional proteins and 3 for cytoskeletal/structural. No such
groups were found for defence and immunity or cell±cell commu-
nication.
The 1-1-1-1 groups probably represent key functions that have
not undergone duplication and elaboration in the various lineages.
They include many anabolic enzymes responsible for such functions
as respiratory chain and nucleotide biosynthesis. In contrast, there
are few catabolic enzymes. As anabolic pathways branch less
frequently than catabolic pathways, this indicates that alternative
routes and displacements are more frequent in catabolic reactions.
If proteins from the single-celled yeast are excluded from the
analysis, there are 1,195 1-1-1 groups. The additional groups
include many examples of more complex signalling proteins, such
as receptor-type and src-like tyrosine kinases, likely to have arisen
early in the metazoan lineage. The fact that this set comprises only a
small proportion of the proteome of each of the animals indicates
that, apart from a modest conserved core, there has been extensive
elaboration and innovation within the protein complement.
Most proteins do not show simple 1-1-1 orthologous relation-
ships across the three animals. To illustrate this, we investigated the
nuclear hormone receptor family. In the human proteome, this
family consists of 60 different `classical' members, each with a zinc
®nger and a ligand-binding domain. In comparison, the ¯y pro-
teome has 19 and the worm proteome has 220. As shown in Fig. 39,
few simple orthologous relationships can be derived among these
homologues. And, where potential subgroups of orthologues and
paralogues could be identi®ed, it was apparent that the functions of
the subgroup members could differ signi®cantly. For example, the
¯y receptor for the ¯y-speci®c hormone ecdysone and the human
retinoic acid receptors cluster together on the basis of sequence
similarity. Such examples underscore that the assignment of func-
tional similarity on the basis of sequence similarities among these
three organisms is not trivial in most cases.
New vertebrate domains and proteins. We then explored how the
proteome of vertebrates (as represented by the human) differs from
those of the other species considered. The 1,262 InterPro families
were scanned to identify those that contain only vertebrate proteins.
Only 94 (7%) of the families were `vertebrate-speci®c'. These
represent 70 protein families and 24 domain families. Only one of
the 94 families represents enzymes, which is consistent with the
ancient origins of most enzymes336. The single vertebrate-speci®c
enzyme family identi®ed was the pancreatic or eosinophil-asso-
ciated ribonucleases. These enzymes evolved rapidly, possibly to
combat vertebrate pathogens337.
The relatively small proportion of vertebrate-speci®c multicopy
families suggests that few new protein domains have been invented
in the vertebrate lineage, and that most protein domains trace at
least as far back as a common animal ancestor. This conclusion must
be tempered by the fact that the InterPro classi®cation system is
incomplete; additional vertebrate-speci®c families undoubtedly
exist that have not yet been recognized in the InterPro system.
The 94 vertebrate-speci®c families appear to re¯ect important
physiological differences between vertebrates and other eukaryotes.
Defence and immunity proteins (23 families) and proteins that
function in the nervous system (17 families) are particularly
enriched in this set. These data indicate the recent emergence or
rapid divergence of these proteins.
Representative human proteins were previously known for nearly
all of the vertebrate-speci®c families. This was not surprising, given
the anthropocentrism of biological research. However, the analysis
did identify the ®rst mammalian proteins belonging to two of these
families. Both of these families were originally de®ned in ®sh. The
®rst is the family of polar ®sh antifreeze III proteins. We found a
human sialic acid synthase containing a domain homologous to
polar ®sh antifreeze III protein (BAA91818.1). This ®nding suggests
that ®sh created the antifreeze function by adaptation of this
domain. We also found a human protein (CAB60269.1) homo-
logous to the ependymin found in teleost ®sh. Ependymins are
major glycoproteins of ®sh brains that have been claimed to be
involved in long-term memory formation338. The function of the
mammalian ependymin homologue will need to be elucidated.
New architectures from old domains. Whereas there appears to be
only modest invention at the level of new vertebrate protein
domains, there appears to be substantial innovation in the creation
of new vertebrate proteins. This innovation is evident at the level of
domain architecture, de®ned as the linear arrangement of domains
within a polypeptide. New architectures can be created by shuf¯ing,
adding or deleting domains, resulting in new proteins from old
parts.
We quanti®ed the number of distinct protein architectures found
in yeast, worm, ¯y and human by using the SMART annotation
resource339 (Fig. 40). The human proteome set contained 1.8 times
as many protein architectures as worm or ¯y and 5.8 times as many
as yeast. This difference is most prominent in the recent evolution of
novel extracellular and transmembrane architectures in the human
lineage. Human extracellular proteins show the greatest innovation:
the human has 2.3 times as many extracellular architectures as ¯y
and 2.0 times as many as worm. The larger number of human
architectures does not simply re¯ect differences in the number of
domains known in these organisms; the result remains qualitatively
the same even if the number of architectures in each organism is
normalized by dividing by the total number of domains (not
shown). (We also checked that the larger number of human
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Figure 39 Simpli®ed cladogram (relationship tree) of the `many-to-many' relationships of
classical nuclear receptors. Triangles indicate expansion within one lineage; bars
represent single members. Numbers in parentheses indicate the number of paralogues in
each group.
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architectures could not be an artefact resulting from erroneous gene
predictions. Three-quarters of the architectures can be found in
known genes, which already yields an increase of about 50% over
worm and ¯y. We expect the ®nal number of human architectures to
grow as the complete gene set is identi®ed.)
A related measure of proteome complexity can be obtained by
considering an individual domain and counting the number of
different domain types with which it co-occurs. For example,
the trypsin-like serine protease domain (number 12 in Fig. 41)
co-occurs with 18 domain types in human (including proteins
involved in the mammalian complement system, blood coagulation,
and ®brinolytic and related systems). By contrast, the trypsin-like
serine protease domain occurs with only eight other domains in ¯y,
®ve in worm and one in yeast. Similar results for 27 common domains
are shown in Fig. 41. In general, there are more different co-occurring
domains in the human proteome than in the other proteomes.
One mechanism by which architectures evolve is through the
fusion of additional domains, often at one or both ends of the
proteins. Such `domain accretion'340 is seen in many human proteins
when compared with proteins from other eukaryotes. The effect is
illustrated by several chromatin-associated proteins (Fig. 42). In
these examples, the domain architectures of human proteins differ
from those found in yeast, worm and ¯y proteins only by the
addition of domains at their termini.
Among chromatin-associated proteins and transcription factors,
a signi®cant proportion of domain architectures is shared between
the vertebrate and ¯y, but not with worm (Fig. 43a). The trend was
even more prominent in architectures of proteins involved in
another key cellular process, programmed cell death (Fig. 43b).
These examples might seem to bear upon the unresolved issue of the
evolutionary branching order of worms, ¯ies and humans, suggest-
ing that worms branched off ®rst. However, there were other cases in
which worms and humans shared architectures not present in ¯y. A
global analysis of shared architectures could not conclusively
distinguish between the two models, given the possibility of line-
age-speci®c loss of architectures. Comparison of protein architec-
tures may help to resolve the evolutionary issue, but it will require
more detailed analyses of many protein families.
New physiology from old proteins. An important aspect of
articles
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Figure 41 Number of different Pfam domain types that co-occur in the same protein, for
each of the 10 most common domain families in each of the ®ve eukaryotic proteomes.
Because some common domain families are shared, there are 27 families rather than 50.
The data are ranked according to decreasing numbers of human co-occurring Pfam
domains. The domain families are: (1) eukaryotic protein kinase [IPR000719];
(2) immunoglobulin domain [IPR003006]; (3) ankyrin repeat [IPR002110]; (4) RING ®nger
[IPR001841]; (5) C2H2-type zinc ®nger [IPR000822]; (6) ATP/GTP-binding P-loop
[IPR001687]; (7) reverse transcriptase (RNA-dependent DNA polymerase) [IPR000477];
(8) leucine-rich repeat [IPR001611]; (9) G-proteinb WD-40 repeats [IPR001680];
(10) RNA-binding region RNP-1 (RNA recognition motif) [IPR000504]; (11) C-type lectin
domain [IPR001304]; (12) serine proteases, trypsin family [IPR001254]; (13) helicase
C-terminal domain [IPR001650]; (14) collagen triple helix repeat [IPR000087];
(15) rhodopsin-like GPCR superfamily [IPR000276]; (16) esterase/lipase/thioesterase
[IPR000379]; (17) Myb DNA-binding domain [IPR001005]; (18) F-box domain
[IPR001810]; (19) ATP-binding transport protein, 2nd P-loop motif [IPR001051];
(20) homeobox domain [IPR001356]; (21) C4-type steroid receptor zinc ®nger
[IPR001628]; (22) sugar transporter [IPR001066]; (23) PPR repeats [IPR002885];
(24) seven-helix G-protein-coupled receptor, worm (probably olfactory) family [IPR000168];
(25) cytochrome P450 enzyme [IPR001128]; (26) fungal transcriptional regulatory protein,



































Figure 40 Number of distinct domain architectures in the four eukaryotic genomes,
predicted using SMART339. The number of architectures is split into three cellular
environments: intracellular, extracellular and membrane-associated. The increase in
architectures for the human, relative to the other lineages, is seen when these numbers
are normalized with respect to the numbers of domains predicted in each phylum. To
avoid artefactual results from the relatively low detection rate for some repeat types,
tandem occurrences of tetratricopeptide, armadillo, EF-hand, leucine-rich, WD40 or
ankyrin repeats or C2H2-type zinc ®ngers were treated as single occurrences.
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vertebrate innovation lies in the expansion of protein families. Table
25 shows the most prevalent protein domains and protein families
in humans, together with their relative ranks in the other species.
About 60% of families are more numerous in the human than in any
of the other four organisms. This shows that gene duplication has
been a major evolutionary force during vertebrate evolution. A
comparison of relative expansions in human versus ¯y is shown in
Fig. 44.
Many of the families that are expanded in human relative to ¯y
and worm are involved in distinctive aspects of vertebrate physiol-
ogy. An example is the family of immunoglobulin (IG) domains,
®rst identi®ed in antibodies thirty years ago. Classic (as opposed to
divergent) IG domains are completely absent from the yeast and
mustard weed proteomes and, although prokaryotic homologues
exist, they have probably been transferred horizontally from
metazoans341. Most IG superfamily proteins in invertebrates are
cell-surface proteins. In vertebrates, the IG repertoire includes
immune functions such as those of antibodies, MHC proteins,
antibody receptors and many lymphocyte cell-surface proteins. The
large expansion of IG domains in vertebrates shows the versatility of
a single family in evoking rapid and effective response to infection.
Two prominent families are involved in the control of develop-
ment. The human genome contains 30 ®broblast growth factors
(FGFs), as opposed to two FGFs each in the ¯y and worm. It
contains 42 transforming growth factor-bs (TGFbs) compared with
nine and six in the ¯y and worm, respectively. These growth factors
are involved in organogenesis, such as that of the liver and the lung.
A ¯y FGF protein, branchless, is involved in developing respiratory
organs (tracheae) in embryos342. Thus, developmental triggers of
morphogenesis in vertebrates have evolved from related but simpler
systems in invertebrates343.
Another example is the family of intermediate ®lament proteins,
with 127 family members. This expansion is almost entirely due to
111 keratins, which are chordate-speci®c intermediate ®lament
proteins that form ®laments in epithelia. The large number of
human keratins suggests multiple cellular structural support roles
for the many specialized epithelia of vertebrates.
Finally, the olfactory receptor genes comprise a huge gene family
of about 1,000 genes and pseudogenes344,345. The number of olfac-
tory receptors testi®es to the importance of the sense of smell in
vertebrates. A total of 906 olfactory receptor genes and pseudogenes
could be identi®ed in the draft genome sequence, two-thirds of
which were not previously annotated. About 80% are found in
about two dozen clusters ranging from 6 to 138 genes and encom-
passing about 30 Mb (,1%) of the human genome. Despite the
importance of smell among our vertebrate ancestors, hominids
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Figure 42 Examples of domain accretion in chromatin proteins. Domain accretion in
various lineages before the animal divergence, in the apparent coelomate lineage and the
vertebrate lineage are shown using schematic representations of domain architectures
(not to scale). Asterisks, mobile domains that have participated in the accretion. Species
in which a domain architecture has been identi®ed are indicated above the diagram
(Y, yeast; W, worm; F, ¯y; V, vertebrate). Protein names are below the diagrams. The
domains are SET, a chromatin protein methyltransferase domain; SWI2, a superfamily II
helicase/ATPase domain; Sa, sant domain; Br, bromo domain; Ch, chromodomain; C, a
cysteine triad motif associated with the Msl-2 and SET domains; A, AT hook motif; EP1/
EP2, enhancer of polycomb domains 1 and 2; Znf, zinc ®nger; sja, SET-JOR-associated
domain (L. Aravind, unpublished); Me, DNA methylase/Hrx-associated DNA binding zinc
®nger; Ba, bromo-associated homology motif. a±c, Different examples of accretion.




















Figure 43 Conservation of architectures between animal species. The pie charts illustrate
the shared domain architectures of apparent orthologues that are conserved in at least
two of the three sequenced animal genomes. If an architecture was detected in fungi or
plants, as well as two of the animal lineages, it was omitted as ancient and its absence in
the third animal lineage attributed to gene loss. a, Chromatin-associated proteins.
b, Components of the programmed cell death system.
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appear to have considerably less interest in this sense. About 60% of
the olfactory receptors in the draft genome sequence have disrupted
ORFs and appear to be pseudogenes, consistent with recent
reports344,346 suggesting massive functional gene loss in the last 10
Myr347,348. Interestingly, there appears to be a much higher propor-
tion of intact genes among class I than class II olfactory receptors,
suggesting functional importance.
Vertebrates are not unique in employing gene family expansion.
For many domain types, expansions appear to have occurred
independently in each of the major eukaryotic lineages. A good
example is the classical C2H2 family of zinc ®nger domains, which
have expanded independently in the yeast, worm, ¯y and human
lineages (Fig. 45). These independent expansions have resulted in
numerous C2H2 zinc ®nger domain-containing proteins that are
speci®c to each lineage. In ¯ies, the important components of the
C2H2 zinc ®nger expansion are architectures in which it is com-
bined with the POZ domain and the C4DM domain (a metal-
binding domain found only in ¯y). In humans, the most prevalent
expansions are combinations of the C2H2 zinc ®nger with POZ
(independent of the one in insects) and the vertebrate-speci®c
KRAB and SCAN domains.
The homeodomain is similarly expanded in all animals and is
present in both architectures that are conserved and lineage-speci®c
architectures (Fig. 45). This indicates that the ancestral animal
probably encoded a signi®cant number of homeodomain proteins,
but subsequent evolution involved multiple, independent expan-
sions and domain shuf¯ing after lineages diverged. Thus, the most
prevalent transcription factor families are different in worm, ¯y and
human (Fig. 45). This has major biological implications because
transcription factors are critical in animal development and differ-
entiation. The emergence of major variations in the developmental
body plans that accompanied the early radiation of the animals349
could have been driven by lineage-speci®c proliferation of such
transcription factors. Beyond these large expansions of protein
families, protein components of particular functional systems
such as the cell death signalling system show a general increase in
diversity and numbers in the vertebrates relative to other animals.
For example, there are greater numbers of and more novel archi-
tectures in cell death regulatory proteins such as BCL-2, TNFR and
NFkB from vertebrates.
Conclusion. Five lines of evidence point to an increase in the
complexity of the proteome from the single-celled yeast to the
multicellular invertebrates and to vertebrates such as the human.
Speci®cally, the human contains greater numbers of genes, domain
and protein families, paralogues, multidomain proteins with
multiple functions, and domain architectures. According to these
measures, the relatively greater complexity of the human proteome
is a consequence not simply of its larger size, but also of large-scale
protein innovation.
An important question is the extent to which the greater
phenotypic complexity of vertebrates can be explained simply by
two- or threefold increases in proteome complexity. The real
explanation may lie in combinatorial ampli®cation of these
modest differences, by mechanisms that include alternative splicing,
post-translational modi®cation and cellular regulatory networks.
The potential numbers of different proteins and protein±protein
interactions are vast, and their actual numbers cannot readily be
discerned from the genome sequence. Elucidating such system-
level properties presents one of the great challenges for modern
biology.
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Table 25 The most populous InterPro families in the human proteome and other species
Human Fly Worm Yeast Mustard weed











IPR003006 765 (1) 140 (9) 64 (34) 0 (na) 0 (na) Immunoglobulin domain
PR000822 706 (2) 357 (1) 151 (10) 48 (7) 115 (20) C2H2 zinc ®nger
IPR000719 575 (3) 319 (2) 437 (2) 121 (1) 1049 (1) Eukaryotic protein kinase
IPR000276 569 (4) 97 (14) 358 (3) 0 (na) 16 (84) Rhodopsin-like GPCR superfamily
IPR001687 433 (5) 198 (4) 183 (7) 97 (2) 331 (5) P-loop motif
IPR000477 350 (6) 10 (65) 50 (41) 6 (36) 80 (35) Reverse transcriptase (RNA-dependent DNA polymerase)
IPR000504 300 (7) 157 (6) 96 (21) 54 (6) 255 (8) rrm domain
IPR001680 277 (8) 162 (5) 102 (19) 91 (3) 210 (10) G-protein b WD-40 repeats
IPR002110 276 (9) 105 (13) 107 (17) 19 (23) 120 (18) Ankyrin repeat
IPR001356 267 (10) 148 (7) 109 (15) 9 (33) 118 (19) Homeobox domain
IPR001849 252 (11) 77 (22) 71 (31) 27 (17) 27 (73) PH domain
IPR002048 242 (12) 111 (12) 81 (25) 15 (27) 167 (12) EF-hand family
IPR000561 222 (13) 81 (20) 113 (14) 0 (na) 17 (83) EGF-like domain
IPR001452 215 (14) 72 (23) 62 (35) 25 (18) 3 (97) SH3 domain
IPR001841 210 (15) 114 (11) 126 (12) 35 (12) 379 (4) RING ®nger
IPR001611 188 (16) 115 (10) 54 (38) 7 (35) 392 (2) Leucine-rich repeat
IPR001909 171 (17) 0 (na) 0 (na) 0 (na) 0 (na) KRAB box
IPR001777 165 (18) 63 (27) 51 (40) 2 (40) 4 (96) Fibronectin type III domain
IPR001478 162 (19) 70 (24) 66 (33) 2 (40) 15 (85) PDZ domain
IPR001650 155 (20) 87 (17) 78 (27) 79 (4) 148 (13) Helicase C-terminal domain
IPR001440 150 (21) 86 (18) 46 (43) 36 (11) 125 (17) TPR repeat
IPR002216 133 (22) 65 (26) 99 (20) 2 (40) 31 (69) Ion transport protein
IPR001092 131 (23) 84 (19) 41 (46) 7 (35) 106 (24) Helix±loop±helix DNA-binding domain
IPR000008 123 (24) 43 (34) 36 (49) 9 (33) 82 (34) C2 domain
IPR001664 119 (25) 4 (71) 22 (63) 1 (41) 2 (98) SH2 domain
IPR001254 118 (26) 210 (3) 12 (73) 1 (41) 15 (85) Serine protease, trypsin family
IPR002126 114 (27) 19 (56) 16 (69) 0 (na) 0 (na) Cadherin domain
IPR000210 113 (28) 78 (21) 117 (13) 1 (41) 54 (50) BTB/POZ domain
IPR000387 112 (29) 35 (40) 108 (16) 12 (30) 21 (79) Tyrosine-speci®c protein phosphatase and dual speci®city
protein phosphatase family
IPR000087 106 (30) 18 (57) 169 (9) 0 (na) 5 (95) Collagen triple helix repeat
IPR000379 94 (31) 141 (8) 134 (11) 40 (10) 194 (11) Esterase/lipase/thioesterase
IPR000910 89 (32) 38 (38) 18 (67) 8 (34) 18 (82) HMG1/2 (high mobility group) box
IPR000130 87 (33) 56 (29) 92 (22) 8 (34) 12 (88) Neutral zinc metallopeptidase
IPR001965 84 (34) 37 (39) 24 (61) 16 (26) 71 (39) PHD-®nger
IPR000636 83 (35) 32 (43) 24 (61) 1 (41) 14 (86) Cation channels (non-ligand gated)
IPR001781 81 (36) 38 (38) 36 (49) 4 (38) 8 (92) LIM domain
IPR002035 81 (36) 8 (67) 45 (44) 3 (39) 17 (83) VWA domain
IPR001715 80 (37) 33 (42) 30 (55) 3 (39) 18 (82) Calponin homology domain
IPR000198 77 (38) 20 (55) 20 (65) 10 (32) 9 (91) RhoGAP domain
...................................................................................................................................................................................................................................................................................................................................................................
Forty most populous Interpro families found in the human proteome compared with equivalent numbers from other species. na, not applicable (used when there are no proteins in an organism in that family).
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Segmental history of the human genome
In bacteria, genomic segments often convey important information
about function: genes located close to one another often encode
proteins in a common pathway and are regulated in a common
operon. In mammals, genes found close to each other only rarely
have common functions, but they are still interesting because they
have a common history. In fact, the study of genomic segments can
shed light on biological events as long as 500 Myr ago and as recently
as 20,000 years ago.
Conserved segments between human and mouse
Humans and mice shared a common ancestor about 100 Myr ago.
Despite the 200 Myr of evolutionary distance between the species, a
signi®cant fraction of genes show synteny between the two, being
preserved within conserved segments. Genes tightly linked in one
mammalian species tend to be linked in others. In fact, conserved
segments have been observed in even more distant species: humans
show conserved segments with ®sh350,351 and even with invertebrates
such as ¯y and worm352. In general, the likelihood that a syntenic
relationship will be disrupted correlates with the physical distance
between the loci and the evolutionary distance between the species.
Studying conserved segments between human and mouse has
several uses. First, conservation of gene order has been used to
identify likely orthologues between the species, particularly when
investigating disease phenotypes. Second, the study of conserved
segments among genomes helps us to deduce evolutionary ancestry.
And third, detailed comparative maps may assist in the assembly of
the mouse sequence, using the human sequence as a scaffold.
Two types of linkage conservation are commonly described353.
`Conserved synteny' indicates that at least two genes that reside on a
common chromosome in one species are also located on a common
chromosome in the other species. Syntenic loci are said to lie in a
`conserved segment' when not only the chromosomal position but
the linear order of the loci has been preserved, without interruption
by other chromosomal rearrangements.
An initial survey of homologous loci in human and mouse354
suggested that the total number of conserved segments would be
about 180. Subsequent estimates based on increasingly detailed
comparative maps have remained close to this projection353,355,356
(http://www.informatics.jax.org). The distribution of segment
lengths has corresponded reasonably well to the truncated negative
exponential curve predicted by the random breakage model357.
The availability of a draft human genome sequence allows the ®rst
global human±mouse comparison in which human physical dis-
tances can be measured in Mb, rather than cM or orthologous gene
counts. We identi®ed likely orthologues by reciprocal comparison
of the human and mouse mRNAs in the LocusLink database, using
megaBLAST. For each orthologous pair, we mapped the location of
the human gene in the draft genome sequence and then checked the
location of the mouse gene in the Mouse Genome Informatics
database (http://www.informatics.jax.org). Using a conservative
threshold, we identi®ed 3,920 orthologous pairs in which the
human gene could be mapped on the draft genome sequence with
high con®dence. Of these, 2,998 corresponding mouse genes had a
known position in the mouse genome. We then searched for
de®nitive conserved segments, de®ned as human regions containing
orthologues of at least two genes from the same mouse chromosome
region (, 15 cM) without interruption by segments from other
chromosomes.
We identi®ed 183 de®nitive conserved segments (Fig. 46). The
average segment length was 15.4 Mb, with the largest segment being
90.5 Mb and the smallest 24 kb. There were also 141 `singletons',
segments that contained only a single locus; these are not counted in
the statistics. Although some of these could be short conserved
segments, they could also re¯ect incorrect choices of orthologues or
problems with the human or mouse maps. Because of this con-
servative approach, the observed number of de®nitive segments is
likely be lower than the correct total. One piece of evidence for this
conclusion comes from a more detailed analysis on human chro-
mosome 7 (ref. 358), which identi®ed 20 conserved segments, of
which three were singletons. Our analysis revealed only 13 de®nitive
segments on this chromosome, with nine singletons.
The frequency of observing a particular gene count in a conserved
segment is plotted on a logarithmic scale in Fig. 47. If chromosomal
breaks occur in a random fashion (as has been proposed) and
differences in gene density are ignored, a roughly straight line
should result. There is a clear excess for n = 1, suggesting that 50%
or more of the singletons are indeed artefactual. Thus, we estimate
that true number of conserved segments is around 190±230, in good
agreement with the original Nadeau±Taylor prediction354.
Figure 48 shows a plot of the frequency of lengths of conserved
segments, where the x-axis scale is shown in Mb. As before, there is a
fair amount of scatter in the data for the larger segments (where the
numbers are small), but the trend appears to be consistent with a
random breakage model.
We attempted to ascertain whether the breakpoint regions have
any special characteristics. This analysis was complicated by impre-
cision in the positioning of these breaks, which will tend to blur any
relationships. With 2,998 orthologues, the average interval within
which a break is known to have occurred is about 1.1 Mb. We
compared the aggregate features of these breakpoint intervals with
the genome as a whole. The mean gene density was lower in
breakpoint regions than in the conserved segments (13.8 versus
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Figure 44 Relative expansions of protein families between human and ¯y. These data
have not been normalized for proteomic size differences. Blue line, equality between
normalized family sizes in the two organisms. Green line, equality between unnormalized
family sizes. Numbered InterPro entries: (1) immunoglobulin domain [IPR003006]; (2) zinc
®nger, C2H2 type [IPR000822]; (3) eukaryotic protein kinase [IPR000719]; (4) rhodopsin-
like GPCR superfamily [IPR000276]; (5) ATP/GTP-binding site motif A (P-loop)
[IPR001687]; (6) reverse transcriptase (RNA-dependent DNA polymerase) [IPR000477];
(7) RNA-binding region RNP-1 (RNA recognition motif) [IPR000504]; (8) G-proteinb WD-
40 repeats [IPR001680]; (9) ankyrin repeat [IPR002110]; (10) homeobox domain
[IPR001356]; (11) PH domain [IPR001849]; (12) EF-hand family [IPR002048]; (13) EGF-
like domain [IPR000561]; (14) Src homology 3 (SH3) domain [IPR001452]; (15) RING
®nger [IPR001841]; (16) KRAB box [IPR001909]; (17) leucine-rich repeat [IPR001611];
(18) ®bronectin type III domain [IPR001777]; (19) PDZ domain (also known as DHR or
GLGF) [IPR001478]; (20) TPR repeat [IPR001440]; (21) helicase C-terminal domain
[IPR001650]; (22) ion transport protein [IPR002216]; (23) helix±loop±helix DNA-binding
domain [IPR001092]; (24) cadherin domain [IPR002126]; (25) intermediate ®lament
proteins [IPR001664]; (26) C2 domain [IPR000008]; (27) Src homology 2 (SH2) domain
[IPR000980]; (28) serine proteases, trypsin family [IPR001254]; (29) BTB/POZ domain
[IPR000210]; (30) tyrosine-speci®c protein phosphatase and dual speci®city protein
phosphatase family [IPR000387]; (31) collagen triple helix repeat [IPR000087]; (32)
esterase/lipase/thioesterase [IPR000379]; (33) neutral zinc metallopeptidases, zinc-
binding region [IPR000130]; (34) ATP-binding transport protein, 2nd P-loop motif
[IPR001051]; (35) ABC transporters family [IPR001617]; (36) cytochrome P450 enzyme
[IPR001128]; (37) insect cuticle protein [IPR000618].
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18.6 per Mb). This suggests that breakpoints may be more likely to
occur or to undergo ®xation in gene-poor intervals than in gene-
rich intervals. The occurrence of breakpoints may be promoted by
homologous recombination among repeated sequences359. When
the sequence of the mouse genome is ®nished, this analysis can be
revisited more precisely.
A number of examples of extended conserved segments and
syntenies are apparent in Fig. 46. As has been noted, almost all
human genes on chromosome 17 are found on mouse chromosome
11, with two members of the placental lactogen family from mouse
13 inserted. Apart from two singleton loci, human chromosome 20
appears to be entirely orthologous to mouse chromosome 2,
apparently in a single segment. The largest apparently contiguous
conserved segment in the human genome is on chromosome 4,
including roughly 90.5 Mb of human DNA that is orthologous to
mouse chromosome 5. This analysis also allows us to infer the likely
location of thousands of mouse genes for which the human
orthologue has been located in the draft genome sequence but the
mouse locus has not yet been mapped.
With about 200 conserved segments between mouse and human
and about 100 Myr of evolution from their common ancestor360, we
obtain an estimated rate of about 1.0 chromosomal rearrangement
being ®xed per Myr. However, there is good evidence that the rate of
chromosomal rearrangement (like the rate of nucleotide substitu-
tions; see above) differs between the two species. Among mammals,
rodents may show unusually rapid chromosome alteration. By
comparison, very few rearrangements have been observed among
primates, and studies of a broader array of mammalian orders,
including cats, cows, sheep and pigs, suggest an average rate of
chromosome alteration of only about 0.2 rearrangements per Myr
in these lineages361. Additional evidence that rodents are outliers
comes from a recent analysis of synteny between the human and
zebra®sh genomes. From a study of 523 orthologues, it was possible
to project 418 conserved segments350. Assuming 400 Myr since a
common vertebrate ancestor of zebra®sh and humans362, we obtain
an estimate of 0.52 rearrangements per Myr. Recent estimates of
rearrangement rates in plants have suggested bimodality, with some
pairs showing rates of 0.15±0.41 rearrangements per Myr, and
others showing higher rates of 1.1±1.3 rearrangements per Myr363.
With additional detailed genome maps of multiple species, it should
be possible to determine whether this particular molecular clock is
truly operating at a different rate in various branches of the
evolutionary tree, and whether variations in that rate are bimodal
or continuous. It should also be possible to reconstruct the karyo-
types of common ancestors.
Ancient duplicated segments in the human genome
Another approach to genomic history is to study segmental dupli-
cations within the human genome. Earlier, we discussed examples
of recent duplications of genomic segments to pericentromeric and
subtelomeric regions. Most of these events appear to be evolution-
ary dead-ends resulting in nonfunctional pseudogenes; however,
segmental duplication is also an important mode of evolutionary
innovation: a duplication permits one copy of each gene to drift and
potentially to acquire a new function.
Segmental duplications can occur through unequal crossing over
to create gene families in speci®c chromosomal regions. This
mechanism can create both small families, such as the ®ve related
genes of the b-globin cluster on chromosome 11, and large ones,
such as the olfactory receptor gene clusters, which together contain
nearly 1,000 genes and pseudogenes.
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Figure 45 Lineage-speci®c expansions of domains and architectures of transcription
factors. Top, speci®c families of transcription factors that have been expanded in each of
the proteomes. Approximate numbers of domains identi®ed in each of the (nearly)
complete proteomes representing the lineages are shown next to the domains, and some
of the most common architectures are shown. Some are shared by different animal
lineages; others are lineage-speci®c. Bottom, samples of architectures from transcription
factors that are shared by all animals (ancient architectures), shared by ¯y and human and
unique to each lineage. Domains: K, kelch; HD, homeodomain; Zn, zinc-binding domain;
LB, ligand-binding domain; C4DM, novel Zn cluster with four cysteines, probably involved
in protein±protein interactions (L. Aravind, unpublished); MATH, meprin-associated TRAF
domain; CG-1, novel domain in KIAA0909-like transcription factors (L. Aravind,
unpublished); MTF, myelin transcription factor domain; SAZ, specialized Myb-like helix-
turn-helix (HTH) domain found in Stonewall, ADF-1 and Zeste (L. Aravind, unpublished); A,
AT-hook motif; E2F, winged HTH DNA-binding domain; GHL, gyraseB-histidine kinase-
MutL ATPase domain; ATX, ATaXin domain; RFX, RFX winged HTH DNA binding domain;
My, MYND domain; KDWK, KDWK DNA-binding domain; POZ, Pox zinc ®nger domain; S,
SAP domain; P53F, P53 fold domain; HF, histone fold; ANK, ankyrin repeat; TIG,
transcription factor Ig domain; SSRP, structure-speci®c recognition protein domain; C5,
5-cysteine metal binding domain; C2H2, classic zinc ®nger domain; WD, WD40 repeats.
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The most extreme mechanism is whole-genome duplication
(WGD), through a polyploidization event in which a diploid
organism becomes tetraploid. Such events are classi®ed as autopo-
lyploidy or allopolyploidy, depending on whether they involve
hybridization between members of the same species or different
species. Polyploidization is common in the plant kingdom, with
many known examples among wild and domesticated crop species.
Alfalfa (Medicago sativa) is a naturally occurring autotetraploid364,
and Nicotiana tabacum, some species of cotton (Gossypium) and
several of the common brassicas are allotetraploids containing pairs
of `homeologous' chromosome pairs.
In principle, WGD provides the raw material for great bursts of
innovation by allowing the duplication and divergence of entire
pathways. Ohno365 suggested that WGD has played a key role in
evolution. There is evidence for an ancient WGD event in the
ancestry of yeast and several independent such events in the ancestry
of mustard weed366±369. Such ancient WGD events can be hard to
detect because only a minority of the duplicated loci may be
retained, with the result that the genes in duplicated segments
cannot be aligned in a one-to-one correspondence but rather
require many gaps. In addition, duplicated segments may be
subsequently rearranged. For example, the ancient duplication in
the yeast genome appears to have been followed by loss of more than
90% of the newly duplicated genes366.
One of the most controversial hypotheses about vertebrate
evolution is the proposal that two WGD events occurred early in
the vertebrate lineage, around the time of jawed ®shes some 500 Myr
ago. Some authors370±373 have seen support for this theory in the fact
that many human genes occur in sets of four homologuesÐmost
notably the four extensive HOX gene clusters on chromosomes 2, 7,
12 and 17, whose duplication dates to around the correct time.
However, other authors have disputed this interpretation374,
suggesting that these cases may re¯ect unrelated duplications of
speci®c regions rather than successive WGD.
We analysed the draft genome sequence for evidence that might
bear on this question. The analysis provides many interesting
observations, but no convincing evidence of ancient WGD. We
looked for evidence of pairs of chromosomal regions containing
many homologous genes. Although we found many pairs contain-
ing a few homologous genes, the human genome does not appear to
contain any pairs of regions where the density of duplicated genes
approaches the densities seen in yeast or mustard weed366±369.
We also examined human proteins in the IPI for which the
orthologues among ¯y or worm proteins occur in the ratios 2:1:1,
3:1:1, 4:1:1 and so on (Fig. 49). The number of such families falls
smoothly, with no peak at four and some instances of ®ve or more
homologues. Although this does not rule out two rounds of WGD
followed by extensive gene loss and some unrelated gene duplica-
tion, it provides no support for the theory. More probatively, if two
successive rounds of genome duplication occurred, phylogenetic
analysis of the proteins having 4:1:1 ratios between human, ¯y and
worm would be expected to show more trees with the topology
(A,B)(C,D) for the human sequences than (A,(B,(C,D)))375. How-
ever, of 57 sets studied carefully, only 24% of the trees constructed
from the 4:1:1 set have the former topology; this is not signi®cantly
different from what would be expected under the hypothesis of
random sequential duplication of individual loci.
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Figure 46 Conserved segments in the human and mouse genome. Human
chromosomes, with segments containing at least two genes whose order is conserved in
the mouse genome as colour blocks. Each colour corresponds to a particular mouse
chromosome. Centromeres, subcentromeric heterochromatin of chromosomes 1, 9 and
16, and the repetitive short arms of 13, 14, 15, 21 and 22 are in black.
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Figure 48 Distribution of lengths (in 5-Mb bins) of conserved segments between human
and mouse genomes, omitting singletons.
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Figure 47 Distribution of number of genes per conserved segment between human and
mouse genomes.
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We also searched for sets of four chromosomes where there are
multiple genes with homologues on each of the four. The strongest
example was chromosomes 2, 7, 12 and 17, containing the HOX
clusters as well as additional genes. These four chromosomes appear
to have an excess of quadruplicated genes. The genes are not all
clustered in a single region; this may re¯ect intrachromosomal
rearrangement since the duplication of these genes, or it may
indicate that they result from several independent events. Of the
genes with homologues on chromosomes 2, 12 and 17, many of
those missing on chromosome 7 are clustered on chromosome 3,
suggesting a translocation. Several additional examples of groups of
four chromosomes were found, although they were connected by
fewer homologous genes.
Although the analyses are sensitive to the imperfect quality of the
gene predictions, our results so far are insuf®cient to settle whether
two rounds of WGD occurred around 500 Myr ago. It may be
possible to resolve the issue by systematically estimating the time of
each of the many gene duplication events on the basis of sequence
divergence, although this is beyond the scope of this report. Another
approach to determining whether a widespread duplication
occurred at a particular time in vertebrate evolution would be to
sequence the genomes of organisms whose lineages diverged from
vertebrates at appropriate times, such as amphioxus.
Recent history from human polymorphism
The recent history of genomic segments can be probed by studying
the properties of SNPs segregating in the current human popula-
tion. The sequence information generated in the course of this
project has yielded a huge collection of SNPs. These SNPs were
extracted in two ways: by comparing overlapping large-insert clones
derived from distinct haplotypes (either different individuals or
different chromosomes within an individual) and by comparing
random reads from whole-genome shotgun libraries derived from
multiple individuals. The analysis con®rms an average heterozyg-
osity rate in the human population of about 1 in 1,300 bp (ref. 97).
More than 1.42 million SNPs have been assembled into a
genome-wide map and are analysed in detail in an accompanying
paper97. SNP density is also displayed across the genome in Fig. 9.
The SNPs have an average spacing of 1.9 kb and 63% of 5-kb
intervals contain a SNP. These polymorphisms are of immediate
utility for medical genetic studies. Whereas investigators studying a
gene previously had to expend considerable effort to discover
polymorphisms across the region of interest, the current collection
now provides then with about 15 SNPs for gene loci of average size.
The density of SNPs (adjusted for ascertainmentÐthat is, poly-
morphisms per base screened) varies considerably across the
genome97 and sheds light on the unique properties and history of
each genomic region. The average heterozygosity at a locus will
tend to increase in proportion to the local mutation rate and the
`age' of the locus (which can be de®ned as the average number of
generations since the most recent common ancestor of two ran-
domly chosen copies in the population). For example, positive
selection can cause a locus to be unusually `young' and balancing
selection can cause it to be unusually `old'. An extreme example is
the HLA region, in which a high SNP density is observed, re¯ecting
the fact that diverse HLA haplotypes have been maintained for
many millions of years by balancing selection and greatly predate
the origin of the human species.
SNPs can also be used to study linkage disequilibrium in the
human genome376. Linkage disequilibrium refers to the persistence
of ancestral haplotypesÐthat is, genomic segments carrying parti-
cular combinations of alleles descended from a common ancestor. It
can provide a powerful tool for mapping disease genes377,378 and for
probing population history379±381. There has been considerably
controversy concerning the typical distance over which linkage
disequilibrium extends in the human genome382±387. With the
collection of SNPs now available, it should be possible to resolve
this important issue.
Applications to medicine and biology
In most research papers, the authors can only speculate about future
applications of the work. Because the genome sequence has been
released on a daily basis over the past four years, however, we can
already cite many direct applications. We focus on a handful of
applications chosen primarily from medical research.
Disease genes
A key application of human genome research has been the ability to
®nd disease genes of unknown biochemical function by positional
cloning388. This method involves mapping the chromosomal region
containing the gene by linkage analysis in affected families and then
scouring the region to ®nd the gene itself. Positional cloning is
powerful, but it has also been extremely tedious. When the
approach was ®rst proposed in the early 1980s9, a researcher wishing
to perform positional cloning had to generate genetic markers to
trace inheritance; perform chromosomal walking to obtain genomic
DNA covering the region; and analyse a region of around 1 Mb by
either direct sequencing or indirect gene identi®cation methods.
The ®rst two barriers were eliminated with the development in the
mid-1990s of comprehensive genetic and physical maps of the
human chromosomes, under the auspices of the Human Genome
Project. The remaining barrier, however, has continued to be
formidable.
All that is changing with the availability of the human draft
genome sequence. The human genomic sequence in public data-
bases allows rapid identi®cation in silico of candidate genes, fol-
lowed by mutation screening of relevant candidates, aided by
information on gene structure. For a mendelian disorder, a gene
search can now often be carried out in a matter of months with only
a modestly sized team.
At least 30 disease genes55,389±422 (Table 26) have been positionally
cloned in research efforts that depended directly on the publicly
available genome sequence. As most of the human sequence has
only arrived in the past twelve months, it is likely that many similar
discoveries are not yet published. In addition, there are many cases
in which the genome sequence played a supporting role, such as
providing candidate microsatellite markers for ®ner genetic linkage
analysis.
The genome sequence has also helped to reveal the mechanisms
leading to some common chromosomal deletion syndromes. In
several instances, recurrent deletions have been found to result from
homologous recombination and unequal crossing over between
large, nearly identical intrachromosomal duplications. Examples
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Figure 49 Number of human paralogues of genes having single orthologues in worm and
¯y.
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include the DiGeorge/velocardiofacial syndrome region on chro-
mosome 22 (ref. 238) and the Williams±Beuren syndrome recur-
rent deletion on chromosome 7 (ref. 239).
The availability of the genome sequence also allows rapid identi-
®cation of paralogues of disease genes, which is valuable for two
reasons. First, mutations in a paralogous gene may give rise to a
related genetic disease. A good example, discovered through use of
the genome sequence, is achromatopsia (complete colour blind-
ness). The CNGA3 gene, encoding the a-subunit of the cone
photoreceptor cyclic GMP-gated channel, had been shown to
harbour mutations in some families with achromatopsia. Compu-
tational searching of the genome sequences revealed the paralogous
gene encoding the corresponding b-subunit, CNGB3 (which had
not been apparent from EST databases). The CNGB3 gene was
rapidly shown to be the cause of achromatopsia in other
families407,408. Another example is provided by the presenilin-1
and presenilin-2 genes, in which mutations can cause early-onset
Alzheimer's disease423,424. Second, the paralogue may provide an
opportunity for therapeutic intervention, as exempli®ed by
attempts to reactivate the fetally expressed haemoglobin genes in
individuals with sickle cell disease or b-thalassaemia, caused by
mutations in the b-globin gene425.
We undertook a systematic search for paralogues of 971 known
human disease genes with entries in both the Online Mendelian
Inheritance in Man (OMIM) database (http://www.ncbi.nlm.nih.
gov/Omim/) and either the SwissProt or TrEMBL protein databases.
We identi®ed 286 potential paralogues (with the requirement of a
match of at least 50 amino acids with identity greater than 70% but
less than 90% if on the same chromosome, and less than 95% if on a
different chromosome). Although this analysis may have identi®ed
some pseudogenes, 89% of the matches showed homology over
more than one exon in the new target sequence, suggesting that
many are functional. This analysis shows the potential for rapid
identi®cation of disease gene paralogues in silico.
Drug targets
Over the past century, the pharmaceutical industry has largely
depended upon a limited set of drug targets to develop new
therapies. A recent compendium426,427 lists 483 drug targets as
accounting for virtually all drugs on the market. Knowing the
complete set of human genes and proteins will greatly expand the
search for suitable drug targets. Although only a minority of human
genes may be drug targets, it has been predicted that the number will
exceed several thousand, and this prospect has led to a massive
expansion of genomic research in pharmaceutical research and
development. A few examples will illustrate the point.
(1) The neurotransmitter serotonin (5-HT) mediates rapid excita-
tory responses through ligand-gated channels. The previously
identi®ed 5-HT3A receptor gene produces functional receptors,
but with a much smaller conductance than observed in vivo.
Cross-hybridization experiments and analysis of ESTs failed to
reveal any other homologues of the known receptor. Recently,
however, by searching the human draft genome sequence at low
stringency, a putative homologue was identi®ed within a PAC clone
from the long arm of chromosome 11 (ref. 428). The homologue
was shown to be expressed in the amygdala, caudate and hippo-
campus, and a full-length cDNA was subsequently obtained. The
gene, which codes for a serotonin receptor, was named 5-HT3B.
When assembled in a heterodimer with 5-HT3A, it was shown to
account for the large-conductance neuronal serotonin channel.
Given the central role of the serotonin pathway in mood disorders
and schizophrenia, the discovery of a major new therapeutic target
is of considerable interest.
(2) The contractile and in¯ammatory actions of the cysteinyl
leukotrienes, formerly known as the slow reacting substance of
anaphylaxis (SRS-A), are mediated through speci®c receptors. The
second such receptor, CysLT2, was identi®ed using the combination
of a rat EST and the human genome sequence. This led to the
cloning of a gene with 38% amino-acid identity to the only other
receptor that had previously been identi®ed429. This new receptor,
which shows high-af®nity binding to several leukotrienes, maps to a
region of chromosome 13 that is linked to atopic asthma. The gene
is expressed in airway smooth muscles and in the heart. As the
leukotriene pathway has been a signi®cant target for the develop-
ment of drugs against asthma, the discovery of a new receptor has
obvious and important consequences.
(3) Abundant deposition of b-amyloid in senile plaques is the
hallmark of Alzheimer's disease. b-Amyloid is generated by pro-
teolytic processing of the amyloid precursor protein (APP). One of
the enzymes involved is the b-site APP-cleaving enzyme (BACE),
which is a transmembrane aspartyl protease. Computational
searching of the public human draft genome sequence recently
identi®ed a new sequence homologous to BACE, encoding a protein
now named BACE2430,431. BACE2, which has 52% amino-acid
sequence identity to BACE, contains two active protease sites and
maps to the obligatory Down's syndrome region of chromosome 21,
as does APP. This raises the question of whether the extra copies of
both BACE2 and APP may contribute to accelerated deposition of
b-amyloid in the brains of Down's syndrome patients. The devel-
opment of antagonists to BACE and BACE2 represents a promising
approach to preventing Alzheimer's disease.
Given these examples, we undertook a systematic effort to
identify paralogues of the classic drug target proteins in the draft
genome sequence. The target list427 was used to identify 603 entries
in the SwissProt database with unique accession numbers. These
were then searched against the current genome sequence database,
using the requirement that a match should have 70±100% identity
to at least 50 amino acids. Matches to named proteins were ignored,
as we assumed that these represented known homologues.
We found 18 putative novel paralogues (Table 27), including
apparent dopamine receptors, purinergic receptors and insulin-like
growth factor receptors. In six cases, the novel paralogue matches at
least one EST, adding con®dence that this search process can
identify novel functional genes. For the remaining 12 putative
paralogues without an EST match, all have long ORFs and all but
articles
912 NATURE | VOL 409 | 15 FEBRUARY 2001 | www.nature.com
Table 26 Disease genes positionally cloned using the draft genome
sequence
Locus Disorder Reference(s)
BRCA2 Breast cancer susceptibility 55
AIRE Autoimmune polyglandular syndrome type 1 (APS1
or APECED)
389
PEX1 Peroxisome biogenesis disorder 390, 391
PDS Pendred syndrome 392
XLP X-linked lymphoproliferative disease 393
DFNA5 Nonsyndromic deafness 394
ATP2A2 Darier's disease 395
SEDL X-linked spondyloepiphyseal dysplasia tarda 396
WISP3 Progressive pseudorheumatoid dysplasia 397
CCM1 Cerebral cavernous malformations 398, 399
COL11A2/DFNA13 Nonsyndromic deafness 400
LGMD 2G Limb-girdle muscular dystrophy 401
EVC Ellis-Van Creveld syndrome, Weyer's acrodental
dysostosis
402
ACTN4 Familial focal segmental glomerulosclerosis 403
SCN1A Generalized epilepsy with febrile seizures plus type 2 404
AASS Familial hyperlysinaemia 405
NDRG1 Hereditary motor and sensory neuropathy-Lom 406
CNGB3 Total colour-blindness 407, 408
MUL Mulibrey nanism 409
USH1C Usher type 1C 410, 411
MYH9 May-Hegglin anomaly 412, 413
PRKAR1A Carney's complex 414
MYH9 Nonsyndromic hereditary deafness DFNA17 415
SCA10 Spinocerebellar ataxia type 10 416
OPA1 Optic atrophy 417
XLCSNB X-linked congenital stationary night blindness 418
FGF23 Hypophosphataemic rickets 419
GAN Giant axonal neuropathy 420
AAAS Triple-A syndrome 421
HSPG2 Schwartz-Jampel syndrome 422
.............................................................................................................................................................................
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one show similarity spanning multiple exons separated by introns,
so these are not processed pseudogenes. They are likely to represent
interesting new candidate drug targets.
Basic biology
Although the examples above re¯ect medical applications, there are
also many similar applications to basic physiology and cell biology.
To cite one satisfying example, the publicly available sequence was
used to solve a mystery that had vexed investigators for several
decades: the molecular basis of bitter taste432. Humans and other
animals are polymorphic for response to certain bitter tastes.
Recently, investigators mapped this trait in both humans and
mice and then searched the relevant region of the human draft
genome sequence for G-protein coupled receptors. These studies
led, in quick succession, to the discovery of a new family of such
proteins, the demonstration that they are expressed almost exclu-
sively in taste buds, and the experimental con®rmation that the
receptors in cultured cells respond to speci®c bitter substances433±435.
The next steps
Considerable progress has been made in human sequencing, but
much remains to be done to produce a ®nished sequence. Even
more work will be required to extract the full information contained
in the sequence. Many of the key next steps are already underway.
Finishing the human sequence
The human sequence will serve as a foundation for biomedical
research in the years ahead, and it is thus crucial that the remaining
gaps be ®lled and ambiguities be resolved as quickly as possible. This
will involve a three-step program.
The ®rst stage involves producing ®nished sequence from clones
spanning the current physical map, which covers more than 96% of
the euchromatic regions of the genome. About 1 Gb of ®nished
sequence is already completed. Almost all of the remaining clones
are already sequenced to at least draft coverage, and the rest have
been selected for sequencing. All clones are expected to reach `full
shotgun' coverage (8±10-fold redundancy) by about mid-2001 and
®nished form (99.99% accuracy) not long thereafter, using estab-
lished and increasingly automated protocols.
The next stage will be to screen additional libraries to close gaps
between clone contigs. Directed probing of additional large-insert
clone libraries should close many of the remaining gaps. Unclosed
gaps will be sized by FISH techniques or other methods. Two
chromosomes, 22 and 21, have already been assembled in this
`essentially complete' form in this manner93,94, and chromosomes
20, Y, 19, 14 and 7 are likely to reach this status in the next few
months. All chromosomes should be essentially completed by 2003,
if not sooner.
Finally, techniques must be developed to close recalcitrant gaps.
Several hundred such gaps in the euchromatic sequence will
probably remain in the genome after exhaustive screening of
existing large-insert libraries. New methodologies will be needed
to recover sequence from these segments, and to de®ne biological
reasons for their lack of representation in standard libraries. Ideally,
it would be desirable to obtain complete sequence from all hetero-
chromatic regions, such as centromeres and ribosomal gene clus-
ters, although most of this sequence will consist of highly
polymorphic tandem repeats containing few protein-coding genes.
Developing the IGI and IPI
The draft genome sequence has provided an initial look at the
human gene content, but many ambiguities remain. A high priority
will be to re®ne the IGI and IPI to the point where they accurately
re¯ect every gene and every alternatively spliced form. Several steps
are needed to reach this ambitious goal.
Finishing the human sequence will assist in this effort, but the
experiences gained on chromosomes 21 and 22 show that sequence
alone is not enough to allow complete gene identi®cation. One
powerful approach is cross-species sequence comparison with
related organisms at suitable evolutionary distances. The sequence
coverage from the puffer®sh T. nigroviridis has already proven
valuable in identifying potential exons292; this work is expected to
continue from its current state of onefold coverage to reach at least
®vefold coverage later this year. The genome sequence of the
laboratory mouse will provide a particularly powerful tool for
exon identi®cation, as sequence similarity is expected to identify
95±97% of the exons, as well as a signi®cant number of regulatory
domains436±438. A public-private consortium is speeding this effort,
by producing freely accessible whole-genome shotgun coverage that
can be readily used for cross-species comparison439. More than
onefold coverage from the C57BL/6J strain has already been
completed and threefold is expected within the next few months.
In the slightly longer term, a program is under way to produce a
®nished sequence of the laboratory mouse.
Another important step is to obtain a comprehensive collection
of full-length human cDNAs, both as sequences and as actual clones.
The Mammalian Gene Collection project has been underway for a
year18 and expects to produce 10,000±15,000 human full-length
cDNAs over the coming year, which will be available without
restrictions on use. The Genome Exploration Group of the
RIKEN Genomic Sciences Center is similarly developing a collec-
tion of cDNA clones from mouse309, which is a valuable complement
articles
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Table 27 New paralogues of common drug targets identi®ed by searching the draft human genome sequence












Aquaporin 7 AQP7 O14520 9 IGI_M1_ctg15869_11 2 92.3 AW593324
Arachidonate 12-lipoxygenase ALOX12 P18054 17 IGI_M1_ctg17216_23 17 70.1
Calcitonin CALCA P01258 11 IGI_M1_ctg14138_20 12 93.6
Calcium channel, voltage-dependent, g-subunit CACNG2 Q9Y698 22 IGI_M1_ctg17137_10 19 70.7
DNA polymerase-d, small subunit POLD2 P49005 7 IGI_M1_ctg12903_29 5 86.8
Dopamine receptor, D1-a DRD1 P21728 5 IGI_M1_ctg25203_33 16 70.7
Dopamine receptor, D1-b DRD5 P21918 4 IGI_M1_ctg17190_14 1 88.0 AI148329
Eukaryotic translation elongation factor, 1d EEF1D P29692 2 IGI_M1_ctg16401_37 17 77.6 BE719683
FKBP, tacrolimus binding protein, FK506 binding protein FKBP1B Q16645 2 IGI_M1_ctg14291_56 6 79.4
Glutamic acid decarboxylase GAD1 Q99259 2 IGI_M1_ctg12341_103 18 70.5
Glycine receptor, a1 GLRA1 P23415 5 IGI_M1_ctg16547_14 X 85.5
Heparan N-deacetylase/N-sulphotransferase NDST1 P52848 5 IGI_M1_ctg13263_18 4 81.5
Insulin-like growth factor-1 receptor IGF1R P08069 15 IGI_M1_ctg18444_3 19 71.8
Na,K-ATPase, a-subunit ATP1A1 P05023 1 IGI_M1_ctg14877_54 1 83
Purinergic receptor 7 (P2X), ligand-gated ion channel P2RX7 Q99572 12 IGI_M1_ctg15140_15 12 80.3 H84353
Tubulin, e-chain TUBE* Q9UJT0 6 IGI_M1_ctg13826_4 5 78.5 AA970498
Tubulin, x-chain TUBG1 P23258 17 IGI_M1_ctg12599_5 7 84.0
Voltage-gated potassium channel, KV3.3 KCNC3 Q14003 19 IGI_M1_ctg13492_5 12 80.1 H49142
...................................................................................................................................................................................................................................................................................................................................................................
* HGM symbol unknown.
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because of the availability of tissues from all developmental time
points. A challenge will be to de®ne the gene-speci®c patterns of
alternative splicing, which may affect half of human genes. Existing
collections of ESTs and cDNAs may allow identi®cation of the most
abundant of these isoforms, but systematic exploration of this
problem may require exhaustive analysis of cDNA libraries from
multiple tissues or perhaps high-throughput reverse transcription±
PCR studies. Deep understanding of gene function will probably
require knowledge of the structure, tissue distribution and abun-
dance of these alternative forms.
Large-scale identi®cation of regulatory regions
The one-dimensional script of the human genome, shared by
essentially all cells in all tissues, contains suf®cient information to
provide for differentiation of hundreds of different cell types, and
the ability to respond to a vast array of internal and external
in¯uences. Much of this plasticity results from the carefully orche-
strated symphony of transcriptional regulation. Although much has
been learned about the cis-acting regulatory motifs of some speci®c
genes, the regulatory signals for most genes remain uncharacterized.
Comparative genomics of multiple vertebrates offers the best hope
for large-scale identi®cation of such regulatory sites440. Previous
studies of sequence alignment of regulatory domains of ortho-
logous genes in multiple species has shown a remarkable
correlation between sequence conservation, dubbed `phylogenetic
footprints'441, and the presence of binding motifs for transcription
factors. This approach could be particularly powerful if combined
with expression array technologies that identify cohorts of genes
that are coordinately regulated, implicating a common set of cis-
acting regulatory sequences442±445. It will also be of considerable
interest to study epigenetic modi®cations such as cytosine methyla-
tion on a genome-wide scale, and to determine their biological
consequences446,447. Towards this end, a pilot Human Epigenome
Project has been launched448,449.
Sequencing of additional large genomes
More generally, comparative genomics allows biologists to peruse
evolution's laboratory notebookÐto identify conserved functional
features and recognize new innovations in speci®c lineages. Deter-
mination of the genome sequence of many organisms is very
desirable. Already, projects are underway to sequence the genomes
of the mouse, rat, zebra®sh and the puffer®shes T. nigroviridis and
Takifugu rubripes. Plans are also under consideration for sequencing
additional primates and other organisms that will help de®ne key
developments along the vertebrate and nonvertebrate lineages.
To realize the full promise of comparative genomics, however, it
needs to become simple and inexpensive to sequence the genome of
any organism. Sequencing costs have dropped 100-fold over the last
10 years, corresponding to a roughly twofold decrease every 18
months. This rate is similar to `Moore's law' concerning improve-
ments in semiconductor manufacture. In both sequencing and
semiconductors, such improvement does not happen automatically,
but requires aggressive technological innovation fuelled by major
investment. Improvements are needed to move current dideoxy
sequencing to smaller volumes and more rapid sequencing
times, based upon advances such as microchannel technology.
More revolutionary methods, such as mass spectrometry, single-
molecule sequencing and nanopore approaches76, have not yet
been fully developed, but hold great promise and deserve strong
encouragement.
Completing the catalogue of human variation
The human draft genome sequence has already allowed the identi-
®cation of more than 1.4 million SNPs, comprising a substantial
proportion of all common human variation. This program should
be extended to obtain a nearly complete catalogue of common
variants and to identify the common ancestral haplotypes present in
the population. In principle, these genetic tools should make it
possible to perform association studies and linkage disequilibrium
studies376 to identify the genes that confer even relatively modest risk
for common diseases. Launching such an intense era of human
molecular epidemiology will also require major advances in the cost
ef®ciency of genotyping technology, in the collection of carefully
phenotyped patient cohorts and in statistical methods for relating
large-scale SNP data to disease phenotype.
From sequence to function
The scienti®c program outlined above focuses on how the genome
sequence can be mined for biological information. In addition, the
sequence will serve as a foundation for a broad range of functional
genomic tools to help biologists to probe function in a more
systematic manner. These will need to include improved techniques
and databases for the global analysis of: RNA and protein expres-
sion, protein localization, protein±protein interactions and chemi-
cal inhibition of pathways. New computational techniques will be
needed to use such information to model cellular circuitry. A full
discussion of these important directions is beyond the scope of this
paper.
Concluding thoughts
The Human Genome Project is but the latest increment in a
remarkable scienti®c program whose origins stretch back a hundred
years to the rediscovery of Mendel's laws and whose end is nowhere
in sight. In a sense, it provides a capstone for efforts in the past
century to discover genetic information and a foundation for efforts
in the coming century to understand it.
We ®nd it humbling to gaze upon the human sequence now
coming into focus. In principle, the string of genetic bits holds long-
sought secrets of human development, physiology and medicine. In
practice, our ability to transform such information into under-
standing remains woefully inadequate. This paper simply records
some initial observations and attempts to frame issues for future
study. Ful®lling the true promise of the Human Genome Project will
be the work of tens of thousands of scientists around the world, in
both academia and industry. It is for this reason that our highest
priority has been to ensure that genome data are available rapidly,
freely and without restriction.
The scienti®c work will have profound long-term consequences
for medicine, leading to the elucidation of the underlying molecular
mechanisms of disease and thereby facilitating the design in many
cases of rational diagnostics and therapeutics targeted at those
mechanisms. But the science is only part of the challenge. We
must also involve society at large in the work ahead. We must set
realistic expectations that the most important bene®ts will not be
reaped overnight. Moreover, understanding and wisdom will be
required to ensure that these bene®ts are implemented broadly and
equitably. To that end, serious attention must be paid to the many
ethical, legal and social implications (ELSI) raised by the accelerated
pace of genetic discovery. This paper has focused on the scienti®c
achievements of the human genome sequencing efforts. This is not
the place to engage in a lengthy discussion of the ELSI issues, which
have also been a major research focus of the Human Genome
Project, but these issues are of comparable importance and could
appropriately ®ll a paper of equal length.
Finally, it is has not escaped our notice that the more we learn
about the human genome, the more there is to explore.
`̀ We shall not cease from exploration. And the end of all our
exploring will be to arrive where we started, and know the place for
the ®rst time.''ÐT. S. Eliot450 M
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